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A commonly quoted axiom in protein biochemistry dictates that a protein’s primary amino acid sequence 
defines the structure of the protein and the structure consequently defines the function of a protein.  
 
Years of research in protein biochemistry and structure-function relationships have revealed that proteins 
populate various alternate and interchanging structures or conformations which are critical for their 
function. Protein dynamics describes the conformational switching in proteins with respect to time. A true 
understanding of the link coupling a protein’s average structure with its function can only be obtained by 




In this dissertation, I have primarily used structural mass spectrometry, in particular Amide 
Hydrogen/Deuterium Exchange Mass Spectrometry (HDXMS), to probe the conformational dynamics 
and allosteric effects of signaling proteins largely in the cAMP pathway. One of the main goals of my 
research is to understand how the cAMP pathway is regulated and terminated from a conformational 
dynamics perspective. Of primary interest is to define models on how allosteric effects on proteins 
correlate with protein function.  
cAMP (3’ 5’- cyclic adenosine monophosphate) is an important second messenger molecule that is 
involved in the regulation of a wide range of metabolic processes. The main receptor for the cAMP 
molecule in cells is the regulatory subunit of Protein Kinase A (PKAR). Inactive PKA in the absence of 
cAMP exists as a heterotetramer of two PKAR molecules each bound to an inactive catalytic kinase 
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subunit (PKAC) collectively termed as PKA holoenzyme. cAMP binding to PKAR causes an allosteric 
chain reaction which results in the PKAC molecule being released from the regulatory subunit. The 
PKAC enzyme once released is activated to carry out its role in phosphorylating numerous targets. Signal 
termination occurs only when the cAMP levels in the cell are depleted by the enzymatic activity of 
Phosphodiesterases (PDEs), which convert cAMP to AMP. Once cAMP levels are depleted the apo 
PKAR molecule binds the PKAC molecule and inactivates it. Though the cAMP pathway is a well-
studied pathway with crystallographic structures available for all end point states, the nature and 
dynamics of transition states are relatively unknown.  
In the first part of this study (Chapter 1), we were interested in probing the dynamics of the activation 
phase transition state complex. This transition state is a state where cAMP binds to the regulatory PKAR 
subunit while the PKAC molecule is simultaneously bound to it, in a transient ternary complex. To 
capture the ternary complex, a Thio-substituted cAMP analog, Rp-cAMPS, was used as a ligand. The Rp-
cAMPS molecule acts as an inverse agonist to cAMP and maintains the PKAR in the Holoenzyme 
conformation, thus a ternary complex of cAMP-PKAR-PKAC can be studied. Time dependent HDXMS 
was used to monitor the allosteric effects of ligand binding on PKA holoenzyme. Most allosteric events 
were observed on the PKAR molecule, but it was also observed that certain regions of the PKAC 
molecule also showed significant increases in conformational dynamics. Thus allosteric effects caused by 
ligand binding on one protein can propagate across the interaction interface to cause conformational 
changes in an interacting protein.  
The previous study provided insights into the conformational dynamics of the activation phase of the 
cAMP pathway. In the next part of this dissertation; I focus on the termination phase of the cAMP 
pathway. Most studies on the termination phase of the cAMP pathway assumed a passive role for 
Phosphodiesterases (PDEs), wherein PDEs deplete levels of free cAMP in the cell, but this model though 
did not adequately explain how cAMP that is bound to PKAR, dissociates from the ligand binding pocket. 
Recent studies with a PDE from Dictyostelium discoideum, RegA, revealed that cAMP signal termination 
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is initiated by direct interactions between RegA and PKAR. RegA binds to the cAMP binding pocket of 
PKAR and in a two-step process catalyzes the dissociation and hydrolysis of bound cAMP.   In this study 
(Chapter 2) we set out to monitor complex formation and cAMP dissociation, using a PDE-resistant 
sulphur substituted cAMP analog, Sp-cAMPS. Reaction monitoring of the PKAR-RegA interaction 
revealed that at high/saturating concentrations, a ternary complex of PKAR-SpcAMPS-RegA exists. 
When diluted, SpcAMPS dissociation from the complex was observed in a time dependent manner. 
While the previous studies on PDE-PKAR interactions were carried out using a mammalian PKAR and 
Dictyostelium PDE, RegA, the aim of this study (Chapter 3) was to ascertain whether PDE-PKAR 
interactions are conserved in mammalian systems, and to determine the mammalian homolog of RegA 
that interacts with PKAR. HDXMS and peptide array analysis were carried out on the PKAR-RegA 
interaction, to probe for the PKAR interacting interface on RegA. Positive ‘hits’ obtained from peptide 
array and regions that showed decreases in deuterium exchange from HDXMS were correlated to obtain a 
map of the binding region. Interestingly the regions that were involved in the interaction interface were 
regions around the catalytic pocket of RegA, particularly the M-loop which is involved in anchoring 
cAMP. Regions that show decreases in deuterium exchange in HDXMS but do not show hits in peptide 
array, are by direct inference, regions which show allosteric effects on PKAR binding. Such allosteric 
effects were observed at both the N and C termini, indicating that PKAR interaction may trigger allosteric 
effects of a regulatory nature. Bioinformatics analysis of the binding interface was carried out to identify 
the closest mammalian homolog. The catalytic pocket and the binding interface is highly conserved 
across all PDEs from all organisms, hence it is likely that all PDEs may undergo interactions with PKAR 
subunits. The closest mammalian homologs to RegA, based on primary sequence are PDE8 and PDE9. Of 
these PDE8 is a cAMP PDE similar to RegA and hence was chosen for further studies. Kinetic assays and 
HDXMS studies of PDE8-PKAR interactions revealed that the catalytic domain of PDE8A binds to 
PKAR and hydrolyzes cAMP bound to PKAR. The interaction interface on both PDE8A and PKAR is 
comprised of the active site of PDE8 interacting with the cAMP binding pocket of PKAR. The PKAR 
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used in this study contains two tandem cAMP binding domains, and it was seen that both domains 
showed significant decreases in deuterium exchange upon PDE8 binding. Computational docking was 
carried out based on HDXMS experimental data, and a model was obtained which showed active site 
coupling between a PDE8 dimer and the two tandem cAMP binding domains of PKAR. Active site 
coupling between PDE and PKAR provides a model to explain the cAMP pathway termination phase. 
In the fourth part (Chapter 4) of this study, we have aimed to apply knowledge gained from protein-
ligand interactions to develop a novel application for HDXMS in Fragment Based Drug Discovery. In this 
study, HDXMS was used to screen for weak affinity inhibitors and capture the allosteric effects that 
fragments molecules have on the target protein, HSP90. It was found that fragment molecules which have 
~10000 fold lower affinities than the natural ligands/inhibitors allosterically affect the same regions as 
that of the natural ligands. It was also seen that by using time series deuterium labeling, direct interaction 
effects can be clearly segregated from conformational stabilization effects. Since direct binding effects of 
small ligands are diffusion dependent, they are easily visualized in earlier deuterium exchange time 
points. Conformational stabilization effects are a product of ligand binding and are an accumulated effect; 
hence they occur at a slower rate than direct binding effects.  
In the final part (Chapter 5) of this study, we push the boundaries of HDXMS technology by applying it 
to biologically complex systems. The main aim of this final study was to derive biologically relevant 
conclusions, by probing the dynamics of complex systems by HDXMS. To this end two test systems were 
studies, 1) Allosteric effects in partially disordered proteins binding to DNA and 2) Capsid protein 
dynamics in viral maturation pathway. In the first example, we propose a model to describe the function 
of the partially disordered protein, H-NS (Heat stable nucleoid protein) based on its dynamic nature. H-
NS is a DNA binding protein which serves two functions in bacterial cells, it is involved in DNA 
packaging and also gene silencing, depending on the type of DNA it is binding and on the concentration 
of Mg2+ ions in the environment. It was found that H-NS exists in an ensemble of conformations, in the 
presence of high Mg2+ concentration or when it binds to a specific recognition motif; H-NS adopts a 
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single conformation and is stabilized. When it binds to a DNA fragment chosen at random, it adopts 
multiple conformations. Thus a model was derived where H-NS undergoes conformational selection, and 
Mg2+ and specific recognition motif select for a stable conformation, while other DNA stretches do no 
stabilize a single conformation.  
In the second example we have aimed to understand conformational dynamics of proteins in 
macromolecular complexes. In this example, we have looked at a key step in the maturation pathway of 
the bacteriophage HK97. In the first step of HK97 maturation, free capsid proteins spontaneously 
assemble through N terminal scaffolding domains. In the next step, a protease cleaves the scaffolding 
domains of the viral coat capsid proteins thereby ensuring the maturation pathway is irreversible. In this 
study, HDXMS is used to probe the dynamics and map the interactions of an inert protease to the capsid 
proteins. It is seen that the protease binds to the N terminal region of the capsid protein and stabilizes the 
capsid proteins and thereby the entire viral capsid. Conformational stabilization effects are observed from 
the N to C terminus of the capsid protein thus indicating that capsid protein stabilizing is an essential step 
in the maturation pathway 
Commonalities in the way allosteric effects propagate can be drawn from globular signaling proteins to 
highly dynamic proteins to macromolecular complexes, but a common underlying theme is that 
conformational dynamics and allostery are important parameters to understand the relationship between a 
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I. Conformational dynamics in proteins 
The field of study known today as structural biology, for most of its nascent years, concentrated on a 
static view of the protein molecules that make up most of the biological world. This static view was 
perpetuated by high resolution structural information obtained from X-ray crystallography studies. X-
ray crystallography is an invaluable technique in structural biology as it provides atomic resolution 
level structural information. But the resulting structural model represents the average structure of 
many molecules in a crystal lattice over long time scales. While it provides structures for end point 
states, and a limited overview of protein dynamics, it does not provide information on conformational 
changes that proteins undergo over time (Figure 1)(Henzler-Wildman and Kern 2007).  
Seminal early work by Anfinsen and colleagues lead to the idea which is now widely proven  that the 
primary sequence of the protein defines its tertiary structure and its fully formed tertiary structure 
defines the function of the protein (Anfinsen, Steinberg et al. 1956, Anfinsen 1973). In recent times it 
has been seen that, in many cases the structure of the protein does not readily present direct 
information on its function, especially in the case of disordered proteins. There is a growing number 
of cases where deciphering the conformational dynamics of a protein leads to a better understanding 
of its function (Berendsen and Hayward 2000). 
Protein dynamics is the study of time dependent changes in the conformations of proteins. Early work 
in the field of protein biochemistry (Koshland 1958, Benson and Linderstrom-Lang 1959, Monod, 
Wyman et al. 1965), introduced the concept that proteins are labile molecules that undergo 
conformational changes. In later work it was seen that protein motions are governed by an energy 
landscape where molecules attempt to move from a high energy conformation to a low energy 
conformation (Frauenfelder, Sligar et al. 1991). This study also introduced the concept of multiple 
meta-stable conformational sub-states that a protein can populate (Figure 1a) and thereby paved the 
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way for the study of protein dynamics. All proteins can theoretically exist in multiple conformations; 
the variations between these multiple conformations define whether a protein is rigid or labile.  
Protein conformational changes are triggered by a wide range of perturbations. These perturbations 
can range from environmental factors such as pH and temperature to molecular factors like 
phosphorylation, protein-ligand, protein-DNA interactions and protein-protein interactions. 
Deciphering how proteins sense these perturbations and react to them has been the subject of intense 
study for past 50 years. In this dissertation I focus here primarily on three types of perturbations, 
protein-ligand, protein-protein and protein-DNA.  
 
Figure 1: Overview of Protein 
dynamics A) Proteins exist in 
multiple meta-stable substates that 
have very similar free energy values 
(conformation A). The protein can 
freely change between 
conformations in this substate. All 
motions in this substate are in 
picosecond to nanosecond regime. 
Free energy is required for the 
protein to change from 
Conformation A to conformation B. 
These changes occur in the 
microsecond to millisecond regime. 
B) The various techniques used in 
structural characterization of 
proteins are plotted on the timescale 
regime that they probe. Hydrogen-
deuterium exchange, the technique 
primarily used in this body of work, 
is unique in that it probes protein 
motions only in the millisecond to 
second regime thereby capturing 
larger domain motions and ignoring 
more short lived conformational 
changes. 
Figure adapted with permissions 





In a cellular context, a protein may be subjected to more than one perturbation at any given point in 
time leading to a ternary complex where more than 2 perturbants influence a protein’s function. In 
these cases, it is essential to decipher the mode in which these perturbations affect the proteins 
conformation and dynamics. While the rules for protein dynamics can apply to any perturbant, I shall 
focus mainly on protein-ligand interactions in this discussion. 
There are two widely accepted models for protein-ligand interactions, 1) the induced fit model 
proposed by (Koshland 1958) and 2) conformational selection model proposed by (Monod, Wyman et 
al. 1965). In the induced fit model, the assumption is that ligand binding to protein provides the free 
energy to the protein to undergo a conformational change to a lower energy conformation. In the 
conformational selection model, the protein is constantly sampling an ensemble of conformations. In 
this ensemble of conformations, the conformation the protein attains on ligand binding is also briefly 
populated. The presence of the ligand stabilizes the protein in the ligand bound populations. The 
population equilibrium shifts towards the ligand bound form over time (Boehr, Nussinov et al. 2009, 
Changeux and Edelstein 2011) (Figure 2). 
Figure 2: Induced fit vs 
conformational selection: 
In the induced fit regime, 
P1 binds to the ligand 
resulting in a 
conformational change to 
the P2L state. In the 
conformational selection 
regime, P1 and P2 are in a 
rapid interchanging 
equilibrium with the P1 
state being the predominant 
state. Ligand binding 
selects sparsely populated 
P2 state resulting in the P2L 
state. Figure adapted with 
permissions from (Boehr, 






It is generally believed that highly dynamic proteins bind ligands in the conformational selection 
regime and more rigid proteins bind in the induced fit regime. This axiom is currently being contested 
by newer results from single molecule FRET experiments (Kim, Lee et al. 2013). It is generally 
assumed that induced fit and conformational selection are mutually exclusive binding regimes, but 
recently postulated theories are beginning to show that they do not need to be mutually exclusive. 
There are many instances of a protein binding a ligand in the conformational selection regime 
followed by structural adjustments which constitute  induced fit mode of binding (Csermely, Palotai et 
al. 2010).  
Differences between induced fit and conformational selection regimes, might appear subtle, but are 
extremely important for recognition and sensing in a cellular and signaling context as it can define the 
sequence of events that govern protein mediated cellular processes. 
II. 3’ 5’-cAMP dependent Protein Kinase pathway 
Cells respond to external hormonal stimuli through membrane bound receptors proteins. There are 
various classes of membrane bound receptor proteins, of which the most well studied class are the G 
protein coupled receptors (GPCRs). They constitute one of the largest families of membrane proteins 
and typically have seven transmembrane helices that anchor the protein to the membrane (Wess 
1997). GPCRs respond to a wide variety of molecular stimuli including hormones, neurotransmitters, 
lipids and nucleotides, and regulate a wide range of physiological functions (Gurrath 2001). GPCRs 
are associated with 3 domains namely Gα, Gβ and Gγ in their cytosolic side. The Gα domain is a 
domain which exhibits GTPase activity. 
3’ 5’ cyclic adenosine monophosphate (cAMP) is an important second messenger molecule in the cell 
which regulates a wide range of cellular functions. In the cAMP dependent protein kinase pathway, an 
external stimulus binds to the extracellular domain of a GPCR causing a conformational change 
across the entire protein. The signal then transduces across the membrane to the cytosolic domain of 
the GPCR. The activated GPCR induces the Gα domain to bind GTP and leading to the activation of 
the Gα  subunit. The activated Gα subunit dissociates from the GPCR and causes the downstream 
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activation of adenylyl cyclases (ACs). Once activated, adenylyl cyclases synthesize 3’ 5’- cyclic 
adenosine monophosphate (cAMP) from ATP. The main target of cAMP in cells is the cAMP- 
dependent protein kinase, or protein kinase A (PKA) (Berman, Ten Eyck et al. 2005). In its inactive 
form, PKA exists as a hetero tetramer composed of a dimer of regulatory subunits each bound to a 
catalytic kinase subunit (Francis and Corbin 1994). In the activation phase of the cAMP signaling 
pathway, high levels of cAMP is produced by adenylyl cyclases and released into the cytosol. The 
free cAMP binds to the inactive PKA holoenzyme, causing the dissociation of the regulatory and 
catalytic subunits. The catalytic kinase once released from the holoenzyme is free to phosphorylate its 
target proteins in its downstream role in regulating myriad cellular functions. Signal termination is 
achieved by a class of enzymes called cyclic nucleotide phosphodiesterases (PDEs). In mammalian 
cells there are 11 families of phosphodiesterases, each with its own substrate specificity, subcellular 
localization and tissue specificity. Phosphodiesterases catalyze  the conversion of 3’ 5’ cAMP to AMP 




Figure 3: Overview of the 3’ 5’ cAMP signaling pathway: Hormonal stimulation of membrane-
anchored GPCRs results in the activation of Gα (α) subunit. This in turn activates the adenylyl 
cyclases to catalyze conversion of ATP to cAMP. The heterotetrameric PKA molecule has 2 cAMP 
binding sites in each regulatory subunit (R) monomer (4 in the stable dimer).  Binding of cAMP 
induces conformational changes releasing the activated Catalytic kinase subunit (C). 
Phosphodiesterases (PDEs) catalyze the hydrolysis of the cAMP to AMP. 
 
III. Regulatory subunit of PKA acts as a conformational switch 
The most prevalent isoform of the regulatory subunit of PKA is the isoform RIα. It is also the most 
well studied isoform of PKA and knockdown studies with RIα show that it was embryonically lethal 
(Amieux and McKnight 2002). RIα was shown to be a highly dynamic protein which exists in an 
ensemble of conformations (Badireddy, Yunfeng et al. 2011, Akimoto, Selvaratnam et al. 2013). It 
has two main end point states, one is the holoenzyme bound state (H form) (Kim, Cheng et al. 2007) 
where it is bound to the Catalytic kinase subunit, and the other is the cAMP bound (B form) state. 
Crystal structures are available for both these states and show the protein has to undergo vast 
conformational changes to transition from one conformation to the other. Conformational switching of 
RIα is depicted in figure 4. 
Figure 4: PKA RIα is 
a conformational 
switch: The ‘H’ 
inactive form structure 
in blue, is an extended 
structure (PDB ID: 
2QCS) while the ‘B’ 
active form structure is 
a compact structure 
(PDB ID: 1RGS). 
cAMP bound to the 
pocket is in blue 
sticks. The ‘H’ form 
represents the 
conformation when 
bound to the C-subunit 
and the ‘B’ form 
represents the cAMP-




IV. Cyclic Nucleotide Phosphodiesterases 
Cyclic nucleotide phosphodiesterases are large group of enzymes, which are classified into 11 
families based on their amino acid sequence, substrate specificity, regulatory domains and tissue 
distribution (Jeon, Heo et al. 2005, Francis, Blount et al. 2011). All PDEs have a highly conserved 
catalytic domain, but show great variability in the regulatory domain (Figure 5). PDEs are mainly 
classified based on their specificity towards cyclic nucleotides, cAMP specific PDES (PDE4, 7, 
8), cGMP specific PDES (PDE5,6 and 9) and dual specific PDEs (PDEs 1, 2, 3, 10 and 11). While 
crystal structures are available for the catalytic domain of PDEs, full length crystal structures are 
proving more difficult (Conti and Beavo 2007). 
Figure 5: Domain organization of the 11 PDE families. Each domain is represented as a block 
figure and shows the diversity of the varied regulatory domains along with the conserved catalytic 




In recent times, a structure of PDE4 with its regulatory domains has shown that the upstream 
conserved regions (UCRs) of PDE4 serve to regulate the activity of the catalytic domain by 
capping the active site. These conserved regions are activated by PKA and ERK phosphorylation 
in PDE4 (Burgin, Magnusson et al. 2010).  
PDEs are generally perceived to act on free cAMP in the cytosol, but it is recently becoming 
evident that cAMP concentrations in the cell are not uniform and point towards the presence of 
microdomains inside the cell (Davare, Avdonin et al. 2001, Zaccolo 2006). I discuss how PDEs 
are involved in direct interactions with the regulatory subunit of PKA, lending further evidence 
for the presence of microdomains of sequestered cAMP. 
V. Amide hydrogen deuterium exchange mass spectrometry 
(HDXMS) 
Early work carried out Linderstrom-Lang on  deuterium exchange in myoglobin (Benson and 
Linderstrom-Lang 1959) has paved the way in monitoring hydrogen/deuterium exchange. In 
recent years, the availability of high end mass spectrometry coupled to ultra-high performance 
liquid chromatograph has greatly advanced the field of HDXMS, and has established HDXMS in 
the forefront of structural biology (Katta and Chait 1991, Hoofnagle, Resing et al. 2003).  
Hydrogen/deuterium exchange is based on the theory that hydrogens in O-H, N-H or S-H groups 
are labile and exchange with OH- groups from the solvent. This can be an acid or base catalyzed 
reaction depending on the pH. In the context of the protein backbone, the labile groups on the 
sidechains exchange too rapidly with solvent to be detectable, while the amides on the peptide 
bond exchange at a slower time scale and can be monitored (Figure 6). This proves as a 




The hydrogen deuterium exchange reaction is carried out by diluting the protein in a buffer 
reconstituted in deuterium oxide.  
Figure 6: Hydrogen/Deuterium exchange at amide positions in proteins: The amide hydrogen 
exchanges freely with the water in the solvent. When water is replaced by deuterium oxide, the 
deuterium also exchanges freely with the amide proton.  
 
The deuterium gets incorporated onto the protein backbone thereby increasing the mass of the peptide 
by ~ 1 Dalton for every deuterium ion incorporated. Mass spectrometry is then carried out to 
determine the average increase in mass for the population of proteins in the reaction mixture. This 
average mass is determined by calculating the centroid of mass spectra (Figure 7). Perturbations are 
introduced to monitor the changes in deuterium exchange caused by the perturbations.  
Figure 7: Effect of H/D exchange on mass 
spectral envelope of peptides: In the 
undeuterated state, the characteristic isotopic 
distribution for a peptide is observed. In the 
deuterated state, the peptide increases in mass. 
The amount of deuteration can be quantified by 
calculating the centroid of the mass spectra. 
Perturbations can change the deuterium exchange 
rates and the effect of these perturbations can be 
calculated by the difference in the centroids of the 
two conditions (represented by the bifunctional 
arrows between the two dashed lines. Condition 
1- represents the results of exchange at time t1 
and condition 2 displays the results at time t2, 
where t1>t2. The results shown here are for a 






The deuterium exchange reaction is governed mainly by two factors, the solvent accessibility of the 
amide and the strength of hydrogen bonding. Other effects including neighborhood effects and amino 
acid side chain moieties also have an effect on exchange rates. It is believed that the hydrogen 
bonding status of the amide has a greater influence on its deuterium exchange rate than the solvent 
accessibility (Englander and Kallenbach 1983) . 
The HDX reaction occurs according to the following equation 
The proteins opening and closing rate constants are kop and kclose. There are two kinetic regimes for 
deuterium exchange that a region of the protein can undergo and it is dependent on the opening and 
closing rate of the protein backbone. The two modes are EX1 and EX2 (Weis, Wales et al. 2006).  
In the EX1 regime, the rate of exchange kch>>kclose, thus this leads to multiple deuterium exchange 
events every instance the structure opens. And  
kHDX=kop 
Since the HDX rate at the amide is governed only by its closing rate, this leads to a bimodal 
distribution. In the population of proteins in the mixture, some proteins may have undergone the 
opening motions while other might not yet have undergone structural opening. This leads to the 
perception of two populations in the mixture indicated by the bimodal distribution. 
In the case of EX2 regime, kcl>>kch, thus 
kHDX=Kopkch 
Where Kop=kop/kcl is the opening reaction equilibrium constant. In EX2, every opening reaction does 
not lead to a deuteration event, and deuteration incrementally adds over time depending on the amide 
opening/closing cycles. Most folded proteins exchange in the EX2 regime. 
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The deuterium exchange reaction is started by diluting the protein in deuterium oxide buffer at the 
physiological pH of the protein. Once the reaction has progressed for a certain time period, the 
reaction is quenched by reducing the pH to 2.5 and 0 °C temperature. The deuterium exchange 
reaction is slowed by several orders of magnitude in the low temperature and pH=2.5 quench 
conditions. The protein is subsequently cleaved by acid stable pepsin protease and subjected to 
reverse phase HPLC separation and analyzed by mass spectrometry. The centroids of the resulting 
mass spectra are quantified and percentage deuterium uptake for a particular peptide is calculated by 
the following formula 
Where m= mass of deuterated peptide, m0%=mass of non-deuterated peptide, m100%= mass of fully 
deuterated peptide and Nmax= maximum possible number deuterium ions incorporated in a given 
peptide. 
VI. Objectives  
In this dissertation, I have chosen to focus on the following objectives for my graduate research 
1. Monitor conformational dynamics and allostery in the activation phase of cAMP pathway by 
capturing a transient ternary complex composed of PKA holoenzyme and a cAMP analog. 
2. Probe dynamics in a transient ternary complex of PKA-PDE and a cAMP analog and monitor 
ligand release from the regulatory subunit of PKA 
3. Discover a mammalian PKA-PDE interaction and map the interaction interface. 
4. Using the knowledge gained from protein ligand interactions, test the viability of HDXMS as 
a fragment screening tool in a fragment based ligand discovery pipeline 
5. By studying the dynamics of the partially disordered protein H-NS, decipher its DNA-binding 
function 
6. Decipher protein dynamics in the macromolecular viral capsid of HK97, and in particular 
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1 Conformational Dynamics in Molecular Signaling I: 
Describing allosteric relays in transient complexes in 
the activation phase of cAMP signaling pathway 
1.1 Introduction 
The Cyclic AMP signaling pathway is an important pathway which regulates a wide range of cellular 
functions. Cyclic AMP-dependent protein kinase (PKA) is an important molecule in the cAMP 
signaling pathway. All isoforms of PKA are composed of two catalytic (C) subunits and homodimeric 
regulatory (R) subunits (Beebe 1986, Johnson, Akamine et al. 2001, Shabb 2001). Of the many 
isoforms of PKA, Cα and RIα are the most widely distributed across all mammalian tissue and also 
the best studied isoforms (Amieux and McKnight 2002). The cAMP pathway is activated by the 
binding of cAMP to the regulatory subunit of PKA. This triggers large conformational changes that 
result in the dissociation of the PKA holoenzyme into the component Regulatory and Catalytic kinase 
domains. The binding of PKAC to its substrate has also been implicated in facilitating the dissociation 
of the PKA holoenzyme (Viste, Kopperud et al. 2005).  
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Figure 1.1: The activation phase of cAMP pathway: The cAMP signaling pathway is activated by 
cAMP (yellow sticks) binding to the PKA holoenzyme composed of the Regulatory subunit (Blue) 
and Catalytic subunit (Purple). The catalytic subunit binds to a kinase substrate (orange) and 
dissociates from the PKA holoenzyme complex. The red box indicates the transient Ternary complex 
of cAMP: PKAR: PKAC which is the focus of this study. The termination phase of the cAMP 
signaling pathway is the process by which the cAMP dissociates from the Regulatory subunit, thereby 
allowing it reassociate with the Catalytic subunit. cAMP dissociation and hydrolysis to AMP 
(magenta sticks) is carried out by enzymes called cyclic nucleotide phosphodiesterases (PDEs) 
(green). 
 
The Catalytic domain once released from the Regulatory domain, is activated to carry out its 
downstream effects (Figure 1.1) (Corbin, Cobb et al. 1988). 
Much progress has been made in the last decade in delineating the molecular basis of action of cAMP. 
An important tactic in this endeavor has been through the comparison of the effects of cAMP with 
those of two phosphorothioate cAMP analogs: (Sp)-cAMPS (a cAMP mimic) and (Rp)-cAMPS (an 





Figure 1.2: Thiol substituted analogs of cAMP: This 
figure depicts Thiol-substituted analogs of cAMP. Sulfur 
substitution at the axial position results in the Sp-cAMPS 
analog which is an agonist to cAMP. A sulfur substitution 
at the equatorial oxygen results in the Rp-cAMPS analog, 





Although the importance of geometry of the sulfur substitution is critical in determining the 
pharmacological properties of the two phosphorothioate cAMP analogs, the molecular basis for this 
behavior is not fully understood. To date, these comparisons have only been made using either wild-
type or truncated mutants of the type Iα regulatory subunit (RIα) that are free in solution, not 
complexed to the C-subunit. X-ray crystallographic examination of ligand-bound RIα(92–379) 
complexes reveals few differences between ligand- bound complexes, but the (Rp)-cAMPS complex 
is structurally “looser” with higher thermal factors than complexes formed with either cAMP or (Sp)-
cAMPS (Wu, Brown et al. 2004, Badireddy, Yunfeng et al. 2011). This is consistent with the 
observation that both cAMP and (Sp)-cAMPS, but not (Rp)-cAMPS, raise the urea concentration 
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required for wild-type RIα unfolding (Dostmann 1995). Further insight into the structural basis of 
cAMP action stems from NMR spectroscopic comparison of the effects of (Rp)-cAMPS, cAMP, and 
(Sp)-cAMPS on chemical shifts and 15N relaxation of the RIα (119–244) mutant (Das and Melacini 
2007). In addition to producing fewer significant chemical shift changes than either cAMP or (Sp)-
cAMPS, (Rp)-cAMPS binding is associated with enhanced millisecond to microsecond time scale 
backbone motions of a β-turn (β2,β3 loop) and around the phosphate-binding cassette (PBC) (Das and 
Melacini 2007). It was  previously reported that (Rp)-cAMPS increased the affinity of RIα toward C-
subunit using a non-quantitative bioluminescence resonance energy transfer assay (Gesellchen, Prinz 
et al. 2006).  
Further insight into the molecular basis of actions of cAMP and its analogs should come from the 
analysis of ligand bound R:C complexes. Unfortunately, the large size of even the heterodimeric R:C 
complex (~95 kDa) and the difficulty of generating (Rp)-cAMPS: R: C-subunit crystals currently 
preclude the use of both NMR spectroscopy and X-ray crystallography. Site-directed labeling 
combined with fluorescence spectroscopy was used to examine both the effects of cAMP and its 
analogs on R: C subunit binding kinetics and on the conformational dynamics of RIα (91–244) 
(Anand, Krishnamurthy et al. 2010). RIα (91–244) includes the “A” cyclic nucleotide binding (CNB) 
domain, the pseudosubstrate, and linker domains and represents the minimal segments necessary for 
high affinity C-subunit binding (Huang and Taylor 1998). For fluorescence stop-flow kinetics and 
fluorescence anisotropy experiments, fluorescein maleimide (FM) was conjugated to three cysteine 
substitution mutants with the substitution sites located near or within the pseudosubstrate sequence, 
the linker domain, or αC (R92C, T104C, and R239C, respectively) of RIα (91–244). Fluorescence 
stop flow experiments indicated that all three ligands tested (cAMP, Sp-cAMPS and Rp-cAMPS) had 
no effects on the PKA holoenzyme association rate. Monitoring dissociation rates revealed that, 
cAMP and Sp-cAMPS increased the dissociation rate 150-200 fold as compared to the basal rate. Rp-
cAMPS on the other hand slowed the dissociation by 5 fold in comparison to the basal dissociation 
rate. The time-resolved fluorescence anisotropy results suggest that cAMP and (Sp)-cAMPS reduce 
the interaction of the RIα linker domain and αC with the two peripheral R:C interaction sites on the C-
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subunit (so-called Sites 2 and 3) without affecting the interaction of the pseudosubstrate sequence 




Table 1.1: Fluorescence stop flow kinetics based quantification of PKA holoenzyme interaction: 
cAMP, Sp-cAMPS and Rp-cAMPS have no discernible effect on the PKA holoenzyme association 
rates. Rp-cAMPS causes 5 fold slower dissociation rate of PKA holoenzyme while cAMP and Sp-
cAMPS increase the dissociation rate. Figure adapted from the following article (Anand, 
Krishnamurthy et al. 2010). 
 
 
In this study we have aimed to examine the effects of cAMP and its analogs on solvent 
exposure/conformational flexibility of RIα (91–244): C-subunit complex using H/D amide exchange 
measured with a combination of mass spectrometry (ESI-QTOF) and proteolytic fragmentation  
(HDXMS). Because of limitations of the amide H/D exchange experiments, only the effects of (Rp)-
cAMPS on H/D amide exchange in RIα (91– 244): C-subunit complex could be investigated. The 
results showed that (Rp)-cAMPS induces a relatively widespread increase in amide exchange, 
indicating limited unfolding and/or enhanced conformational flexibility that is propagated almost 
globally through the C-subunit and, at least, part of RIα. These conformational changes were 
accompanied by a 5-fold increase in the affinity of RIα (91–244) toward C-subunit, suggesting that, at 
least, some of the (Rp)-cAMPS effects are mediated by an increase in internal entropy. Finally, the 
(Rp)-cAMPS induced increase in PKAR: PKAC affinity indicates that (Rp) cAMPS is better 
described as an inverse agonist because the basal activity of the PKA holoenzyme should be 
decreased by (Rp)-cAMPS. For ease of understanding RIα (91-244) fragment will henceforth be 
referred to as RIαA and the PKA catalytic subunit shall be referred to as PKA C. 
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1.2 Materials and Methods 
1.2.1 Reagents 
ATP, cAMP, and MOPS were obtained from Sigma-Aldrich. (Sp)-cAMPS, (Rp)-cAMPS and 8-AEA-
cAMP were obtained from Biolog (Bremen, Germany). NHS-activated sepharose 4 Fast Flow was 
obtained from GE (Chicago, IL). Talon Cobalt based metal affinity resin (Clontech laboratories, 
Mountain View, CA) was used for purification of hexahistidine-tagged PKA C-subunit following the 
manufacturer’s specifications. BL21 (DE3) E.coli strains were from Novagen (Madison, WI). 
Immobilized pepsin cartridges (Poroszyme) were obtained from Applied Biosystems (Redwood City, 
CA). Deuterium oxide (99.9% deuterium) was obtained from Cambridge Isotopes (Andover, MA). 
Trifluoroacetic acid (TFA) and acetonitrile were from Fisher Scientific. PD10 columns were from GE 
Healthcare. All other chemicals were at least reagent grade. 
1.2.2 Expression and Purification of PKA RIαA 
Recombinant PKA RIαA was expressed and purified from bacterial cells using cAMP sepharose 
affinity resin as previously described (Diller, Xuong et al. 2000, Anand, Taylor et al. 2007).  Plasmid 
containing PKA RIαA from bovine source was transformed into E.coli [BL21 (DE3)] and grown in 
LB media at 37 ºC, till mid log phase growth with an OD of 0.7 was achieved. Cells were 
subsequently induced to express recombinant protein by the addition of 500 µM of IPTG and left to 
shake overnight at 18 ºC. Cells were harvested by centrifugation at 6000×g and 4 ºC (Beckman 
Coulter JA-10 rotor) for 20 min. The cell pellet was resuspended in lysis buffer ( 20 mM MES pH 6.5, 
100 mM NaCl, 2 mM EDTA) and lysed by sonication for 15 min. Cell lysates were centrifuged at 
17000 × g for 30 min at 4 ºC and the supernatant was precipitated using 45% ammonium sulphate. 
The ammonium sulphate precipitate was subjected to centrifugation at 6500 × g for 15 min to remove 
the supernatant. The precipitate was subsequently resuspended in lysis buffer followed by overnight 
incubation with cAMP sepharose resin at 4 ºC. cAMP sepharose resin was made by conjugating 8-
AEA-cAMP with NHS activated sepharose beads using a manufacturer prescribed protocol. The resin 
was then transferred into columns and purified PKA RIαA was eluted with 40 mM cGMP elution 
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buffer (50 mM MES pH 5.8, 200 mM NaCl, 2mM EDTA, 40 mM cGMP). The purified PKA RIαA 
was further purified by size exclusion chromatography (S75 size exclusion AKTA column, GE 
healthcare) as a final purification step. 
1.2.3 Expression and Purification of PKA C-subunit 
The PKA C-subunit was expressed with an N-terminal hexahistidine tag in E.coli [BL21 
(DE3)] cells and purified by Talon cobalt His-tag resin(Anand, Hughes et al. 2002). Cells 
expressing PKA-C were cultured at 37 ºC until mid-log phase growth with an OD of 0.7 was 
achieved. Protein expression was induced by the addition of 500 µM IPTG and shaken at 180 
rpm overnight at 18 ºC. Cells were harvested by centrifugation at 6000 × g and 4 ºC (Beckman 
Coulter JA-10 rotor) for 20 min. The cell pellet was resuspended in lysis buffer (50 mM KH2PO4, 20 
mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM β-mercaptoethanol (βME), 5 mM imidazole) and lysed 
by sonication for 15 min. Cell lysates were centrifuged at 17000 × g for 30 min at 4 ºC and the 
supernatant was incubated with Talon metal affinity resin for 1 hr at 4 ºC. The resin was then 
transferred into columns and washes thrice with Lysis buffer. PKA-C was eluted with elution buffer 
(Lysis buffer with 200 mM Imidazole, pH 7.0). The purified PKA-C was further purified by size 
exclusion chromatography (S200 size exclusion AKTA column, GE healthcare) as a final purification 
step. 
1.2.4 Formation and Purification of PKA RIαA: C holoenzyme 
The PKA holoenzyme is formed by combining PKA RIαA with PKA-C subunit in a condition which 
favors dissociation of cGMP from the active site of PKA RIαA and thereby allows PKA-C to bind to 
PKA RIαA. To this end PKA RIαA (1 µM)  and PKA-C were mixed in a 1:1.2  molar ratio in a buffer 
containing 50 mM MOPS, 50 mM NaCl, 1 mM DTT, 2 mM MgCl2, 0.2 mM ATP, pH 7.0 (Buffer A) 
using Spectra/por 30 kDa molecular weight cut off dialysis membrane. Dialysis was allowed to 
proceed for 16h at 4 ºC with constant mixing with 3×1 litre buffer changes. The holoenzyme was 
further purified by size exclusion chromatography (S200 size exclusion column, AKTA GE 
healthcare) to separate holoenzyme from the individual proteins. 
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1.2.5 Amide Hydrogen/ Deuterium Exchange Mass spectrometry (HDXMS) 
of PKA holoenzyme in complex with thiol substituted cAMP analog, Rp-
cAMPS 
The PKA RIαA: C holoenzyme obtained from Size exclusion chromatography was concentrated to a 
final concentration of 109 µM using Vivaspin concentrators (Satrorius Stedim Biotech GmbH, 
Goettingen, Germany). For this experiment, deuterium exchange in PKA holoenzyme was measure in 
in the absence and presence of 1 mM (Rp)-cAMP. 1 µL of PKA holoenyzyme at 109 µM was 
incubated with 1 µL of 20 mM Rp-cAMPS for 30 min on ice. Deuterated buffer was obtained by 
drying Buffer A (50 mM MOPS, 50 mM NaCl, 1 mM DTT, 2 mM MgCl2, 0.2 mM ATP, pH 7.0) in a 
Centrivap vacuum dryer, the dried buffer was subsequently reconstituted in D2O. The complex was 
allowed to exchange with deuterated buffer solutions by 10-fold dilutions of protein samples in 
deuterated Buffer A. The reactions were then quenched after timed intervals of 30 s, 1 min, 2 min, 5 
min, and 10 min by chilling on ice and the addition of 30 µl of 0.2% trifluoroacetic acid, to obtain a 
final pHread of 2.5. Undeuterated samples were included to serve as a template for peptide 
identification and also to provide a baseline value for deuterium exchange quantification. One sample 
was allowed to exchange with deuterated buffer A for 24 h to allow for complete deuteration of 
solvent-exposed regions of the protein. This was used to calculate back-exchange under our 
experimental conditions and is described in greater detail in subsequent sections. 50 µl of the reaction 
samples was washed through an on-line Poroszyme immobilized pepsin cartridge (Applied 
Biosystems) to digest proteins into peptides and trapped onto 2.1×5 mm C18 trap (ACQUITY BEH 
C18 Vanguard pre-column, 1.7 µM, Waters, Milford, MA). Higher resolution peptide separation was 
achieved by reverse phase HPLC through a C18 column (ACQUITY UPLC BEH 1.0 × 100 mm, 1.7 
µM, Waters, Milford, MA) in a 10 min gradient with water as the polar phase and Acetonitrile as the 
organic phase. 0.1% TFA was added to all buffers to lower the pH to 2.5 and also to serve as an ion 
pairing agent to increase chromatographic resolution and greater detection in mass spectrometry. 
Peptides resolved by reverse phase HPLC were subsequently injected onto an ESI-QTOF Waters 
Synapt high definition mass spectrometry (HDMS) system (Waters) operating in positive ion mode. 
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The Mass spectrometer was operated in MSE mode, where it simultaneously collects primary peptide 
mass spectra along with peptide fragmentation spectra. Both the pepsin cartridge and C18 column 
were housed in a refrigerated module at 2 °C to minimize deuterium back-exchange during analysis 
(Wu, Engen et al. 2006, Engen 2009).  
 
1.2.6 Peptide Identification and HDXMS Data analysis 
Mass spectra of peptides and peptide fragmentation data obtained from the undeuterated control were 
used for peptide identification by Protein Lynx Global Server (PLGS) (v2.4) search software 
(Waters). A database containing a primary sequence of PKA RIα and C-subunits was used as a 
template for peptide identification. A mass error tolerance of 10 ppm was used to sequence the 
peptides. Continuous instrument calibration was carried out with Glu-fibrinogen peptide at 100 
fmol/µl. Deuterium exchange quantitation was carried out with HX-Express software (Weis, Engen et 
al. 2006) 
1.2.7 Calculation of back exchange correction factor	
Deuterium back exchange is the loss of deuterium ions from labeled peptides over time. Each 
experimental system has a different back exchange factor which is dependent on temperature, pH of 
buffers, time of experiment, length of tubing, etc. Though the back exchange rate is at its minimum at 
pH 2.5 and cold conditions, a significant amount of deuterium ions are lost during the course of the 
experiment. Deuterium back exchange loss for our experimental system was determined by 
calculating the deuterium loss from peptides that have undergone theoretically maximum deuterium 
exchange. To this end, ligand-free RIαA was incubated with deuterated buffer A for 24 h at room 
temperature (20 °C). Certain regions of RIαA get rapidly incorporated with deuterium ions while other 
regions are involved in rigid secondary structural elements and do not exchange even after 24 h of 
deuterium exchange. The regions which undergo rapid exchange were mainly considered for back 
exchange factor calculation; these regions are mainly found in the N-terminal region PKA RIαA. The 
region in RIαA spanning residues 111–130 is a highly solvent-exchangeable region (Anand, Hughes et 
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al. 2002), and  peptides used for calculations of back-exchange span this region and showed nearly 
complete exchange in ligand-free RIαA following 10-min deuterium exchange and would represent 
fully deuterated samples following 24-h exchange. The average deuterium back-exchange loss of 
32.8±1.6% was calculated from average back-exchange values for five peptides: RIα(111–123) (m/z 
547.65) (back-exchange, 34.4%), RIα(111–119) (m/z 559.34) (back-exchange, 33.7%), RIα(111–126) 
(m/z  632.701) (back-exchange, 30.4%), RIα(111–119) (m/z 595.34) (back-exchange, 33.7%), and 
RIα (112–126) (m/z  578.35) (back-exchange, 32.0%) (Anand, Krishnamurthy et al. 2010, Badireddy, 
Yunfeng et al. 2011). All deuterium exchange values reported were corrected for a 32.7% back-
exchange by multiplying the raw centroid values by a multiplication factor of 1.49. Deuterium 
exchange kinetic plots were obtained by plotting deuterium uptake values against labeling time and 
fitting the points to a one phase association curve to account for fast exchanging solvent accessible 
amides which exchange deuterium ions within 10 mins of deuterium labeling (Mandell, Falick et al. 
1998). 
1.3 Results and Discussion 
The activation phase of the cAMP signaling pathway has two end state complexes, namely PKA 
RIαA: PKA C holoenzyme complex and the cAMP: PKA RIαA end state complex (Figure 1.1). These 
are well studied stable complexes, with the availability of high resolution crystal structures (Su, 
Dostmann et al. 1995, Kim, Cheng et al. 2007). The transition state between these two end-states is a 
ternary complex of PKA RIαA: cAMP: PKA C which is a transient and dynamic complex. The goal of 
this study is to probe the dynamics of the ternary complex and understand the processes involved in 
cAMP mediated dissociation of PKA holoenzyme. To this end we captured the ternary complex in a 
meta-stable state by using a thiol substituted analog of cAMP, Rp-cAMPS. Rp-cAMPS is chemically 
similar to cAMP and differs by a single Sulfur substitution at the equatorial oxygen postion of cAMP. 
Though very similar to cAMP, Rp-cAMPS has been shown to act antagonistically to cAMP by 
capturing RIαA in ‘C’ bound conformation (Badireddy, Yunfeng et al. 2011). HDXMS mass 
spectrometry was carried out to ascertain the nature of the holoenzyme interaction in the presence and 
absence of Rp-cAMPS and to come up with a model to explain the increased affinity of the complex 
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in the presence of Rp-cAMPS. The same experiment when repeated with cAMP or the agonist Sp-
cAMPS lead to the dissociation of the PKA holoenzyme. The ultimate aim of this study was to 
capture the Rp-cAMPS bound ternary complex and map out the conformational dynamics and 
allosteric relays in cAMP mediated dissociation of PKA holoenzyme. 
1.3.1 Pepsin digestion of PKA RIαA and PKA C 
Undeuterated control of the PKA holoenzyme was carried out as described in Materials and Methods. 
Output from PLGS global server was subsequently analyzed and a list of peptides was generated. 
Only peptides with a high confidence and multiple fragment ions were considered. All peptides which 
were selected for subsequent deuterium exchange quantification had a signal to noise ratio (S/N) of 
atleast 6. In total, 22 peptide fragments were obtained for RIαA, which accounted for 92% of the 
protein sequence with overlapping peptides available for almost all important regions of the protein. 
The presence of high number of overlapping peptides especially at the cAMP binding pocket, enabled 
higher resolution in probing for subtle changes in amide exchange rates. Coverage was not available 
mainly for the beginning 10 amino acids in the N-terminal and final 6 amino acids in the C-terminal 
of RIαA. In PKA C, 50 peptide fragments were obtained which accounted for 85% of the sequence 
coverage. Numerous overlapping peptides were also obtained for PKA C thereby increasing the 
resolution of the study. The sequence coverage obtained from HDXMS experiment is mapped onto 
the crystal structure of PKA holoenzyme in Figure 1.3, regions showing coverage are in color while 
regions showing no coverage are in grey. All analyzed peptides are listed with the deuterium ions 
incorporated after 10 min of deuterium labeling and are summarized in Table 1.2 for PKA RIαA and 
Table 1.3 for PKA C. Regions which show significant differences upon Rp-cAMPS binding to PKA 
holoenzyme are highlighted in bold. A difference of a minimum of 0.5 Da was considered significant 









Figure 1.3: Sequence coverage map: Structure of PKA holoenzyme (PDB ID: 3FHI) with regions 
showing coverage in PKA RIαA in light orange, and PKA-C N-lobe in Cyan and the C-lobe in Teal. 





Table 1.2: Effects of Rp-cAMPS on H/D exchange of RIαA in the PKA holoenzyme complex. 
 
   Maximum Amides Exchangeda 








(Mean ± S.E.) 
Plus Rp-cAMPS 
(Mean ± S.E.) 
92- 102(588.3)[pseudo substrate] 10 2 3.12 ± 0.04 3.27 ± 0.1 
102-106(640.29)[linker] 4 1 3.0 ± 0.01 2.9 ± 0.07 
111-126 (632.70)[linker] 14 3 8.7 ± 0.26 9.0 ± 0.34 
112-119 (477.81)[linker] 6 2 4.2 ± 0.09 4.6 ± 0.13 
126-134 (493.29)[αXn] 8 2 3.4 ± 0.05 3.6 ± 0.10 
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136-143 (976.40)[loop-αA] 7 1 1.8 ± 0.12 2.4 ± 0.14 
136-148 (797.86)[loop-αA] 12 2 1.3 ± 0.08 1.7 ± 0.10 
144-148 (637.34)[αA] 4 1 0.3 ± 0.24 0.1 ± 0.02 
149-156 (913.42)[αA] 6 1 1.2 ± 0.03 1.2 ± 0.23 
157-172 (846.89)[β2-β3] 15 2 5.7 ± 0.18 4.8 ± 0.22 
161-172 (1322.58)[β2-β3] 11 1 4.8 ± 0.17 3.9 ± 0.21 
162-172 (1225.54)[β2-β3] 10 1 4.7 ± 0.16 3.9 ± 0.20 
172-180 (1101.49)[β4] 8 1 1.1 ± 0.02 1.1 ± 0.04 
183-187 (638.28)[β4] 4 1 2.0 ± 0.02 2.0 ± 0.04 
188-198 (1097.49)[β5-β6] 10 1 4.0 ± 0.10 4.0 ± 0.15 
188-201(1396.64)[β5-β6-αB’] 13 1 6.4 ± 0.22 4.5 ± 0.16 
202-212 (567.32)[αB’] 9 2 3.7 ± 0.14 1.9 ± 0.18 
202-221 (705.76)[αB’-β7] 18 3 4.1 ± 0.18 2.4 ± 0.14 
204-221(644.3)[αB’-β7] 16 3 4.0 ± 0.13 2.0 ± 0.14 
213-221 (500.83)[β7] 8 2 0.8 ± 0.01 1.0 ± 0.03 
222-229 (506.23)[β8-αB] 6 2 0.6 ± 0.05 0.6 ± 0.07 
230-238 (523.81) [(αB-αC] 8 2 2.6 ± 0.05 2.6 ± 0.11 
 
* Non-overlapping 95% confidence intervals relative to control values determined by PrizmTM 
computer program.  
 
 
a Average number of deuterons exchanged determined from fitting plots of the time course of 
deuteration during a 10-min exposure to deuterium oxide to a single -exponential equation. 
Values reported are the mean and standard error of the amplitude term of fits and results are 
from at least two independent experiments. Peptides showing significant differences upon Rp-
















   Maximum Amides Exchangeda 
 








(Mean ± S.E.) 
Plus Rp-cAMPS 
(Mean ± S.E.) 
7-18(700.32)[αA] 11 2 8.2 ± 0.05 9.7 ± 0.19 
14-31 (732.72)[αA] 17 3 4.3 ± 0.11 5.3 ± 0.11 
19-26 (461.25)[αA] 7 2 4.2 ± 0.10 5.3 ± 0.37 
19-27 (534.79)[αA] 8 2 4.4 ± 0.13 4.9 ± 0.18 
21-36 (953.5)[αA-β1] 14 2 8.4 ± 0.19 9.5 ± 0.22 
27-40 (822.44)[αA-β1] 12 2 7.7 ± 0.17 8.3 ± 0.20 
28-40 (765.90)[αA-β1] 11 2 7.6 ± 0.12 8.2 ± 0.19 
42-55 (792.90)[β1] 13 2 1.9 ± 0.07 2.0 ± 0.13 
45-55 (597.83)[β1] 10 2 3.0 ± 0.11 3.0 ± 0.14 
60-71 (700.84)[β1-β2] 11 2 0.4 ± 0.02 0.9 ± 0.04 
83-100 (727.74)[αB-αC] 17 3 3.3 ± 0.09 3.2 ± 0.13 
92-100 (544.83)[αC] 8 2 1.7 ± 0.06 1.6 ± 0.09 
98-103 (736.403)[αC] 4 1 0.9 ± 0.02 0.8 ± 0.04 
98-104 (807.44)[αC] 5 1 1.6 ± 0.03 1.6 ± 0.09 
104-108 (635.38)[β4] 4 1 Solvent inaccessible Solvent inaccessible 
104-110 (869.48)[β4] 6 1 1.0 ± 0.02 1.2 ± 0.07 
105-110 (770.41)[β4] 5 1 1.0 ± 0.05 1.1 ± 0.08 
106-115 (1200.55)[β4] 9 1 1.7 ± 0.06 1.7 ± 0.11 
109-116 (924.44)[β4] 7 1 1.0 ± 0.02 1.1 ± 0.06 
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119-126 (825.38)[β5] 7 1 0.2 ± 0.02 0.4 ± 0.02 
122-128 (726.32)[β5-αD] 6 1 1.0 ± 0.17 0.8 ± 0.08 
122-129 (855.36) [β5-αD] 7 1 1.0 ± 0.14 1.0 ± 0.29 
133-145 (570.29)[αD-αE] 12 3 1.2 ± 0.03 1.3 ± 0.01 
144-151(470.26)[αE] 7 2 3.0 ± 0.10 2.9 ± 0.03 
156-163 (989.49)[αE-β6] 7 1 0.3 ± 0.02 0.3 ± 0.01 
162-173 (743.94)[β6-β7] 10 2 0.5 ± 0.04 0.3 ± 0.3 
173-178 (673.35)[β7] 5 1 1.3 ± 0.01 0.9 ± 0.05 
180-185 (722.36)[β8] 5 1 0.3 ± 0.24 0.2 ± 0.19 
180-187 (926.46)[β8] 7 1 Solvent inaccessible Solvent inaccessible 
182-187 (685.32)[β8] 5 1 Solvent inaccessible Solvent inaccessible 
188-212(981.52)[β9-
activation loop] 
22 3 3.5 ± 0.08 3.5 ± 0.08 
189-212(932.50)[β9-activation loop] 21 3 3.3 ± 0.08 3.2 ± 0.09 
198-211(1418.73)[β9-activation loop] 10 1 Solvent inaccessible Solvent inaccessible 
205-211(768.49) 5 1 Solvent inaccessible Solvent inaccessible 
222-227 (658.40)[αF] 5 1 Solvent inaccessible Solvent inaccessible 
231-245 (826.90)[αF-αG] 11 2 5.3 ± 0.12 5.0 ± 0.19 
232-239 (869.43)[αF] 5 1 1.1 ± 0.03 1.2 ± 0.02 
241-247 (784.42)[αF-αG] 5 1 3.0 ± 0.10 2.9 ± 0.27 
262-269 (890.48)[αH] 7 1 Solvent inaccessible Solvent inaccessible 
262-273 (693.90)[αH] 11 2 Solvent inaccessible Solvent inaccessible 
268-273 (741.50)[αH] 5 1 Solvent inaccessible Solvent inaccessible 
268-274 (869.56)[αH] 6 1 Solvent inaccessible Solvent inaccessible 
278-302(748.40)[αH-αI] 24 4 7.0 ± 0.20 8.1 ± 0.20 
291-303 (831.41)[αH-αI] 12 2 3.1 ± 0.16 3.3 ± 0.22 
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298-303 (740.33)[αH-αI] 5 1 2.4 ± 0.08 2.6 ± 0.15 
303-326(669.87)[C-terminal tail] 19 4 9.5 ± 0.12 9.9 ± 0.20 
303-327(706.64)[C-terminal tail] 20 4 9.0 ± 0.17 9.4 ± 0.17 
305-327(623.85)[C-terminal tail] 18 4 10.0 ± 0.13 10.5 ± 0.25 
306-327 (632.34)[C-terminal tail] 17 4 8.1 ± 0.06 8.5 ± 0.13 
336-347 (728.36)[C-terminal tail] 11 2 7.0 ± 0.10 7.9 ± 0.11 
 
* Non-overlapping 95% confidence intervals relative to control values determined by PrizmTM 
computer program. 
a Average number of deuterons exchanged determined from fitting plots of the time course of 
deuteration during a 10-min exposure to deuterium oxide to a single -exponential equation. Values 
reported are the mean and standard error of the amplitude term of fits and results are from at least 
two independent experiments. Peptides showing significant differences upon Rp-cAMPS binding are 
in bold.  
1.3.2 Rp-cAMPS binding does not lead to the dissociation of PKA 
holoenzyme 
The primary goal of this study was to capture the ternary complex of Rp-cAMPS:PKA RIαA: PKA C, 
thus it was important to first determine that Rp-cAMPS, being almost identical to cAMP, does not 
cause dissociation of PKA holoenzyme.  This was confirmed by quantifying deuterium exchange at 
the N-terminal pseudeosubstrate region of RIαA. This loop is involved in direct interactions with the 
substrate binding pocket of PKA C and shows decreased deuterium exchange in HDXMS experiments 
(Anand, Law et al. 2003, Kim, Cheng et al. 2007). Rp-cAMPS binding to the apo RIαA CNB domain 
causes significant decreases in deuterium exchange across the entire protein but has no effects at the 
N- terminal pseudo substrate region (Badireddy, Yunfeng et al. 2011).  RIαA in the PKA holoenzyme 
state shows significant decreases in deuterium exchange at the pseudo substrate region when 
compared with the RIαA in the ligand free State and Rp-cAMPS bound state. The ternary complex of 
Rp-cAMPS:PKA holoenzyme also shows significant protection at the pseudosubstrate region, 
equivalent to the free holoenzyme form (Figure 1.4). This shows that Rp-cAMPS does not cause the 
dissociation of the PKA holoenzyme. Subsequent sections will highlight Rp-cAMPS induced 




Figure 1.4:  Time course 
of deuterium exchange 
for a peptide spanning the 
N-terminal pseudo 
substrate region. Open 
circle (○) denotes RIαA in 
the apo state, filled circle 
(●) denotes RIαA in the 
Rp-cAMPS bound state, 
open diamond (◊) 
indicates RIαA in the PKA 
holoenzyme state and 
closed diamond (♦) 
indicates RIαA in the 
ternary complex state of 
RIαA:Rp-cAMPS:PKAC. 
Deuterium labeling 
reaction was carried out for 0.5, 1, 2, 5 and 10 min and the data was plotted against time. Data was fit 
to a one-phase association nonlinear exponential curve fit (Graphpad Prizm 5.0, San Diego, CA) 
 
1.3.3 Direct binding effects of Rp-cAMPS at the CNB domain of RIαA  
Rp-cAMPS binds to RIαA at the cAMP binding pocket and causes protein-wide changes in dynamics. 
The most significant differences are observed at a β-barrel and loop region spanning residues 200-
212. This region is important in forming multiple direct hydrogen bonds with the cAMP molecule, 
and all peptides spanning this region show a decrease in deuterium exchange. The decreased exchange 
seen in this region is consistent with the roles of Glu200 and Arg209 in coordinating the 2’ -OH and  
 
Figure 1.5: Kinetic plot of 
deuterium exchange for peptide 
spanning the cAMP binding 
pocket. Open circle (○) denotes 
RIαA in the PKA holoenzyme 
state, close circle (●) indicates 
RIαA in the ternary complex 
state of RIαA:Rp-cAMPS:PKAC. 
Deuterium labeling reaction was 
carried out for 0.5, 1, 2, 5 and 10 
min and the data was plotted 
against time. Data was fit to a 
one-phase association nonlinear 
exponential curve fit (Graphpad 
Prizm 5.0, San Diego, CA) 
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phosphodiester moieties of cAMP, respectively (Su, Dostmann et al. 1995). In the absence of ligand, 
this region is partially protected, Rp-cAMPS causes further protection at this loci. Kinetic plot for a 
peptide lining the PBC is depicted in Figure 1.5. In all overlapping peptides spanning this region, Rp-
cAMPS binding to PKA holoenzyme induces ~ 2 Da decrease in deuterium exchange. This is 
consistent with previous reports, where Rp-cAMPS binding to apo RIαA also showed 2 Da decrease in 
deuterium exchange (Badireddy, Yunfeng et al. 2011). This proves that the Rp-cAMPS molecule 
occupies the cAMP binding pocket and forms stable hydrogen bonds with residues lining the pocket.  
Cyclic AMP binding to the PBC of PKA is generally considered a phosphorylation event and cAMP 
can be seen as a soluble phosphate group. This notion stems from the fact that the phosphate group of 
cAMP makes one key hydrogen bond with the guanidinium nitrogen of an Arginine residue that lines 
the cAMP binding pocket. While other moieties of the ligand form stable hydrogen bonds with other 
residues lining the pocket, the key interaction occurs between the cAMP molecule and Arg209 in the 
PBC, and this interaction sets off an allosteric relay that activates the PKA molecule. This is largely 
similar to a phosphorylation event where a single phosphate group activates the protein/ enzyme.  
The Arg209 residue is involved in an allosteric relay with Asp170 in the presence of cAMP molecule. 
The equatorial oxygen of cAMP’s phosphate group forms direct hydrogen bonds with Arg209 and 
stabilizes this allosteric relay. This relay is disrupted in the PKA holoenzyme state. In the case of Rp-
cAMPS, the equatorial oxygen is occupied by a Sulfur group, and due its higher electronegativity, 
sulfur does not form hydrogen bonds with nitrogen of Arg209. While Rp-cAMPS confers ~2 Da of 
protection at the binding pocket for both the PKA holoenzyme state and apo RIαA, cAMP confers ~4 
Da of protection to the apo protein. This thus shows that Rp-cAMPS forms a more dynamic 
interaction with the binding pocket as compared to cAMP. 
1.3.4 Allosteric effects in RIαA caused by Rp-cAMPS binding 
Allosteric effects are the ligand induced conformational changes which occur are loci distal to the 
actual binding site. Allosteric effects of cAMP binding to RIαA are well documented, with the main 
locus of allosteric effects to be located around the crucial Arg209-Asp170 relay (Anand, Hughes et al. 
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2002, Das and Melacini 2007, Kim, Cheng et al. 2007).  Two important allosteric effects were 
observed upon Rp-cAMPS binding to RIαA. 
A region showing significant differences was a region spanning residues 126-143 which form a 310 
helix. Differences in this region were seen on two contiguous peptides one spanning residues 126-135 
and the other spanning residues 136-143. Interestingly, this region showed increases in deuterium 
exchange indicating increased dynamics. While region spanning residues 136-143 showed 
consistently increased deuterium exchange of ~ 0.7 Da upon ligand binding, the region spanning 
residues 126-143 shows significantly increased deuterium exchange (1.5 Da) for early time points. 
But as labeling time increases the difference between ligand free and ligand bound states becomes 
negligible. Time dependent differences points towards the dynamics nature of the ternary complex.  
Another peptide spanning the residues 161-172 showed decreased deuterium exchange by ~1 Da, 
upon Rp-cAMPS binding. This peptide spans the crucial Asp170 allosteric relay site. Kinetics plots of 
these 3 peptides are depicted Figure 1.6.  
Figure 1.6: Allosteric effects induced on RIαA by Rp-cAMPS binding to PKA holoenzyme: 
Kinetic plots of deuterium exchange for peptides that undergo allosteric changes upon Rp-cAMPS 
binding to PKA holoenzyme. Peptide sequences are indicated and residue numbers are in brackets. 
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Open circle (○) denotes RIαA in the PKA holoenzyme state, close circle (●) indicates RIαA in the 
ternary complex state of RIαA:Rp-cAMPS:PKAC. Deuterium labeling reaction was carried out for 
0.5, 1, 2, 5 and 10 min and the data was plotted against time. Data was fit to a one-phase association 
nonlinear exponential curve fit (Graphpad Prizm 5.0, San Diego, CA) 
 
The region spanning residues 133-140 of PKA RIαA is important in forming direct interactions with 
Site 2 of PKA C (Kim, Xuong et al. 2005) and increased dynamics in this region could indicate that 
the RIαA and PKA C interaction at this region is less stable. This provides a model on how ligand 
cAMP at the binding pocket drives the conformation of RIαA from PKA C high affinity form to a 
conformation with low affinity for PKA C by inducing an increase in dynamics at key interaction 
interfaces. 
 
As discussed in the previous section, the Asp170 molecule is involved in an allosteric relay with Arg209. 
Since Rp-cAMPS does not form stable hydrogen bonds with the Arg209 molecule, the Asp170 allosteric 
relay is also not fully stabilized. This should result in a highly dynamic profile at the Asp170 loci, but it 
was seen that Rp-cAMPS binding to the PKA holoenzyme results in protection of 1 Da at this locus. 
On the other hand, Rp-cAMPS or cAMP binding to apo RIαA causes significantly greater protection 
of up to 2 Da, thus the protection seen in the Rp-cAMPS:PKA holoenzyme ternary complex, though 
significant, is significantly less than the protection seen in cAMP: apo RIαA. This indicates that 
though the Arg209-Asp170 allosteric relay is the most important relay at this locus, it is also stabilized 
by other allosteric relays independent of the Arg209-Asp170 relay. This points towards a multi-state 
model for allostery whereby allostery progresses via multiple pathways as opposed to a single 
allosteric relay (Moorthy and Anand 2012).  
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A summary of Rp-cAMPS induced effects on RIαA is mapped onto the crystal structure of PKA 
holoenzyme in figure 1.7. 
 
 
Figure 1.7: Rp-cAMPS induced changes on RIαA: Structure of the PKA holoenzyme (PDB 
ID:3FHI) with RIαA in pale green. Regions showing decreases in deuterium exchange upon Rp-
cAMPS binding are in blue, and regions showing increased dynamics on ligand binding are in red. 







1.3.5 Allosteric effects propagate across the interaction interface	
Peptides from PKA C were also analyzed and a number of peptides showed significant changes in 
deuterium exchange upon ligand binding. This was an interesting result as it shows that ligand 
binding on RIαA induces allosteric effects to propagate across the protein-protein interaction interface 
and cause changes in protein dynamics in the interacting protein.  Most of the regions showing 
differences in PKA C showed significant increases in deuterium exchange indicating an overall 
increase in dynamics in PKA C. The regions showing increased dynamics were mainly seen at the N 
terminal αA helix, β1-β2 beta strand at the C-terminal tail region. One peptide proximal to the ATP 
binding site showed decrease in deuterium exchange.  
Kinetic plots for peptides showing significant changes in PKA C are depicted in Figure 1.8. 
Figure 1.8: Allosteric effects induced on PKA C by Rp-cAMPS binding to PKA holoenzyme: 
Kinetic plots of deuterium exchange for peptides on PKA C that undergo allosteric changes upon Rp-
cAMPS binding to PKA holoenzyme. Peptide sequences are indicated and residue numbers are in 
brackets. Open circle (○) denotes PKA C in the PKA holoenzyme state, close circle (●) indicates PKA 
C in the ternary complex state of RIαA:Rp-cAMPS:PKAC. Deuterium labeling reaction was carried 
out for 0.5, 1, 2, 5 and 10 min and the data was plotted against time. Data was fit to a one-phase 
association nonlinear exponential curve fit (Graphpad Prizm 5.0, San Diego, CA) 
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The regions showing changes were mapped onto the structure of PKA holoenzyme as shown in Figure 
1.9. Even though changes were mainly seen at the N-terminal and C terminal ends of the protein, from 
the structure it is evident that these regions form a contiguous surface. Interestingly, these regions 
which show high dynamics are distal to the RIαA: PKA-C interaction interface. This shows that PKA 
C, along with RIαA, is also in a highly dynamics state in the ternary complex state.  
 
 
Figure 1.9: Rp-cAMPS induced changes on PKA C: Structure of the PKA holoenzyme (PDB 
ID:3FHI) with PKA-C N-lobe in cyan and the C-lobe in teal. Regions showing decreases in deuterium 
exchange upon Rp-cAMPS binding are in blue, and regions showing increased dynamics on ligand 








1.3.6 Rp-cAMPS: PKA holoenzyme ternary complex is a ‘frustrated’ 
molecule	
From previous results it was seen that both RIαA and PKA C exhibited increased dynamics upon Rp-
cAMPS binding. Since ligand binding induces the increased dynamics in the entire protein, we can 
trace the allosteric path that leads to increased dynamics across the entire PKA holoenzyme molecule, 
to begin at the PBC of RIαA. The apo RIαA protein is a highly dynamic protein which exists in an 
ensemble of conformations. RIαA binds to its target molecules (cAMP/PKAC) by the process of 
conformation selection, thus, presence of cAMP molecule drives the conformation of RIαA to the ‘B’ 
form (ligand bound), while the PKA C molecule drives the conformation of RIαA to the ‘H’ form 
(Holoenzyme). It was previously shown that Rp-cAMPS is a unique cAMP analog as it drives the 
conformation of RIαA to the ‘H’ form rather than the ‘B’ form, but it has to be remembered that Rp-
cAMPS is almost identical to cAMP expect for a single sulfur substitution (Badireddy, Yunfeng et al. 
2011). While it is incapable of activating the Arg209-Asp170 relay, thereby causing the dissociation of 
the PKA holoenzyme, it is still capable of activating other allosteric relays through other interactions 
it forms at the PBC. In the PKA holoenzyme state, RIαA already exists in the ‘H’ conformation as it is 
bound to PKA C, Rp-cAMPS binding, though largely drives the RIαA conformation towards the ‘H’ 
form, also triggers allosteric relays that destabilize the PKA holoenzyme. These allosteric relays are 
weaker than the Arg209-Asp170 relay that is essential to disrupt the high affinity PKA holoenzyme 
complex. These weaker allosteric relays destabilize the interaction interface at Site 2 of PKA C, and 
initiate a cascade of destabilization that traverses across the interaction interface and affects regions 
distal to the interaction interface. This increased dynamics and, in turn increased entropy, at one end 
of the protein causes a counter effect of stabilizing the Site 1 of the interaction interface. Rp-cAMPS 
also drives the conformation of RIαA towards the ‘H’ form, the addition of these two effects leads to 
the increased affinity seen in PKA holoenzyme upon Rp-cAMPS binding.  
The adenosine and ribose moieties in Rp-cAMPS induce dissociation of the PKA holoenzyme while 
the sulfur group, not only prevents dissociation of the holoenzyme, but indirectly increases the affinity 
of the PKA holoenzyme. Thus the PKA holoenzyme in the Ternary complex state is a ‘frustrated’ 
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protein, which exists in a high dynamic state as it cannot attain a stable end point state. Localized 
frustration has been implicated as the basis of allosteric transitions. The degree of local frustration can 
define whether the region is a ‘hinge’ or a ‘crack’, wherein hinges result in large scale conformational 
changes and cracks lead to degeneracy in conformations of the protein (Ferreiro, Hegler et al. 2011). 
The regions of PKA that show higher dynamics upon binding Rp-cAMPS may be correlated to 
regions that are involved in cAMP dependent dissociation of the PKA holoenzyme. Further studies 
have to be carried out to accurately characterize the nature of ligand induced frustration in the PKA 
holoenzyme. 
This also provides a model for multiple allosteric pathways that occur upon cAMP binding that leads 




Figure 1.10: Allosteric relays that lead to the PKA dissociation: The weak allosteric relay that 
induces PKA destabilization is highlight by the green arrow. By tracing the regions showing higher 
dynamics upon Rp-cAMPS binding (in red), the weak allosteric relay can be determined. The strong 
allosteric relay (Arg209-Asp170 relay) that is essential to fully dissociate PKA is in red. This relay is 
inactive in the presence of Rp-cAMPS. Structure and color coding for the PKA holoenzyme are the 
same as for Figure 1.8 and 1.10. 
The next two sections, aim to highlight the utility and application of HDXMS in studying protein-
ligand interactions with examples obtained from this study. 
1.3.7 Using HDXMS to map ligand binding at amino acid resolution 
HDXMS has been shown to be a powerful technique to probe and monitor the conformation dynamics 
of proteins in the influence of a variety of perturbations (Hoofnagle, Resing et al. 2003). In this 
section I highlight how HDXMS can map subtle effects of ligand binding at amino acid resolution. 
For this analysis, two peptides close to the PBC of RIαA were chosen. One peptide spans residues 
188-198 while the other peptide has three additional amino acids and spans residues 188-201. The 
three additional amino acids are highly significant as 2 of the amino acids are known to form highly 
stable hydrogen bonds with the 2’OH group of the Ribose sugar of cAMP (Su, Dostmann et al. 1995). 
The ligand free and ligand bound states of the peptides were compared and quantified. While the 
peptide spanning residues 188-198 shows no significant differences, the peptide containing elements 
from the PBC, shows a decrease of 2 Da upon ligand binding. The 2 deuterons decrease most likely 
corresponds to the 2 hydrogen bonds formed by the ligand molecule to the amino acids. This example 
highlights the sensitivity of HDXMS to accurately identify and localize hydrogen bonding networks. 
The results are 
summarized in Figure 1.11 
Figure 1.11: Sensitivity 
of HDXMS in 
deciphering protein 
ligand interactions: A) 
Residues in the PBC of 
RIαA are depicted with the 
key hydrogens bonds 
formed with cAMP. 
Residues 199 and 200 
which form key hydrogen 
bonds with 2’OH group on 
cAMP are circled in red. 
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B) Kinetic plot for peptide spanning residues just outside the PBC shows no significant difference 
upon Rp-cAMPS binding, while  C) is the kinetic plot of peptide which contains residues 199 and 200 
and shows a 2 deuteron protection in the Rp-cAMPS bound state. Open circle (○) denotes PKA C in 
the PKA holoenzyme state, close circle (●) indicates PKA C in the ternary complex state of RIαA:Rp-
cAMPS:PKAC. Deuterium labeling reaction was carried out for 0.5, 1, 2, 5 and 10 min and the data 
was plotted against time. Data was fit to a one-phase association nonlinear exponential curve fit 
(Graphpad Prizm 5.0, San Diego, CA) 
1.3.8 Differentiating Induced fit from Conformational Selection by HDXMS 
RIαA in its apo form is a highly dynamic protein and detects and binds cAMP by the process of 
conformational selection (Badireddy, Yunfeng et al. 2011). Proteins that undergo conformational 
selection would by definition be highly dynamic as they are constantly sampling an ensemble of 
structures (Boehr, Nussinov et al. 2009, Csermely, Palotai et al. 2010). This high degree of dynamics 
can be evidenced by the hydrogen bonding network, as rigid proteins would have a stable hydrogen 
bonding network, while more dynamic proteins would have less stable hydrogen bonding networks. 
To probe these hydrogen bonding networks, HDXMS is a technique of choice as it mainly monitors 
hydrogen bonding and to a lesser degree solvent accessibility of the protein backbone. (Englander and 
Kallenbach 1983). 
The apo RIαA protein shows an average of 30% to 60% relative deuterium uptake across all peptides, 
but upon ligand binding shows decreases in deuterium exchange across all regions (Badireddy, 
Yunfeng et al. 2011). In the apo state RIαA takes up deuterium ions while sampling all conformations, 
but upon ligand binding, the protein is stabilized. This suggests that the ligand selects, stabilizes and 
locks RIαA into one stable conformation. In the case of ligand binding to PKA holoenzyme, both 
decreases and increases in deuterium exchange are observed. This indicates that in the PKA 
holoenzyme state, both proteins have reached a stable conformation, and ligand binding induces 
changes in protein conformation and in some regions increases in dynamics. This implies an ‘induced 
fit’ model for ligand binding. The underlying assumption is that proteins that are involved in 
conformational selection regime are more dynamic as they sample multiple conformations.  
It has to be noted that conformational selection and induced fit are just two different pathways of the 
same thermodynamic cycle. The same protein system may favor conformational selection for one 
perturbant and induced fit for another perturbant. It is also conceivable that a protein may respond to a 
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perturbant through the conformational selection regime followed by the induced fit regime or vice 
versa. 
1.4 Conclusions 
The activation phase of cAMP pathway is a well-studied pathway but most of the earlier studies have 
targeted the end state complexes alone. In this study we capture the transient ternary complex of the 
cAMP activation pathway using the inverse agonist Rp-cAMPS and characterize the conformational 
dynamics of the ternary complex by HDXMS. It was found that Rp-cAMPS stabilizes RIαA in the ‘H’ 
conformation but simultaneously initiates a weak allosteric relay that serves to dissociate the complex. 
This weak allosteric relay causes an increase in entropy across the interaction interface in the PKA C 
molecule. The increased entropy and dynamics indirectly causes greater affinity at Site 1 of the 
interaction interface. It was seen that Rp-cAMPS is unable to activate the Arg209-Asp170 allosteric 
relay that ultimately leads to the disruption of the complex. This study provides insights into the 
dynamics involved in ligand mediated complex dissociation. A key conclusion from this study is an 
example of allosteric effects transmitting across protein-protein interaction interfaces. 
HDXMS is a powerful method to monitor conformational changes and allosteric effects. It has proven 
to be a highly sensitive method to probe ligand binding and elucidate protein-ligand hydrogen bonds 
with high resolution sequence specific information. 
While the activation phase of the cAMP signaling pathway is elucidated in this study, the next two 
chapters aim to understand the processes involved in the termination phase of the cAMP signaling 
pathway. The role for HDXMS in monitoring protein-ligand interactions is also explored in great 
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Monitoring Phosphodiesterase-mediated cAMP dissociation 






















2 Conformational Dynamics in Molecular Signaling II: 
Monitoring Phosphodiesterase-mediated cAMP dissociation 
from Protein Kinase A in the termination phase of cAMP 
signaling pathway 
2.1 Introduction 
The previous chapter detailed allostery and conformational dynamics in the activation phase of the 
cAMP signaling pathway. In this chapter we attempt to elucidate protein dynamics correlated with 
enzyme kinetics involved in cAMP termination pathway. While the structural biology (Zheng, Trafny 
et al. 1993, Su, Dostmann et al. 1995, Wu, Brown et al. 2004, Kim, Xuong et al. 2005, Kim, Vigil et 
al. 2006), biochemistry and dynamics of cAMP binding to the PKA R-subunit leading to PKA 
activation have been studied extensively(Herberg, Taylor et al. 1996, Gibson and Taylor 1997, 
Johnson, Akamine et al. 2001, Esposito, Sjoberg et al. 2006, Abu-Abed, Das et al. 2007, Das, 
Esposito et al. 2007), very little is known on how ‘active’ PKA is reset to its ‘inactive’ state to 
complete the signaling cycle. The critical step in cAMP signal termination requires cAMP that is 
tightly bound to the R-subunit to be released (Ogreid and Doskeland 1983) and hydrolyzed by the 
large family of cAMP phosphodiesterases (PDEs) (Conti and Beavo 2007) (Figure 2.1). This is a 
critical step as cAMP binds the PKA R-subunit singularly with high affinity (KD ~ 2-10 nM) (Corbin, 
Sugden et al. 1978, Doskeland 1978, Moorthy, Gao et al. 2011) and cAMP once bound to the R-
subunit does not readily dissociate (t1/2 > 5 days) (Corbin, Sugden et al. 1978, Doskeland 1978, 






Figure 2.1: Overview of Activation and Termination phases in cAMP signaling. Second 
messenger cAMP signaling by hormonal stimulation of G-Protein-Coupled Receptors 
(GPCRs) which activate adenylyl cyclases which in turn catalyze the synthesis of cAMP 
from ATP. The principal target of cAMP in eukaryotes is Protein Kinase A ( PKA) which 
exists in the absence of cAMP as an inactive complex of Regulatory (R) (blue) and Catalytic 
(C) subunits (tan). Binding of cAMP to PKA R-subunit results in dissociation of the R-
subunit dimer and two C-subunits (activation phase). Phosphodiesterases mediate 
dissociation and hydrolysis of cAMP bound to the R-subunit to 5’AMP and reassociation 




In a recent study, it was reported that PDEs catalyze dissociation of cAMP from the R-subunit and 
this constitutes the signal termination phase of cAMP signaling (Moorthy, Gao et al. 2011). This 
occurs through a two-step process involving PDE-induced dissociation of bound cAMP followed by 
its hydrolysis. The cAMP-free R-subunit then remains bound to the PDE (Figure 2.2). The final step 
in the process is reassociation of the C-subunit with the cAMP-free R-subunit and dissociation of the 
PDE to complete the cAMP signaling cycle. For this study, the catalytic domain of RegA, a PDE from 
Dictyostelium discoideum (Moorthy, Gao et al. 2011) was used as a model PDE as it shows high 
homology to the entire PDE superfamily. Furthermore, it has been known to interact with both 
Dictyostelium discoideum as well as the mammalian PKA R-subunit isoform RIα (Shaulsky, Fuller et 
al. 1998).  
Figure 2.2: Two-state model for PDE-induced dissociation of cAMP from PKA R-subunit: 
Mechanism of PDE-induced dissociation of bound cAMP from RIαA. Structure of cAMP-bound PKA 
RIαA (PDB ID: 3PNA) in blue showing cAMP interacting with two critical anchoring residues, Arg209 
and Asp170. Interaction of the catalytic domain of RegA PDE (green) with RIαA by HDXMS (red), 
leads to formation of a transient ternary complex of RegAc, RIαA and cAMP. Binding of RegAc 
facilitates dissociation of cAMP. The cAMP is released from the cAMP binding pocket and is 
subsequently hydrolyzed by RegAc to 5’AMP. 
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The RIα isoform is widely prevalent in mammalian cells and exists as a dimer in solution and each 
monomer consists of two tandem cAMP binding domains (CNB domains). As in the previous chapter, 
in order to monitor the kinetics of cAMP dissociation, the double deletion mutant, RIα (91-244) 
(henceforth referred to as RIαA) was used. This deletion mutant still retains full functionality with 
respect to its ability to inhibit the PKA C-subunit in a cAMP-dependent manner (Anand, Taylor et al. 
2007). This deletion mutant was also shown to interact with the catalytic domain of RegA (RegAc) 
via a distinct interface contributed primarily by the β-sheet containing subdomain (Moorthy, Gao et 
al. 2011). This together with deletion mutagenesis and fluorescence polarization assays confirmed that 
RegAc interacted with cAMP-bound RIα, facilitated dissociation of the bound cAMP (koff = 0.5 min-1) 
followed by hydrolysis, in a two-step reaction (Figure 2.2). Given that we now know structures and 
dynamics of the apo and cAMP-bound R-subunit (Badireddy, Yunfeng et al. 2011) as well as an 
HDXMS-based interaction map of RegAc-bound to apo R-subunit (Moorthy, Gao et al. 2011), we 
were interested in mapping the ternary complex of RegAc-bound to cAMP-bound R-subunit by 
HDXMS. We reasoned that this ternary complex would provide important insights into how PDEs 
mediate dissociation of cAMP bound to PKA R-subunit.   
We therefore set out to characterize this ternary complex intermediate formed by the interactions of 
cAMP-bound RIαA with RegAc. Since cAMP is readily hydrolyzed by the PDE, it was critical to use 
a PDE nonhydrolyzable cAMP analog to characterize this intermediate complex. cAMP 
phosphorothioates have been invaluable for uncovering the mechanism  of cAMP action(Schwede, 
Maronde et al. 2000). Substitution of the equatorial oxygen of cAMP with sulfur (R-enantiomer) 
generates an antagonist or inverse agonist (Rp-cAMPS) while substitution of the axial oxygen (S-
enantiomer), the cAMP agonist generates an agonist (Sp-cAMPS) (Dostmann and Taylor 1991). 
Comparing the structure and dynamics of agonist and antagonist-bound states of PKA revealed that 
‘Conformational Selection’ best explained the basis for cAMP allostery wherein unliganded RIαA 
referred to as the apo form in the rest of the text,  existed as an ensemble of conformations. Sp-
cAMPS ‘selected’ the cAMP-bound (B) conformation whereas Rp-cAMPS ‘selected’ the inactive (H) 
conformation (Badireddy, Yunfeng et al. 2011).  
45 
 
In order to monitor dynamics of the PDE-PKARIα-cAMP ternary complex intermediate, we used 
amide hydrogen/deuterium exchange mass spectrometry (HDXMS) (Hoofnagle, Resing et al. 2003). 
This powerful method has been extensively used to map protein-ligand and protein-protein 
interactions but we wanted to examine its suitability for monitoring dynamics of transient ternary 
ligand-protein-protein complexes. In this study, we have used HDXMS for monitoring the RegAc-
mediated dissociation of the cAMP reaction and map interactions in the ternary complex of RegAc, 
RIαA and Sp-cAMPS. Our results indicate that RegA interacts with cAMP-bound R-subunits to 
generate a ternary complex. This complex is highly dynamic leading to active cAMP dissociation 
while maintaining the RegA-RIα complex. Our results thus support the two step model for RegA-
mediated cAMP dissociation and enable monitoring ternary complex formation at early time points 
and cAMP dissociation. This study highlights a novel application of HDXMS in capturing the 
dynamics of transient protein-protein-ligand complexes. 
2.2 Materials and Methods 
2.2.1 Reagents 
Unless otherwise mentioned all reagents were from Sigma Aldrich (St. Louis, MO). CIAP (calf 
intestinal alkaline phosphatase) was from Fermentas (Burlington, Canada).  BL21 (DE3) E.coli strains 
were from Novagen (Madison, WI). Glutathione sepharose 4B and NHS-activated sepharose 4 Fast 
Flow were obtained from GE (Chicago, IL). 8-AEA-cAMP and 3’,5’– cyclic adenosine 
phosphorothioate, Sp-isomer or Sp-cAMPS, were from Biolog Life Science Institute (Bremen, 
Germany), cyclic nucleotide phosphodiesterase assay kit was from BIOMOL (Plymouth Meeting, 
PA), TFA protein sequence analysis grade was from Fluka BioChemika (Buchs, Switzerland), 
Poroszyme immobilized pepsin cartridges were from Applied Biosystems (Foster city, CA).   
2.2.2 Purification of RIαA and RegAc (RegA (385-780))  
RIαA was purified using cAMP affinity chromatography resin synthesized by coupling 8-AEA-cAMP 
to NHS-activated sepharose 4 Fast Flow ® beads according to manufacturer specifications (GE Life 
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Sciences Singapore) and purified first as a cGMP-eluted protein. Apo RIαA was then obtained by 
removing weakly bound cGMP by dialysis and size-exclusion chromatography as previously 
described (Moorthy, Gao et al. 2011). RegAc or RegA (385-780) was expressed as a GST fusion 
protein in E. coli BL21*(DE3). The protein was purified using glutathione sepharose 4B (GE Life 
Sciences) according to manufacturer specifications followed by size exclusion-gel filtration 
chromatography as described (Moorthy, Gao et al. 2011). The RIαA:RegAc complex was purified by 
immobilizing purified GST-tagged RegAc on glutathione beads and incubating with equimolar ratios 
of RIαA at concentrations greater than the estimated Kd ~ 1.5 µM, whereby apo RIαA would be fully 
saturated with RegAc as described previously (Moorthy, Gao et al. 2011). This was concentrated to 
~7mg/ml total protein using vivaspin concentrators (Sartorius Stedim Biotech GmbH, Goettingen, 
Germany). The complex was then incubated with 3 mM (final concentration) Sp-cAMPS.  
2.2.3 Amide Hydrogen/Deuterium Exchange Mass Spectrometry (HDXMS) 
A 2 μl aliquot of protein samples RIαA bound to Sp-cAMPS and RIαA: RegAc in the presence of 
excess Sp-cAMPS (3 mM or 30 mM final concentration) in 20 mM Tris HCl, 50 mM NaCl, 10 mM 
MgCl2, 5 mM BME, pH 7.5 was mixed with 18 μl of D2O (99.90%) resulting in a final concentration 
of 90.0% in D2O buffer (20 mM Tris HCl, 50 mM NaCl, 5 mM BME, pHread 7.5) to initiate the 
deuterium exchange reaction. Exchange was carried out at 20ºC for various times (1, 2, 5 and 10 min).  
The exchange reaction was quenched by adding 40 μl of pre-chilled 0.1% TFA to obtain a final pHread 
of 2.5. 50 μl (100 pmol protein) of the reaction sample was then injected on to a chilled nano-UPLC 
sample manager (beta test version, Waters, Milford, MA) as previously described(Wales, Fadgen et 
al. 2008).  Proteolysis of protein samples was achieved by passing the sample through a 2.1 x 30 mm 
immobilized pepsin column (Porozyme, ABI, Foster City, CA) using 100 μL/min of 0.05% formic 
acid in water.  The digest peptides were trapped on a 2.1 x 5 mm C18 trap (ACQUITY BEH C18 
VanGuard Pre-column, 1.7 μm, Waters, Milford, MA). Peptides were eluted using an 8-85% gradient 
of acetonitrile in 0.1% formic acid at 40 μL/min, supplied by a nanoACQUITY Binary Solvent 
Manager (Waters, Milford, MA), on to a reverse phase column (ACQUITY UPLC BEH C18 Column, 
1.0 x 100 mm, 1.7 μm, Waters, Milford, MA) for resolution. Peptides were detected, mass measured 
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and sequenced on a SYNAPT HDMS mass spectrometer (Waters, Manchester, UK) acquiring in MSE 
mode (Bateman, Carruthers et al. 2002, Silva, Denny et al. 2005). 
Peptides were identified by MSE data of undeuterated samples using Protein Lynx Global Server 
(PLGS 2.4 (beta test version)) (Waters, Milford, MA) (Li, Vissers et al. 2009). These identifications 
were mapped on to subsequent deuteration experiments using DynamX HDX software (Version 
1.3.0.25(64-bit) (Waters, Milford, MA).   
Continuous instrument calibration was carried out with Glu-Fibrinogen peptide (GFP) at 100 fmol/μL. 
We also visually examined the data to ensure only well-resolved peptide isotopic envelopes were 
subjected to quantitative analysis.  The centroid masses for the isotopic envelopes of all the peptides 
which reflected the average mass of the peptide were generated by the DynamX software. Deuterium 
exchange of each pepsin digest fragment was calculated by subtracting the centroid of the 
undeuterated sample from that of the deuterium exchanged sample. The N-terminal amide of all the 
peptide fragments exchanges too rapidly to measure and was not included in calculation of average 
deuterons exchanged (Bai, Milne et al. 1993, Hoofnagle, Resing et al. 2003). All deuterium exchange 
values reported were corrected for a 32.8% back exchange by multiplying the raw centroid values by 
a multiplication factor of 1.49 (Anand, Krishnamurthy et al. 2010, Moorthy, Gao et al. 2011).  
2.2.4 Phosphodiesterase Assay 
 GST RegAc was assayed for cAMP hydrolytic activity using a colorimetric cyclic nucleotide 
phosphodiesterase assay (BIOMOL, Plymouth Meeting, PA) as described previously(Moorthy, Gao et 
al. 2011). 
2.3 Results and Discussion 
We have previously used HDXMS in cAMP signaling to map interactions of cAMP and its analogs 
with RIαA (Badireddy, Yunfeng et al. 2011) and interactions of apo RIαA with RegAc (Moorthy, Gao 
et al. 2011). A new method of displaying HDXMS results has been via mirror-plots which plot the 
relative deuterium exchange for each pepsin digest fragment of interest (Houde, Berkowitz et al. 
2011). Even though this plot does not factor in the nonuniform cleavage of the target protein by 
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pepsin or including the possibility of generating nested peptides by giving an impression of regularly 
spaced pepsin digest fragments of uniform sizes, it nevertheless allows rapid identification of regions 
showing altered deuterium exchange within the entire protein. A difference plot highlights the 
differences in exchange where positive and negative differences indicates greater or less exchange in 
the sample on top compared to the sample on the bottom of the plot respectively. We set out to map 
the ternary complex of RegAc and RIα in the presence of molar excess of Sp-cAMPS by HDXMS 
and used a combination of mirror and difference plots to obtain a protein-wide overview of the 
differences between the two states and probe the dynamics of the ternary complex. Sp-cAMPS is 
resistant to PDE hydrolysis according to reagent specifications (Biolog, Bremen, Germany) and this 
allowed us to use Sp-cAMPS to characterize the ternary RegAc-RIαA-Sp-cAMPS complex. 
2.3.1 Dynamics of RegAc-RIαA interactions in the presence of excess Sp-
cAMPS 
GST-tagged RegAc was used to pull-down apo RIαA as described in Materials and Methods  
(Moorthy, Gao et al. 2011) and incubated with an excess of Sp-cAMPS as described in Materials and 
Methods. While we predicted that RIα would mediate mutually exclusive interactions with Sp-
cAMPS and RegAc, we estimated that an excess of Sp-cAMPS (3 mM), significantly greater than the 
50 uM protein concentration, would maintain the ternary complex. This was then diluted 10-X fold 
with buffer prepared in D2O to initiate the deuterium exchange reaction. Deuterium exchange was 
carried out for 1, 2, 5 and 10 min and the results are shown in Figure 2.3 in the form of a mirror plot 








cAMPS RIαA and 
RegAc: RIαA: Sp-
cAMPS complex : 




exchange for each 
peptide from the N 
to C terminus of 
RIαA for the Sp-
cAMPS bound state 
of RIαA and in a 
RegAc: RIαA:Sp-
cAMPS complex. 
(B) A ‘difference 
plot’, plotting the 
difference in 
absolute deuterium 
uptake between the 
Sp-cAMPS bound 
state of RIαA and   
RIαA:RegAc:Sp-
cAMPS bound complex state. Two regions of the protein showed significant increases in deuterium exchange difference are boxed in dark red. The residues 
spanning the cAMP binding pocket (PBC) (Residues 203-222) are boxed in purple. These residues show decrease in deuterium exchange difference for 
shorter labeling times (<2 min Dex) but this effect is inverted after longer labeling times. Dashed box in red shows an enlarged view of this segment on the 
difference plot (C) Structure of cAMP-bound RIαA (PDB ID: 3PNA), with the N-terminal regions (residues 113-127) showing significant increased exchange 
in the presence of RegAc in dark red. The cAMP binding pocket residues (199-210) are in purple and show decreased deuterium exchange at 1 min and 
increased exchange at later time points. 
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The three important loci for conformational dynamics all showed changes in deuterium exchange 
although the magnitude differences in exchange between the two states were smaller than Sp-cAMPS-
bound compared to apo RIA (Badireddy, Yunfeng et al. 2011), (summarized in Figure 2.4A) and 
RegAc-bound apo RIA compared to apo RIA (Moorthy, Gao et al. 2011), (Figure 2.4B).  
Figure 2.4: Loci showing significant changes upon cAMP/RegA binding on RIαA: Comparative 
HDXMS analysis of ligand free and Sp-cAMPS bound states of RIαA. Structure of ligand free RIαA 
(PDB ID: 3IIA) (top). Structure of RIαA bound to cAMP (PDB ID: 3PNA). Structures are color coded 
on the basis of crystallographic B-factor values, with blue and red representing the lowest and highest 
relative B–factor values. Green arrows highlight the three regions showing the biggest shifts in 
deuterium exchange upon Sp-cAMPS binding. (B) Comparative HDXMS analysis of ligand free and 
RegAc bound states of RIαA Structure of ligand free apo RIαA (PDB ID: 3IIA) and color coded on the 
basis of crystallographic B-factor values (top), structure of ligand free apo RIαA (PDB ID: 3IIA) with 
regions showing significant changes in deuterium exchange in red. Green arrows highlight the two 
regions showing the greatest changes upon binding of RegAc (II, III) which also correspond to the 
regions showing greatest shifts upon binding Sp-cAMPS. 
 
Deuterium exchange (corrected for deuterium back exchange of 32.6%) after 10 min labeling for all 
37 pepsin digest fragment peptides of RIA are listed in Table 2.1.  
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Table 2.1.  Summary of H/D exchange data for SpcAMPS-bound RIαA and SpcAMPS-bound RIαA:RegA 
          Maximum Deuterons   
No. Pepsin digest fragments  Charge Residue  Maximum Exchanged after 10 min  







  (m/z)     amides (Mean ± Error) (Mean ± Error)  
1 GCRRRGAISAE (588.30) 2 91-101 10 3.6 ± 0.0 6.3 ± 0.4  
2 AEVYTEE (840.36) 1 100-106 6 3.6 ± 0.0 4.9 ± 0.1  
3 EVYTEE (769.32) 1 101-106 5 2.7 ± 0.0 3.7 ± 0.1  
4 VYTEE (640.28) 1 102-106 4 1.9 ± 0.0 2.7 ± 0.0  
5 DAASY (526.21) 1 107-111 4 2.4 ± 0.1 3.0 ± 0.0  
6 YVRKVIPKD (559.34) 2 111-118 7 4.8 ± 0.0 6.3 ± 0.0  
7 YVRKVIPKDYKTM (547.95) 3 111-123 11 7.3 ± 0.0 9.7 ± 0.1  
8 YVRKVIPKDYKTMAA (595.31) 3 111-125 13 8.9 ± 0.0 11.6 ± 0.0  
9 YVRKVIPKDYKTMAAL (632.33) 3 111-126 14 9.8 ± 0.1 12.8 ± 0.1  
10 YKTMAA (684.34) 1 120-125 5 3.4 ± 0.0 4.2 ± 0.1  
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11 AALAKAIE (394.23) 2 124-131 7 1.9 ± 0.0 2.5 ± 0.1  
12 LAKAIEKNV (493.81) 2 126-134 8 4.3 ± 0.1 6.0 ± 0.0  
13 FSHLDDNE (976.91) 2 136-143 7 2.1 ± 0.0 2.4 ± 0.0  
14 FSHLDDNERSDIF (798.36) 2 136-148 12 3.3 ± 0.0 3.6 ± 0.0  
15 RSDIF (880.41) 1 144-148 6 0.3 ± 0.0 0.4 ± 0.0  
16 DAMFPVSF (913.41) 1 149-156 6 1.0 ± 0.0 1.2 ± 0.0  
17 AMFPVSF (798.39) 1 150-156 5 0.9 ± 0.0 1.6 ± 0.1  
18 FPVSF (596.30) 1 152-156 3 0.7 ± 0.0 1.0 ± 0.1  
19 IAGETV (589.32) 1 157-162 5 1.5 ± 0.1 1.9 ± 0.1  
20 IAGETVIQQGDEGDN (773.35) 2 157-171 14 5.4 ± 0.1 6.3 ± 0.1  
21 IAGETVIQQGDEGDNF (846.88) 2 157-172 15 5.1 ± 0.1 6.0 ± 0.0  
22 TVIQQGDEGDN (1175.54) 1 161-171 10 4.6 ± 0.0 5.4 ± 0.0  
23 VIQQGDEGDNF (1221.58) 1 162-172 10 4.8 ± 0.0 4.8 ± 0.0  
24 FYVIDQGEM (1101.50) 1 172-180 8 1.2 ± 0.0 1.3 ± 0.1  
25 FYVIDQGEMD (1216.52) 1 172-181 9 1.3 ± 0.0 1.5 ± 0.0  
26 DVYVNNE (852.37) 1 181-187 6 1.6 ± 0.0 1.6 ± 0.0  
27 WATSVGEGGSF (1097.49) 1 188-198 10 4.5 ± 0.0 5.5 ± 0.1   
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28 ALIYGTPRAAT (567.31) 2 202-212 9 3.9 ± 0.0 4.0 ± 0.0  
29 ALIYGTPRAATVKAKT (554.63) 3 202-217 14 4.8 ± 0.1 5.1 ± 0.1  
30 ALIYGTPRAATVKAKTNVKL(705.75) 3 202-221 18 3.2 ± 0.0 3.4 ± 0.0  
31 LIYGTPRAATVKAKTNVK (644.00) 3 204-220 16 3.6 ± 0.1 3.4 ± 0.0  
32 YGTPRAAT (836.43) 1 205-212 6 3.0 ± 0.0 2.8 ± 0.0  
33 VKAKTNVKL (501.33) 2 213-221 8 1.3 ± 0.0 1.3 ± 0.00  
34 KTNVKL (351.72) 2 216-221 5 0.6 ± 0.0 0.6 ± 0.0  
35 WGIDRDSY (1011.45) 1 222-228 7 1.5 ± 0.0 1.6 ± 0.0  
36 RRILMGST (467.26) 2 230-237 7 3.1 ± 0.0 3.7 ± 0.0  
37 RRILMGSTL (1046.61) 1 230-238 8 3.6 ± 0.0 4.5 ± 0.00  
               
  






A detailed description of the HDXMS in each of the important loci is provided below: 
cAMP-binding site (PBC) shows decreased exchange in the presence of RegAc at early timepoints 
and increased exchange at later time points of HDXMS: 
When we examined deuterium exchange at the phosphate binding cassette (Figure 2.4), which is the 
most important locus for RegAc and cAMP binding containing the linear motif of invariant residues 
(residues 199-210) required for high affinity cAMP binding(Canaves and Taylor 2002), we observed 
a surprising result. After 30s or 1 min HDXMS, we observed decreased exchange in RIα: RegA:Sp-
cAMPS compared to RIα:Sp-cAMPS but no differences at the 2 and 5 min time points. Interestingly, 
this pattern was reversed with the same peptide from RIα:RegA:Sp-cAMPS showing increased 
exchange after 10 min deuterium exchange (Figure 2.3). Under our experimental conditions, we had 
expected to capture the ternary complex and this would have translated into decreased exchange in 
RIα:RegA:Sp-cAMPS relative to RIα:Sp-cAMPS at all time points of exchange, reflecting formation 
of the ternary complex but instead we observed an inversion in magnitude of relative exchange from 
the 1 min to 10 min time point of deuterium exchange (Figure 2.5).  
These results indicate that in addition to dynamics of the ternary complex, we were also monitoring 
PDE-dependent dissociation of cAMP from RI. It appeared that under conditions prior to deuterium 
exchange, the ternary complex was indeed maintained under excess Sp-cAMPS conditions (3 mM). 
However, upon initiation of the deuterium exchange reaction by 10-X dilution of the samples in 
buffered D2O, RegA actively mediated dissociation of Sp-cAMPS from the R-subunit and blocked 
reassociation of excess Sp-cAMPS. This explains the inversion in the difference plot and are 
consistent with the rates of RegA-mediated active dissociation of cAMP bound to RIA ( kcAMPdissociation 
= 0.5 min-1) measured with PDE-resistant 8-Fluorescein-cAMP (Moorthy, Gao et al. 2011). cAMP 
dissociation from the R-subunit takes a full minute only after which increases in deuterium exchange 
were observed. This indicates that at all time points less than 1 min under our HDXMS reaction 
conditions, we were monitoring deuterium exchange in a ternary complex of PDE, RI and Sp-
cAMPS. After 1 min, HDXMS is probing the dynamics of mutually exclusive interactions of the PBC 




Figure 2.5: Maintaining ternary complex under high ligand concentrations: Left panel: ESI-Q-
TOF mass spectra for a peptide spanning residues 202-221 (m/z= 705.75, z=3) for apo RIαA, Sp-
cAMPS-bound RIαA,  Sp-cAMPS-bound RIαA in the presence of RegAc (300 µM Sp-cAMPS) and  
Sp-cAMPS-bound RIαA in the presence of RegAc (3 mM Sp-cAMPS) after 1 min deuterium 
exchange as indicated. Right panel: isotopic envelope shifts after 10 min deuterium exchange. 
Centroids for mass spectra are indicated by ▲. 
 
It should be noted that Sp-cAMPS behaves identically to cAMP in kinetic assays and 
HDXMS and we anticipate that Sp-cAMPS shows the same slow off-rate from RIα as cAMP. 
In our study this is reflected in a constant magnitude of decreased exchange in Sp-cAMPS-
56 
 
bound RIA for all time points relative to apo RI. Furthermore, it is clear that under 
reduced Sp-cAMPS concentrations in our HDXMS experimental conditions (300 M), 
RegAc (estimated to be 5 M) is capable of blocking reassociation of Sp-cAMPS. To 
unequivocally demonstrate existence of the ternary complex at higher concentrations of Sp-
cAMPS, we carried out HDX-MS of RIαA in the presence of RegAc at a 10-X fold higher 
starting concentration (30 mM) which upon dilution in deuterated buffer resulted in a 
concentration of Sp-cAMPS of 3 mM. Under these conditions, the phosphate binding cassette 
did not show any inversion of deuterium exchange shifts at the 1 min and 10 min time points 
of deuterium exchange (Figure 2.5), confirming that higher concentrations of Sp-cAMPS 
maintain the ternary complex.  This validated our original assumption for stabilization of the 
ternary complex at concentrations of Sp-cAMPS (3 mM) and interestingly revealed the time-
dependent dissociation under deuterium exchange conditions (300 µM Sp-cAMPS). 
 
Molecular basis for adaptation in cAMP signaling:  
The inversion in deuterium exchange differences under a reduced molar excess (300 µM) at 
early and late time points is highly significant as it explains the basis for adaptation in cAMP-
PKA signaling. It has been a mystery why PKA is suited to respond to a flux of cAMP rather 
than to fixed levels of cAMP (Leiser, Fleischer et al. 1986). Our surprising results from 
HDXMS, where we ended up monitoring the reaction of PDE-mediated cAMP dissociation, 
provide insights into adaptation. Once cAMP binding activates the PKA holoenzyme by 
dissociating the C-subunit, PDEs interact with cAMP-bound R-subunit and mediate the active 
dissociation and hydrolysis of bound cAMP. It is self-evident that cAMP levels cannot 
remain constant under these conditions of PDE-mediated active cAMP dissociation and 
hydrolysis. That RegAc is capable of blocking cAMP reassociation to PKA R-subunit at a 
specific range of concentrations (300 M but not 3 mM) further indicates that PDEs block 
57 
 
reassociation of cAMP and function to reset cAMP signaling to prime it for subsequent 
activation by fluxes of cAMP. This constitutes the basis for adaptation in cAMP signaling. 
Changes in RegAc and Sp-cAMPS interaction surface Region II (residues 161-172): 
 The -strand proximal to the PBC also shows increased deuterium exchange in the dynamic 
ternary complex (Figure 2.6). Based on subtractive analysis of overlapping peptides (Table 
2.1), the motif consisting of residues 161-163 (Thr-Val-Ile) showed increased exchange in the 
presence of both RegAc and Sp-cAMPS. This motif is disordered in the structure of apo 
RIA (PDB ID:3IIA ) but ordered (-sheet) in the structure of cAMP-bound RI (PDB ID: 
3PNA) (Badireddy, Yunfeng et al. 2011). Since this region shows increased exchange in 
RIαA bound to Sp-cAMPS and in the presence of RegAc, it resembles apo RIα more than Sp-
cAMPS-bound RIα. We therefore believe that this increased deuterium exchange in this 
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Increased dynamics in the PKA pseudosubstrate site and N-terminal segments of RIαA : 
The N-terminal region including the PKA pseudosubstrate region and residues 113-127 show 
correlated increases in deuterium exchange in the presence of RegAc and Sp-cAMPS with 
Region II. These regions are part of the dynamic PKA C-subunit interaction interface and are 
typically most dynamic in apo RIA (Figure 2.7 and 2.8). This is part of the allosteric site that 
couples cAMP binding to PKA regulation and shows a time-dependent increase in exchange 
and reflects the active RegAc-mediated dissociation of Sp-cAMPS. Together, all the results 
are consistent with a two-state model for RegA-mediated cAMP dissociation and hydrolysis 




Figure 2.7: Effects of Sp-cAMPS dissociation on allosteric sites: Left panel: ESI-Q-TOF 
mass spectra for a peptide spanning residues 111-123 (m/z= 446.25, z=4) of RIαA for apo, Sp-
cAMPS-bound and Sp-cAMPS in the presence of RegAc after 10 min Deuterium exchange as 
indicated. Right panel: Time course of deuterium exchange fit to a single exponential association 
(Graphpad Prism 5.0, San Diego, CA). 
 
Figure 2.8: Effects of Sp-cAMPS dissociation at PKAC interaction site: Left panel: ESI-Q-
TOF mass spectra for a peptide spanning residues 92-102 (m/z= 587.80, z=2) of RIαAfor apo, Sp-
cAMPS-bound and Sp-cAMPS in the presence of RegAc after 10 min Deuterium exchange as 
indicated. Right panel: Time course of deuterium exchange fit to a single exponential association 
(Y=Ymax*(1-exp(-K*X) (Graphpad Prism 5.0, San Diego, CA). 
2.4 Conclusions:  
We have examined dynamics of a transient ternary complex formed by PKA R-subunit, 
RegA PDE and a nonhydrolyzable cAMP analog, Sp-cAMPS. The R-subunit mediates 
mutually exclusive interactions with RegAc and Sp-cAMPS. RegAc mediates the active 




In an experiment using lower concentrations (300 µM final concentration) of Sp-cAMPS it 
was seen that the ternary complex was observable at earlier time points of the experiements, 
but as labeling time increased, the Sp-cAMPS was actively dissociated from the pocket. It 
was interesting to note that even though Sp-cAMPS was at a 100 fold higher concentration to 
the RegAc: RIαA complex, reassocation of Sp-cAMPS was not observed. This indicates that 
under specific concentrations of Sp-cAMPS, RegAc was effective in blocking reassociation. 
When Sp-cAMPS concentration was increased, the ternary complex was observed for the all 
labeling times.  
This provides a model for adaptation, where the cAMP signaling pathway is reactivated only 
in the presence of large fluxes of cAMP rather than the basal cAMP levels in the cytoplasm. 
In addition to mapping the dynamics of the reaction, our results highlight the molecular basis 
for PDE action in promoting cAMP signal termination.  
Our study highlights that with the right conditions, HDXMS can be a powerful tool for 
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3 Conformational Dynamics in Molecular Signaling III: Active 
site coupling in PDE-PKA Complexes Promotes cAMP Signal 
Termination 
3.1 Introduction 
While the previous study monitors cAMP dissociation from the cAMP binding pocket of RIα, this 
study aims to map the interaction interface of PDEs with RIα. Cyclic AMP levels are controlled both 
by GPCR-mediated activation of adenylyl cyclases, that synthesize cAMP from ATP (Kamenetsky, 
Middelhaufe et al. 2006), and phosphodiesterases (PDEs) that catalyze hydrolysis of cAMP to 5’AMP 
(Conti and Beavo 2007). Even though cAMP is synthesized by adenylyl cyclases that are 
predominantly at the plasma membrane, it does not diffuse uniformly throughout the cell and instead 
exists in pools or microdomains (Rich, Fagan et al. 2001, Steinberg and Brunton 2001, Conti and 
Beavo 2007). This has been attributed to diverse PDEs that function to limit cAMP diffusion. An 
alternative explanation for the limited cAMP diffusion is via ‘channeling’ of cAMP from cyclases to 
PDEs through the cAMP receptors in large macromolecular complexes (Davare, Avdonin et al. 2001). 
The cAMP signaling pathway can be divided into the activation and termination phase (Figure 3.1). 
While the activation phase is well studied, how the cAMP-PKA signaling system resets itself by 
regenerating inactive PKA holoenzyme can be defined as the termination phase and very little is 
known about this process. cAMP binds the PKA R-subunit with strong affinity (~ 2-10 nM) (Herberg, 
Dostmann et al. 1994) and a major gap in cAMP signaling is in identifying how the tightly bound 
cAMP is released from the R-subunit. This is critical to allow reassociation with the C-subunit and 
resetting of the system through formation of the inactive PKA holoenzyme. A role for PDEs in 
termination by catalyzing hydrolysis of bound cAMP has come from recent studies with a cAMP PDE 
from Dictyostelium discoideum, RegA (Moorthy, Gao et al. 2011), where RegA is capable of a two-
step dissociation and hydrolysis of cAMP bound to PKA R-subunit (Krishnamurthy, Moorthy et al. 
2013). The first step in the termination pathway can be defined as the ‘Encounter complex’ where the 
PDE first ‘encounters’ cAMP bound PKA R-subunit (Figure 3.1). PDE-PKA interactions mediate the 
dissociation and hydrolysis of cAMP from PKA R-subunit leading the ‘End-state’ complex. This is 
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critical since cAMP remains tightly bound to the R-subunit and shows negligible dissociation rates 
(Corbin, Sugden et al. 1978, Doskeland 1978) in the absence of the C-subunit.  However the nature of 
PDE-RIα interactions is completely unknown. Furthermore, no such interactions have been reported 
in mammalian cAMP signaling whose complexity arises from myriad types/isoforms/splice variants 
of PDEs (Conti and Beavo 2007) and PKA as well as the presence of diverse scaffold proteins, the A-
Kinase Anchoring Proteins (AKAPs) (Dodge, Khouangsathiene et al. 2001).  
Figure 3.1: Role of PDEs in signal termination of PKA mediated cAMP pathway: The cAMP-PKA 
signaling pathway can be divided into Activation and Termination phases. Activation phase: In the 
presence of cAMP (yellow) and a kinase substrate (orange), the inactive PKA holoenzyme dissociates 
to yield cAMP bound PKA R-subunit (blue) and active PKA C-subunit (purple). Termination phase: 
PDEs in green mediate direct interactions with PKA R-subunit to hydrolyze cAMP bound to both 
CNB domains of PKAR.  The resulting cAMP-free (apo) PKAR (green) is primed for reassociation 
with PKA C-subunit to form the inactive PKA holoenzyme. How PDEs interact with RIα and catalyze 
hydrolysis of cAMP bound to the R-subunit to 5’AMP is unknown and a focus of this study 
(highlighted in red). Space filling models based on coordinates of structures of the different proteins 
are indicated. C-subunit (PDB ID: 1ATP), R-subunit (cAMP-bound PKA RIα(113-379) (PDB ID: 
1RGS)), RIα(91-379):C complex (PDB ID:2QCS). Only the monomeric deletion fragment of PKA 
RIα (residues 113-379) is shown. Apo RIα (green) is modeled on the structure of RIα (91-379) bound 
to PKA C-subunit (PDB ID:2QCS). 
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In this study we report, a mammalian PDE-PKA RIα complex through an integrated approach 
combining structural mass spectrometry, fluorescence with computational methods. While 
localization of PDEs with PKA R-subunits have been observed with specific classes of AKAPs 
(Dodge, Khouangsathiene et al. 2001), we describe for the first time AKAP-independent interactions 
between PKA and PDEs in a mammalian system. We also describe a mechanism for PDE-mediated 
dissociation of cAMP from the two binding sites on the R-subunit. The binding interface residues on 
RegA mapped by hydrogen/deuterium exchange mass spectrometry (HDXMS) was used to 
computationally identify and establish PDE8 as a cAMP-PDE interacting partner using cAMP 
dissociation assays. A combination of HDXMS and computational docking was then used to map and 
model the PDE8-RIα interface. The power of computational docking has been greatly improved by 
combination with HDXMS, which provides experimental filters for narrowing the solutions for 
protein interfaces. This has been used for mapping protein-protein interactions (Anand, Law et al. 
2003, Pandit, Tuske et al. 2012) and protein-DNA interactions (Roberts, Pique et al. 2012). The R-
subunit is highly modular and is composed of an N-terminal dimerization domain, a pseudosubstrate 
site and two tandem CNB domains (Johnson, Akamine et al. 2001). The CNB domains are capable of 
functioning as high affinity binders of both cAMP and C-subunit in the absence of the dimerization 
domain. This has made it possible to use monomeric deletion mutant constructs of pseudosubstrate 
region with CNB-A alone (Residues 91-244) or as a construct spanning both CNB domains A and B 
together with the pseudosubstrate region (Residues 75-379)  for detailed mapping of PDE-R-subunit 
interactions. These are referred to as RIαA and RIαAB respectively.  Of the two PDE8 isoforms, we 
have used full length PDE8A in this study or a deletion mutant spanning its catalytic domain (residues 
472-829), henceforth referred to as PDE8AC. 
Our results provide a model which describes a mechanism for how PDE8 catalyzes hydrolysis of 
cAMP tightly associated with RIα. It also presents a unified explanation for how PDE-cAMP-
receptors might form extended macromolecular complexes functioning as regulatory barriers for 
cAMP diffusion.  PDEs are thus an entirely new class of RIα interacting partner proteins involved in a 
novel mechanism for cAMP signal termination. 
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3.2 Materials and Methods 
3.2.1 Materials 
Unless otherwise mentioned all reagents were from Sigma Aldrich (St. Louis, MO).  BL21 (DE3) 
E.coli strains were from Novagen (Madison, WI). Glutathione sepharose 4B and NHS-activated 
sepharose 4 Fast Flow were obtained from GE (Chicago, IL). 8-AEA-cAMP was from Biolog Life 
Science Institute (Bremen, Germany), TFA protein sequence analysis grade was from Fluka 
BioChemika (Buchs, Switzerland), Poroszyme immobilized pepsin cartridge was from Applied 
Biosystems (Foster city, CA). Purified recombinant GST-tagged PDE2A (catalog # 60020), 
PDE5A(catalog # 60050), PDE8A (catalog # 60080)  and PDE9A (catalog # 60090) were purchased 
from  BPS Bioscience (San Diego, CA). Recombinant GST-tagged PDE8A (1mg/ml) was also 
obtained from Signal Chem (Richmond, Canada) for HDXMS experiments.  
3.2.2 Subcloning of PDE8AC and full length RIα into pETDuet-1 vector 
Oligonucleotide primers for PDE8A1 catalytic domain spanning residues 472-829, were designed 
using codon optimized Human PDE8A1 synthetic gene as a template (DNA 2.0, Menlo Park, CA). 
The DNA fragments were amplified by PCR and subcloned using BamHI and NotI restriction 
enzymes into Multiple Cloning Site 1 (MCS1) of pETDuet-1 vector containing a hexahistidine tag, N-
terminal to the protein sequence. Full length RIα was cloned into Multiple Cloning Site 2 (MCS2) of 
pETDuet-1 using NdeI and KpnI restriction enzymes.  
3.2.3 Protein expression and purification 
We hypothesized that co-expression of full length RIα with PDE8AC in E.coli BL21 (DE3) cells might 
aid solubility of PDE8AC. Though some of the PDE8ACwas found to be soluble, most of it was still 
present in inclusion bodies. To improve yields of soluble PDE8AC, refolding of inclusion bodies with 
denaturants was carried out. Thus the pellet with insoluble PDE8AC was denatured by 6M 
Guanidinium Hydrochloride and the solubilized PDE8AC was purified by affinity chromatography 
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using Cobalt affinity His-Tag resin (Clontech Laboratories, Mountain View, CA). PDE8AC was 
refolded by a previously described protocol (Yan, Wang et al. 2009), with the only modification that 
the Hexahistidine tag was not removed by thrombin cleavage. 
cAMP affinity chromatography resin for R-subunit purification was synthesized by coupling 8-AEA-
cAMP to the NHS-activated sepharose 4 Fast Flow ®  beads according to manufacturer specifications 
(GE Life Sciences Singapore) (Diller, Xuong et al. 2000). Both cAMP-bound and cAMP-free RIαA 
were expressed and purified as described previously (Anand, Taylor et al. 2007). cAMP-bound RIαAB 
was expressed and purified by cAMP affinity chromatography resin similar to RIαA. cAMP-free 
RIαAB was prepared by the dissociation of cAMP by urea stripping and refolding (Buechler and Taylor 
1991). RegA (385-780) (RegAC) was expressed as a GST fusion protein in E. coli BL21*(DE3). The 
protein was purified using glutathione sepharose 4B (GE Life Sciences) according to manufacturer 
specifications followed by size exclusion-gel filtration chromatography on an AKTA system (GE Life 
Sciences) (Moorthy, Gao et al. 2011). 
3.2.4 Fluorescence polarization (FP) assay for cAMP dissociation 
To determine if all PDEs were capable of dissociating bound cAMP from RIα, we carried out a 
fluorescence polarization (FP) assay using 8-(2-[Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- 
cyclic monophosphate (8-Fluo-cAMP) saturated RIαA as described (Moorthy, Gao et al. 2011) with 
PDEs 2A,5A, 8A and 9A. A Biotek Synergy 4 Multi-Detection microplate reader (Winooski, VT) was 
used in FP mode for the plate reader assays. The excitation and emission wavelengths used were 485 
nm and 528 nm, respectively with a bandwidth of 20 nm with an instrument G-factor of 0.87. 96-well 
black plates were from Greiner (Germany). The FP signals for 0.12 μM of 8-Fluo-cAMP bound RIαA 
in buffer A (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME) were monitored  in 
the presence of a 10-X fold molar excess PDE ( Figure 3A) and  were repeated with equimolar 
PDE8A (Figure 3B). FP measurements were taken at time intervals of 2 min up to 45 min. In all 
samples, 0.5 mM cAMP/10 µM cAMP/cGMP was added at 18 min. Data from early time points (0 – 
18 min) were fit to a one phase exponential decay equation using Graph Pad Prism software version 5 
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(San Diego, CA). Fluorescence polarization experiments were carried out together with Dr. B. S. 
Moorthy, a then senior graduate student in my research group in the Department of Biological 
Sciences, National University of Singapore. 
3.2.5 Amide hydrogen/deuterium exchange mass spectrometry (HDXMS) 
To carry out HDXMS experiments of the GST-RegAC: RIαA complex, 50 μL of 20 μM GST-RegAC 
and 60 μM cAMP free RIαA (1:3 molar ratio) was incubated at room temperature for 30 min.  
HDXMS experiments with the full length PDE8A1: RIαAcomplex were carried out maintaining 
sample concentration at 6 µM of PDE8A1 and 42 µM of cAMP-free RIαA(1:7 molar ratio) in a total 
reaction volume of 4 µl for each HDXMS experiment.  
HDXMS experiments of the PDE8ACRIαAB complex were carried out in two ways. To maintain 
saturating amounts of RIαAB and maintain all available PDE8AC in complex form, 30 µM of 
PDE8ACwas incubated with 90 µM cAMP bound RIαAB (1:3 molar ratio) for 1 h on ice. For the 
inverse experiment, where saturating amounts of PDE8AC are maintained so all available RIαAB is in 
complex form, 30 µM of cAMP-bound RIαAB was incubated with 100 µM of PDE8AC(1:3.3 molar 
ratio) for 1 h on ice. HDXMS of cAMP bound RIαAB was carried out by maintaining a final cAMP 
concentration of 300 µM. HDXMS of cAMP bound RIαAB without excess cAMP was also carried out 
to monitor time dependent dissociation of cAMP from RIαAB. All samples were allowed to equilibrate 
to room temperature prior to deuterium exchange experiments. Deuterium exchange was carried out 
by diluting the samples in storage buffer (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 
mM BME) 15X for RegA:PKA R-subunit complex in D2O (99.90%) resulting in a final concentration 
of 93.3% deuterated buffer. For full length PDE8A or PDE8AC: RIαAB complexes, samples were 
diluted 10X in storage buffer resulting in a final concentration of 90% deuterated buffer. . Reaction 
monitoring experiments, where we monitored PDE-dependent catalytic dissociation of cAMP, were 
carried out by mixing 90 µM of cAMP bound RIαAB with 30 µM of PDE8AC (3:1 molar ratio) while 
simultaneously diluting in D2O storage buffer (99.9%), obtaining a final D2O concentration of 90%.   
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Exchange was carried out at 20ºC for various labeling times (0.5, 1, 2, 5 and 10 min). For initial 
experiments with full length PDE8A, only a single labeling time of 2 min was carried out. Reaction 
monitoring experiments were subjected to extended labeling times to allow the catalytic reaction to 
proceed to completion, thus labeling times for these experiments were 0.5, 1, 2,5, 10, 30 and 60 min. 
The exchange reaction was quenched by addition of pre-chilled 0.1% TFA to obtain a final pHread of 
2.5. 50 μL of the quenched sample was then injected on to a chilled nano-UPLC sample manager 
(Waters, Milford, MA) as previously described (Wales, Fadgen et al. 2008). The sample was washed 
through a 2.1 x 30mm immobilized pepsin column (Porozyme, ABI, Foster City, CA) using 100 
μL/min 0.05% formic acid in water.  The digest peptides were trapped on a 2.1 x 5 mm C18 trap 
(ACQUITY BEH C18 VanGuard Pre-column, 1.7 μm, Waters, Milford, MA). Peptides were eluted 
using an 8-40% gradient of acetonitrile in 0.1% formic acid at 40 μL/min, supplied by a 
nanoACQUITY Binary Solvent Manager (Waters, Milford, MA), on to a reverse phase column 
(ACQUITY UPLC BEH C18 Column, 1.0 x 100 mm, 1.7 μm, Waters, Milford, MA) for resolution. 
Peptides were detected and mass measured on a SYNAPT HDMS mass spectrometer (Waters, 
Manchester, UK) acquiring in MSE mode (Bateman, Carruthers et al. 2002, Silva, Denny et al. 2005). 
Peptides were identified from MSE data of undeuterated samples using ProteinLynx Global Server 
(PLGS 2.4, Waters, Milford, MA) (Geromanos, Vissers et al. 2009, Shen, Li et al. 2009). 
Identifications were only considered if they appeared at least twice out of three replicate runs and had 
a minimum of 4 digest fragment ions. These identifications were mapped on to subsequent deuteration 
experiments using prototype custom software (DynamX, Waters, Milford, MA).  Data on each 
individual peptide at every time point was extracted and analyzed using this software. Instrument 
calibration was carried out as described (Anand, Krishnamurthy et al. 2010, Moorthy, Badireddy et al. 
2011).Reported values for all HDXMS experiments are the average of at least two independent 
deuterium exchange experiments. 
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3.2.6 Docking  
The model of PKA RIαAB bound to PDE8AC was generated using the HADDOCK web server 
(Dominguez, Boelens et al. 2003) as a result of our collaboration with Dr. Kavitha Bharatham and Dr. 
Ivana Mihalek, Bioinformatics Institute, Singapore. The available crystal structures of dimeric 
PDE8AC (PDBID: 3ECN) and the cAMP-bound conformation of RIα (PDBID:1RGS) were 
considered as starting structures for the docking. Since the linker between the two cAMP domains of 
RIα is highly flexible leading to potentially large conformational changes upon binding PDE8, RIα 
was split into two CNB domain fragments, RIα_CNB-A (residues 113-235) and RIα _CNB-B 
(residues 241-379) and docked independently. The active residues that drive the docking calculations 
were selected based on regions showing decreased deuterium exchange upon complexation with 
PDE8. Since this region outlined by the experiment was large, and including residues that are buried 
in the static crystal structure, we only selected a subset of residues that were solvent exposed as the 
input for docking. The residues around the active residues were considered passive (the default 
option). The C- and N-termini were kept uncharged as they were not the actual termini. The residues 
230-235 in RIα_CNB-A and 241-250 in RIα_CNB-B, were treated as fully flexible. For each run, a 
total of 1000 structures were calculated by rigid-body minimization of the docking score. Semi 
flexible simulated annealing followed by refinement in explicit water was performed for the best 200 
solutions based on the HADDOCK score. The calculated models were clustered using a 7.5-Å 
interface RMSD cutoff. The following residues were defined as Ambiguous Interaction Restraints 
(AIR) to drive the docking:  
PDE8 residues: 526, 527, 529, 530, 531, 532, 609, 610, 611, 621, 622, 651, 652, 653, 681, 682, 683, 
686, 687, 690, 691, 693, 694, 696, 698, 699, 700, 702, 703, 706, 756, 759, 760, 761, 762, 763.  
RIα (CNB-A) residues:  128, 131, 132,133,134, 171,177, 178, 179, 189, 191, 194, 196, 197, 199, 
200, 201, 204, 205, 206, 207, 208, 210,216, 217, 218 and  
RIα (CNB-B) residues:  268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 322, 323, 324, 325, 
328, 329, 330, 331, 332, 333, 334, 335, 336, 354, 355, 356, 358, 359, 361, 362, 363 
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3.2.7 Selection of the docked pose 
The binding models of CNB-A and CNB-B to PDE8AC dimer from the docked poses of two 
independent runs were picked based on the following criteria: i) the quality of RIα contacts with the 
PDE8AC (using the native HADDOCK score), ii) the accessibility of the RIα bound cAMP to the 
catalytic site of the PDE8 AC,  and iii) whether the distance and orientation of the two independently 
docked domains was consistent with the fact that the two are connected by the RIα linker α:C-helix in 
vivo. The criterion (ii) was quantitated in an ad hoc way by counting the number of peptide atoms 
inside the sphere that can be inscribed between the centers of the cAMP binding pockets in PDE and 
RIα. Namely, if our model is correct, we expect that the cAMP binding pockets in the two proteins 
should be mutually accessible, allowing the transfer of the substrate between the two. Thus we look 
for a configuration of the complex in which as few peptide atoms as possible appear in the space 
between the two pockets. The criterion (iii) was tested by manually modeling back in the central 
helix. 
3.3 Results 
3.3.1 Peptide Array Analysis identifies locus of contiguous RegA:RIα 
Interactions* 
We applied peptide array analysis to independently probe the binding site for full-length RIα on 
RegA. A library of overlapping peptides of 15-mers from the primary sequence of RegA, each 
frameshifted by 5 amino acids was synthesized and immobilized on a cellulose membrane (A2 to D8 
in Figure 3.2) as described (Burns-Hamuro, Ma et al. 2003). The cellulose membrane was then 
incubated with cAMP-free full length RIα followed by extensive washing. The bound RIα was then 
detected with RIα specific antibodies followed by secondary antibodies similar to immunoblotting 
assays (Sathyanarayana, Houde et al. 2009). Dark spots reflect direct interaction sites with RIα, 





overlapping peptides where binding to RIα was detected (Bogacheva, Bogachev et al. 2008). Analysis 
of the modeled structure of RegA based on that of PDE8A showed that the two overlapping sets of 
interacting peptides are contiguous. Consecutive peptides showing positive interactions span residues 
516-540 important for divalent metal binding and catalysis. A second region included overlapping 
peptides 556-570, 561-575 and 566-580 that together with the first set highlights the linear loci for 
interactions with the CNB:A domain of RIα (Figure 3.6B). 
Figure 3.2: Peptide array data shows interaction of RIα with RegA: Peptides that interacted 
with RIα generated dark spots in contrast to non-interacting peptide (blank spots) and 
peptides interacts specifically with RIα are shown in red box. Spot numbers (A2 to D8) relate 
to peptides in the scanned array (A2 to D8,  spot A2 → 301-315 residues, spot A3 → 306-
320 residues and so on to D8→ 781-793) and whose sequence which interacts specifically are 
listed in the table.  
3.3.2 HDXMS analysis of RIα CNB:A-RegAc interaction reveals that the 
interface encompasses the PDE catalytic active site 
To map the interface on RegA that interacted with the CNB:A domain of RIα (Moorthy, Gao et al. 
2011), we carried out HDXMS on the RIαA: RegAc complex. Prior to deuterium exchange, 
undeuterated samples of RegAc were subjected to complete proteolysis by pepsin, followed by 
peptide sequencing and identification as described in materials and methods (Moorthy, Gao et al. 
2011). Overall 32 peptides were detected, which covered ~ 81% of the RegAc sequence. These were 
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each well resolved with high signal to noise ratios (S/N = 6) and were subsequently analyzed in the 
deuterium exchange experiments. 
Based on the estimated KD (≤ 1.6 μM) for the RegAc-cAMP free RIαA complex (Moorthy, Gao et al. 
2011), excess cAMP-free RIαA (60 μM) was incubated with RegAC (20 μM) to bind RegAc to 
saturation. Deuterium exchange was then carried out as described in materials and methods. Since the 
observed rate of exchange, kobs is dependent on an interplay of both the dissociation constant and the 
intrinsic deuterium exchange rate, we factored in the upper limit of the dissociation constant to 
optimize the relative and absolute concentrations of both RegAc and RIαA. With a 3X excess of RIαA 
(60 μM) for RegAC (20 μM), we estimated complete saturation of RegAc in complex with RIαA 
(Mandell, Baerga-Ortiz et al. 2001), enabling us to monitor the changes in RegAc upon interactions 
with RIαA. A Difference plot (Houde, Berkowitz et al. 2011) was used to provide a protein-wide 
overview of the difference in relative deuterium exchange for free and RIαA bound RegAc (Figure 
3.3) for a time course ranging from 0 -10 min.  ESI-QTOF spectra for three peptides from RegAC 
which show the largest shifts in deuterium exchange (Don=10 min) upon interactions with RIαA are 
shown in Figure 3.4. Kinetic plots of deuterium exchange for these peptides (Figure 3.5) reveal 
significant differences in deuterium exchange that are observable for all of the time points monitored. 
HDXMS results for the catalytic domain of RegA were mapped onto the homology modeled PDE 
structure of the closest cAMP PDE homolog of RegA, PDE8 (PDB ID: 3ECM) using SWISS-
MODELLER) (Figure 3.6A) (Arnold, Bordoli et al. 2006, Wang, Yan et al. 2008). 
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Figure 3.3: Mapping the interaction interface of RIαA on RegAC by HDXMS: A) Difference in 
HDXMS levels (y-axis) between free RegAC and in complex with RIαA are plotted for the pepsin 
digest fragments (x-axis) analyzed in this study. Time points are represented in different colors; 
orange, brown, blue and black for 1, 2, 5 and 10 min respectively. Blue dotted boxes highlight the 
three regions (I, II and III) within RegAC showing decreased deuterium exchange in the PDE-RIα 
complex. Plots are the average from two independent HDX-MS experiment generated using the 
DynamX software (Version 2.0, Waters, Milford). 
Figure 3.4: ESI-
QTOF mass spectra 
of pepsin digest 
fragments from 
different regions of 
RegAC that showed 
significant changes 
in amide H/D 
exchange upon 
interactions with 
RIαA. (i) The 
isotopic envelope 
for the peptides 
from RegAC in the 
presence of RIαA 
after 10 min 
deuteration (ii) The isotopic envelope for the peptides from RegAC in the absence of RIαA after 10 





Figure 3.5: Time 
course (1 - 10 min) of 
deuterium exchange for 
peptides from RegAC. 
Open circle (○), RegAC 
in the absence of RIαA; 
Close circle (●), RegAC 






Within RegAC, the catalytically important M loop showed decreased exchange upon interactions with 
RIαA. From multiple sequence analyses, the residues are highly conserved across the PDE superfamily 
and are critical for the coordination of the two divalent metal ions Zn2+ and Mg2+ necessary for 
catalysis. Interestingly HDXMS results showed that pepsin fragment peptides 525-538 and 634-642, 
which span catalytically important residues H527, D528 and D639 showed significantly reduced 
exchange upon binding RIαA. Peptides spanning residues also critical for substrate cAMP recognition 
525-538, 634-642, 656-661 and 668-693 showed decreased exchange upon interactions with RIαA. 
The results enabled a detailed map of the interface which encompassed the PDE active site, when 
modeled onto the closest cAMP PDE homolog of RegA, PDE8 (PDB ID: 3ECM) using SWISS-







Figure 3.6: Summary of peptide array analysis and HDXMS of RIα-RegAc interactions mapped 
onto the structure of PDE8A: A) Results from HDXMS for the catalytic domain of RegA mapped 
onto the homology modeled PDE structure of the closest cAMP PDE homolog of RegA, PDE8 (PDB 
ID: 3ECN) using SWISS-MODELLER. Peptide fragments showing decreased exchange (after 10 min 
Deuterium exchange) in the presence of RIαA are in blue. Regions showing no difference are in green 
and regions with no pepsin-digest fragment coverage are in grey. B) Results from peptide array 
analysis for RegAC mapped onto the homology modeled PDE structure of PDE8 (PDB ID: 3ECN). 
Peptides showing direct interactions with RIα are blue. C) Composite of HDXMS and peptide array 
results mapped onto the structure of homology modeled PDE8. Regions showing decreased exchange 
are red, peptide array fragments are blue, and intersection sites are purple. In addition to Zn2+ and 
Mg2+, the nonspecific PDE inhibitor, 3-isobutyl-1-methylxanthine (IBMX) is shown in B and C (stick 
representation). D)  Results from HDXMS of RegAC:RIαA interaction are mapped in red onto the 
surface representation of the modeled RegA structure. The inhibitor IBMX is shown in stick 
representation in yellow. E) Evolutionary trace analysis of RegA:RIαA interaction interface mapped 
onto the structure of the cGMP phosphodiesterase PDE9 (PDB ID: 2HD1). 
3.3.3 PDE-RIα interaction interface shows broad conservation across the 
PDE superfamily 
The regions in RegA that interacted with RIα, are regions which show high sequence homology 
across all PDEs from Dictystelia to mammals as these regions are important the catalytic activity of 
PDE(Conti and Beavo 2007). We nonetheless carried out a comprehensive primary sequence analysis 
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based on sequence conservation and exon-intron structure, to determine whether any mammalian PDE 
is an obvious homolog of RegA. Regions on RegA which showed a high sequence homology with 
other PDEs were the same regions identified by HDXMS and peptide array to form the locus of 
RegAC-RIα interactions (Figures 3.6D and 3.6E). Broadly the overlap between regions of RIα 
interaction and the PDE catalytic active site is reflected in high conservation at the PKA-RIα 
interaction interface within the PDE catalytic domain across vertebrate PDEs, raising the possibility 
that multiple PDE families interact with PKA RIα. Sequence homology of the catalytic domains alone 
showed that the closest homolog was the cGMP PDE, PDE9 followed by the cAMP PDE, PDE8. 
Interestingly, the domain organization of PDE8 shows parallels with RegA, in containing a putative 
N-terminal response regulator domain (receiver domain) (Shaulsky, Fuller et al. 1998, Thomason, 
Traynor et al. 1998). 
In order to test the broad specificity of PDE interactions with RIα, we used Fluorescence polarization 
spectroscopy with 8-(2-[Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate (8-
fluo-cAMP) as a rapid screen for identifying potential PDEs that are capable of hydrolyzing cAMP 
bound to the PKA R-subunit. We chose 4 full-length PDEs (2 cGMP PDEs- PDE5A and PDE9A, and 
2 cAMP PDEs- PDE2A and PDE8A) to test for dissociation of cAMP bound to CNB-A domain of 
RIαA. PDE9A and PDE8A were chosen due to the high sequence homology with RegA. Two GAF-
domain containing PDEs, PDE2A (dual specificity cAMP/ cGMP PDE) and PDE5A (cGMP-specific 
PDE) were also examined as controls. Fluorescence polarization assays with 8-fluo-cAMP -labelled 
RIαA were carried out as described previously (Moorthy, Gao et al. 2011). 8-fluo-cAMP is resistant to 
PDE hydrolysis and therefore offered an opportunity for direct monitoring of cAMP dissociation from 
RIα (Poppe, Rybalkin et al. 2008). No dissociation of 8-fluo-cAMP was observable from CNB-A of 
RIα in the absence of excess cAMP or upon addition of excess PDE. This is a consequence of a slow 
kinetic off-rate for cAMP from the R-subunit or fast reassociation rate of released cAMP. This was 
used as a basis for testing the ability of PDEs to dissociate cAMP bound to CNB-A in RIαA (Figure 
3.7). In these experiments, 8-Fluo-cAMP bound to RIαA was mixed with excess or equimolar PDEs 
and FP was measured. In the presence of a 10-X molar excess of full-length PDEs, small increases in 
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fluorescence polarization (FP) values were observable with time in the presence of PDEs 5,8 and 9. 
This can be attributed to the ability of PDEs to bind 8-fluo-cAMP despite being incapable of readily 
hydrolyzing it (Poppe, Rybalkin et al. 2008). Even though equivalent analogs resulting from 
substitutions at the 8’ position of the adenine ring such as 8-Br-cAMP confer resistance to PDE 
hydrolysis, they nevertheless are capable of binding and functioning as competitive inhibitors of 
PDEs. Addition of PDE2 resulted in a steady increase in fluorescence polarization with time (Figure 
3.7A). This increase is consistent with 8-fluo-cAMP functioning as a cAMP analog and binding the 
GAF domain of PDE2.  
The addition of 0.5 mM cAMP after 18 min showed important differences between the cGMP-
specific and cAMP-specific PDEs. Samples containing PDEs 5 and 9 showed a steady drop in FP upto 
time t=40 min when it reached baseline, upon addition of cAMP. Since cAMP is hydrolyzed poorly 
by cGMP PDEs, all of the 8-fluo-cAMP bound to RIα is displaced by excess unhydrolyzed cAMP and 
this is reflected in the drop in FP. The sample containing PDE8 showed a more gradual drop in FP 
upon addition of cAMP upto time t=28 min after which it increased to a steady intensity at time t=32 
min, slightly lower and close to the signal at time t=18 min before the addition of cAMP. PDE8 
rapidly hydrolyzes the excess cAMP added to 5’AMP and once the cAMP is depleted, 8-fluo-cAMP 
reassociates with PDE8 to increase the FP signal. In the sample with PDE2, a further increase in FP 
was seen upon addition of cAMP (Figure 3.7A).  
PDE8 interacts with RIα and facilitates cAMP dissociation: 
We next carried out fluorescence polarization assays at lower concentrations of PDE8A (1:1 molar 
ratios). We observed at these lower concentrations (0.13 µM), PDE8A alone showed no changes in FP 
suggesting that it did not bind the ligand, 8-fluo-cAMP (Figure 3.7B). These conditions therefore 
allowed monitoring of cAMP dissociation by PDE8A. Our results showed that PDE8A promotes 
dissociation of 8-fluo-cAMP both in the presence and absence of the nonspecific PDE inhibitor 
IBMX. Upon addition of excess cAMP, a larger dip in the FP signal was observed for IBMX-bound 
PDE8A1. This reflects slower cAMP hydrolysis in the presence of IBMX and consequently a lag in 
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reassociation of released 8-fluo-cAMP to RIα. This indicates that PDE catalysis and PDE-mediated 
dissociation of bound cAMP are separate steps (Figure 3.7B). The 8-fluo-cAMP-bound RIαA showed 
shifts in fluorescence polarization with all PDEs except PDE9. Thus all the PDEs we tested, with the 
exception of PDE9A, were capable of interactions with RI resulting in dissociation of cAMP. 
While these results do not exclude PDEs 2A and 5A as potential RIA binders, we chose to explore 
these PDE8A-RIA interactions further given its higher homology with RegA.  
Figure 3.7: PDE8A interacts with RIα and blocks cAMP reassociation: A) Dissociation of 8-fluo-
cAMP from RIαA(0.12 μM) was monitored by measuring the fluorescence polarization (FP) change in 
the presence of a molar excess (1.2 μM) of the following phosphodiesterases at (x) PDE2A, (●) 
PDE8A, () PDE5A and () PDE9A. Interpolated FP values are plotted vs time; arrow indicates the 
addition of cAMP (0.5 mM) after 18 min to all reactions. Baseline signal for 8-fluo-cAMP (0.12 
μM)(o). B) Dissociation of 8-fluo-cAMP from RIαA(0.12 μM) was monitored by measuring the 
fluorescence polarization (FP) change in the presence of (0.13 μM) PDE8A (●) and IBMX-saturated 
PDE8A (x); arrow indicates addition of cAMP (10 μM)  or cGMP (10 μM) (▲) after 18 min of the 
reaction. Baseline signal for 8-fluo-cAMP (0.12 μM)(o) and PDE8A (0.12 μM)( ). 
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PDE assays showed that PDE8A was capable of hydrolyzing cAMP bound to RIαA with cAMP-bound 
RIαA as the sole substrate (Figure 3.8). This is consistent with previous results obtained with RegA 
(Moorthy, Gao et al. 2011). We then set out to examine the interactions of the catalytic domain of 
PDE8A with the CNB domains of PKA R-subunit in greater detail.  
 
Figure 3.8: PDE8A1 is capable of catalyzing hydrolysis of cAMP bound to RIα: Phosphodiesterase 
activity was calculated using a phosphate coupled colorimetric assay based on hydrolysis of cAMP to 
AMP by phosphodiesterases coupled to the hydrolysis of AMP to inorganic phosphate by alkaline 
phosphatase. In this assay, catalytic amounts of PDE8A1 (50 nM) was incubated with 22 µM of 
cAMP bound RIαA for different incubation times. Phosphodiesterase activity of PDE8A1 (50 nM) 
with 22 µM of free cAMP was also carried out for comparison. The plot compares the amount of 5’ 
AMP released (y-axis) with increasing labeling times (x-axis). The plot shows that PDE8A1 is 
capable of hydrolyzing cAMP bound to RIαA (■), albeit at a rate 8 times slower than rate of 
hydrolysis of PDE8A1 for free cAMP (●). The points were fit to a linear equation (Graphpad Prism 
version 5 (San Diego, CA)). 
3.3.4 Expression and purification of Catalytic domain of PDE8A 
PDE8AC was cloned and expressed in Bl21 (DE3) cells as described in materials and methods. 
PDE8AC was purified by a refolding procedure as previously described (Yan, Wang et al. 2009). After 
refolding, Anion exchange chromatography was carried out (MonoQ 5/50 GL, GE healthcare) and 
protein eluted in 2 peaks at ~ 300 mM salt concentration (Figure 3.9A). Size exclusion 
chromatography was carried using S200 10/300 size exclusion columns (AKTA columns,GE 
healthcare ). Protein eluted as a monomer-dimer pair, with the dimer peak eluting at ~ 0.54 column 
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volumes and the monomer eluting at ~0.62 column volumes (Figure 3.9B). SDS- PAGE gels of the 
fractions revealed protein had a purity of > 95%. 
Figure 3.9: Purification of PDE8AC: A) Peak profile of  anion-exchange chromatography FPLC of 
PDE8AC. PDE8AC was eluted at 300 mM of NaCl. B) Peak profile of FPLC size exclusion 
chromatography. Dimer-monomer peaks eluted at 0.54 and 0.62 column volumes respectively   
3.3.5 Catalytic domain of PDE8A interacts with both cAMP-binding domains 
of RIα 
The model for PDE-mediated dissociation and hydrolysis of cAMP proposed previously (Moorthy, 
Gao et al. 2011) necessitated interaction of PDE with cAMP-bound RIα (‘Encounter’ complex) 
followed by cAMP dissociation resulting in an ‘End state’ complex of cAMP-free (apo) RIα bound to 
PDE. We first set out to test parallels between the ‘End state’ complexes of RegA and PDE8A with 
RIα. This complex was generated as described in materials and methods with PDE8A1 and cAMP-
free RIαA and HDXMS was carried out on the complex. Given that the locus of interactions with RIα 
in RegA was entirely within the catalytic domain, deuterium exchange analysis for PDE8A1 was 
restricted to the catalytic domain. A total of 24 peptides were analyzed corresponding to a sequence 
coverage of 72% for the catalytic domain (residues 480-818). Four regions showed decreased 
deuterium exchange upon binding to RIαA (Figure 3.10). The regions span residues 527-547 of H4 
and H5, 619-648 of H10, 765-781 of the M-loop, 685-706 on HE1 and HE2. Of these regions, three 
are proximal to the catalytic site while residues 685-706, represented by two contiguous peptides, are 
located on a helix loop helix motif (HE1 and HE2) unique to PDE8 (Wang, Yan et al. 2008).  
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In order to map in greater detail the locus of PDE-PKA interactions, we studied binding of the 
catalytic domain of PDE8A, PDE8AC, with RIα. Size-exclusion chromatography of PDE8AC showed 
two peaks representing a dimer and monomer with a majority of PDE8AC eluting as a dimer (Figure 
3.9). Given that PDE8A and other PDEs exist as dimers in solution (Conti and Beavo 2007), we tested 
the possibility that a PDE dimer (PDE8AC) interacted with monomeric RIα that included both CNB 
domains (RIαAB).  
Figure 3.10: Map of the RIaA interaction interface on the catalytic domain of full-length PDE8A: 
Effects of RIαA interactions with the catalytic PDE domain of full-length PDE8A by HDXMS is 
mapped onto the dimeric structure of PDE8AC (PDB ID: 3ECN). Regions of the PDE8AC that show 
significant reduction in deuterium exchange upon complex formation are colored green, regions 
showing no difference in exchange are white. Regions for which no coverage was obtained are in light 
blue. Mass spectra of peptides showing significant changes upon RIαA complex formation 
(Difference>1Da) are shown. The isotopic envelopes of pepsin fragment peptides of i) Undeuterated 
control of PDE8A ii) free PDE8A  after 2 min deuteration iii) PDE8A in a complex with RIαA after 2 
min deuteration are depicted. Centroids are indicated (▲). 
We subsequently carried out HDXMS of the PDE8AC: RIαAB complex to map the interface of RIαAB 
on the surface of PDE8AC. A total of 69 peptides were observed and analyzed by HDXMS, which 
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corresponds to a coverage of 81% of the primary sequence of PDE8AC. On PDE8AC, regions 
spanning the conserved catalytic residues showed decreased exchange in the PDE8AC-RIαAB complex 
(Figure 3.11 and 3.12), and overlapped with the regions that showed decreased exchange in full length 
PDE8A.  
In the inverse HDXMS experiment to map the interaction of PDE8AC onto the surface of RIαAB in the 
RIαAB:PDE8AC complex, 49 peptides were observed and quantified, corresponding to a coverage of 
80% of the primary sequence of RIαAB. The RIαAB:PDE8AC complex  was generated by incubating 
RIαAB with a 3-X molar excess of PDE8AC for 1 h to ensure all the cAMP bound is fully dissociated 
from the complex. Interestingly, results for RIαAB showed decreased exchange at both cAMP binding 
sites (CNB-A and CNB-B) and across regions connecting these two domains (Figure 3.13 and 3.14). 
Sites showing the greatest shifts in deuterium exchange upon complexation with PDE8AC thus were 
not only at the binding sites  but also at flanking allosteric sites important for propagation of the 
effects of cAMP binding. Importantly, N-terminal regions of RIαAB spanning the PKA 
pseudosubstrate site showed only minor changes in deuterium exchange upon complexation with 
PDE8AC.  A table summarizing deuterium exchange for all the peptides from PDE8AC and RIαAB 
across all time points is in Table 3.1 and 3.2.  
The effects of cAMP binding on RIαAB (Figure 3.15A, top panel) were different from the effects of 
PDE complexation (Figure 3.14, bottom panel). This is summarized in Figure 3.15A (bottom panel).  
cAMP binding results in large decreases in deuterium exchange that are largely within the specific 
binding pockets in CNB-A and CNB-B. PDE8AC complexation on the other hand shows smaller 
magnitude decreases in the cAMP binding sites but shows protein-wide decreases in deuterium 




Figure 3.11: Protein-wide 
overview of interaction of 
RIαAB on PDE8AC: A) i) 
‘Mirror’ plot representation for 
comparative analysis of 
HDXMS of free PDE8AC 
(catalytic domain) and in the 
presence of RIαAB. The relative 
deuterium exchange (y-axis) of 
each pepsin digest fragment is 
listed from the N to C terminus 
(x-axis) of PDE8AC, with 
deuterium exchange times color 
coded as per key. In this plot, 
relative deuterium exchange (y 
axis) of free PDE8AC (upper 
half) is compared with relative 
deuterium exchange of 
PDE8AC in complex with 
RIαAB (lower half). In the 
bottom panel the absolute 
difference in numbers of 
deuterons (inferred from 
difference in mass in Daltons 
(Da)) (y-axis) between the free 
and complexed state is plotted 
for each pepsin digest fragment 
listed from the N to C terminus 
(x-axis) of PDE8AC for each 
Deuterium exchange time point 
(t= 0.5, 2, 5, 10 min) in a 
‘difference plot’. Shifts in the 
positive scale represent increases in deuterium exchange and shifts in the negative scale represent  decreases in deuterium exchange. A difference of 0.5 Da is 
considered significant, and is represented by a dashed red line. Plots were generated using the DynamX software (Version 2.0, Waters, Milford). Each point 




Effects of RIαAB 
interactions from 
HDXMS analysis 
mapped onto the 
dimeric structure 
of PDE8AC (PDB 
ID: 3ECN), IBMX 
at the active site is 








are colored in 
shades of blue.  
Mass spectra of 
peptides showing 
significant changes 
upon RIα AB complex formation (Difference>1 Da) are shown. The isotopic envelopes of pepsin 
fragment peptides of i) Undeuterated control of PDE8AC ii) Free PDE8AC after 2 min deuteration iii) 
PDE8AC in a complex with RIαAB after 2 min deuteration are depicted. Centroids are indicated (▲). 
Figure 3.13: A summary of 
results from HDXMS analysis 
is mapped onto the structure 
of cAMP-bound RIα(113-379) 
(PDB ID: 1RGS). Regions in 
RIα(113-379) that show 
significant reduction in 
deuterium exchange upon 
complex formation are colored 
in shades of red. cAMP is 
shown in stick representation 
(C: yellow, O: red, N: blue). 
Mass spectra of peptides 
showing significant changes 
upon PDE8AC complex 
formation (Difference>1 Da) 
are shown. The isotopic 
envelopes of pepsin fragment 
peptides of i) Undeuterated 
control of RIαAB  ii) Free 
RIαAB after 2 min deuterium 
exchange iii) RIαAB in a 




Figure 3.14: Protein-wide 
overview of interaction of 
PDE8AC on RIαAB: A) 
i)‘Mirror’ plot 
representation for 
comparative analysis of 
HDXMS of free RIαAB 
bound to PDE8AC. In this 
plot, relative deuterium 
exchange  (y axis) of free 
RIαAB (upper half) is 
compared with relative 
deuterium exchange of 
RIαAB complexed to 
PDE8AC (lower half). 
Difference Plot ii) shows 
the difference in absolute 
number of deuterons 
exchanged between the 




PDE8AC. Plots were 
generated using the 
DynamX software 
(Version 2.0, Waters, 
Milford).  Each point 
represents a pepsin digest 






Figure 3.15: RIαAB 
adopts distinct 
conformations in 
cAMP bound and 
‘End state’ complex 
forms: A) Top panel; 
Difference plot 
comparing RIαAB in the 
cAMP bound state to 
the apo state (top 
panel). Peptides in the 
positive range 
represent increased 
deuterium exchange in 
the cAMP bound state 
as compared to the apo 
state, while peptides in 





comparing RIαAB in 
the cAMP bound state 
to the ‘End state’ 
complex. Peptides in 
the positive range 
indicate peptides 
showing decreased 
deuterium exchange in the ‘End state’ complex in comparison to the apo state, while peptides in the negative range  represent peptides showing decreased 
deuterium exchange in the cAMP bound state in comparison to the ‘End state’ complex. Peptide residue numbers, from the N to C terminal of RIαAB, are 
marked along the x-axis; absolute difference in deuterons (Daltons (Da)) is marked along the y-axis. Each point represents a pepsin digest fragment and 
brackets group overlapping fragment peptides. Deuterium exchange labeling times are colored according to key. B) Results from the cAMP bound state vs 
‘End state’ complex difference plot were plotted onto the structure of RIα (PDB ID: 1RGS). Regions in red show greater protection in ‘End state’ complex 
while regions in blue show greater protection in the cAMP bound state. cAMP molecules are depicted as orange sticks bound to CNB-A and CNB-B. 
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Table 3.1: Summary of H/D exchange data for free PDE8AC and PDE8AC bound to RIαAB. Peptides 












Maximum deuterons exchanged 
after 2 min 
Free 
PDE8AC 




1 DDVPPRIARA (555.303) 2 482-491 7 4.06 ± 0.01 3.79 ± 0.07 
2 DDVPPRIARAME (685.344) 2 482-493 9 5.08 ± 0.00 4.66 ± 0.02 
3 DDVPPRIARAMENE (801.887) 2 482-495 11 6.07 ± 0.02 5.60 ± 0.10 




5 487-518 30 6.72 ± 0.08 5.28 ± 0.04 
6 ELEAATHNRPLIY (763.898) 2 504-516 11 0.79 ± 0.08 0.84 ± 0.05 
7 ELEAATHNRPLIYL (820.44) 2 504-517 12 0.60 ± 0.05 0.67 ± 0.05 
8 LEAATHNRPLIY (699.377) 2 505-516 10 0.67 ± 0.03 0.64 ± 0.04 
9 LEAATHNRPLIYLGLKM (647.359) 3 505-521 15 0.55 ± 0.08 0.68 ± 0.04 
10 EAATHNRPLIYL (699.377) 2 506-517 10 0.38 ± 0.06 0.48 ± 0.05 
11 ATHNRPLIYL (599.337) 2 508-517 8 0.32 ± 0.03 0.34 ± 0.01 
12 LGLKM (561.342) 1 517-521 4 0.21 ± 0.00 0.16 ± 0.04 
13 FGICEFLHCSESTLRSWL (1064.499) 2 525-542 17 6.55 ± 0.04 4.67 ± 0.02 
14 CSESTLRSWLQIIEAN (925.455) 2 533-548 15 5.10 ± 0.03 3.78 ± 0.04 
15 QIIEANY (850.430) 1 543-549 6 5.10 ± 0.03 3.78 ± 0.04 
16 ANYHSSNPYHNSTHSADVL (705.310) 3 547-565 17 1.25 ± 0.06 0.90 ± 0.07 
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17 NYHSSNPYHNSTHSADVL (681.631) 3 548-565 16 1.06 ± 0.06 0.80 ± 0.00 
18 SNPYHNSTHSADVLHATA (641.293) 3 552-569 16 2.51 ± 0.09 1.68 ± 0.03 
19 FLSKERIKE (575.331) 2 571-579 8 1.81 ± 0.03 1.47 ± 0.06 
20 FLSKERIKETLDPIDE (645.009) 3 571-586 14 
3.03 ± 0.10
  
2.66 ± 0.05 
21 LSKERIKETLDPIDE (595.986) 3 572-586 13 2.98 ± 0.09 2.62 ± 0.06 
22 RIKETLDPIDE (664.853) 2 576-586 9 1.68 ± 0.04 1.56 ± 0.00 
23 TLDPIDE (802.382) 1 580-586 5 1.07 ± 0.00 1.02 ± 0.01 
24 IAATIHDVDHPGRTNS (568.615) 3 591-606 14 2.50 ± 0.01 1.90 ± 0.05 
25 IAATIHDVDHPGRTNSF (617.633) 3 591-607 15 2.37 ± 0.04 1.92 ± 0.03 
26 IAATIHDVDHPGRTNSFL (655.332) 3 591-608 16 2.29 ± 0.03 1.81 ± 0.04 
27 CNAGSELAILYNDT (742.336) 2 609-622 13 2.66 ± 0.04 1.91 ± 0.10 
28 ESHHAAL (373.684) 2 626-632 6 1.20 ± 0.00 0.94 ± 0.04 
29 ESHHAALA (418.202) 2 626-633 7 1.62 ± 0.01 1.29 ± 0.02 
30 LTTGDDKCNIFKNM (800.375) 2 636-649 13 2.85 ± 0.01 2.05 ± 0.01 
31 TGDDKCNIFKNMER (835.881) 2 638-651 13 3.06 ± 0.00 2.53 ± 0.10 
32 KNMERNDY (535.236) 2 647-654 7 2.37 ± 0.03 1.91 ± 0.07 
33 KNMERNDYRTLRQGIIDM (751.707) 3 647-664 17 3.76 ± 0.01 3.07 ± 0.00 
34 RTLRQGIID (536.313) 2 655-663 8 1.16 ± 0.01 1.14 ± 0.06 
35 LRQGIID (814.478) 1 657-663 6 0.64 ± 0.00 0.60 ± 0.01 
36 VLATE (532.297) 1 665-669 4 0.59 ± 0.01 0.67 ± 0.04 














4 667-692 23 6.03 ± 0.18 5.22 ± 0.16 
41 MTKHFEHVNKF (473.235) 3 670-680 10 1.23 ± 0.04 1.05 ± 0.04 








3 670-691 20 5.41 ± 0.07 4.72 ± 0.04 
45 VNSINKPLAT (528.802) 2 681-690 8 3.38 ± 0.02 3.08 ± 0.02 
46 INKPLAT (756.461) 1 684-690 5 2.46 ± 0.01 2.21 ± 0.01 
47 INKPLATL (435.272) 2 684-691 6 2.93 ± 0.01 2.46 ± 0.00 
48 LEENGETDKNQE (703.304) 2 691-702 11 3.85 ± 0.00 3.17 ± 0.05 
49 LEENGETDKNQEVINT (916.925) 2 691-707 15 6.30 ± 0.05 5.17 ± 0.00 
50 LEENGETDKNQEVINTM (982.445) 2 691-708 16 6.49 ± 0.09 5.20 ± 0.02 
51 EENGETDKNQEVINTM (925.903) 2 692-708 15 5.99 ± 0.08 4.82 ± 0.01 
52 MLRTPENRTL (615.831) 2 707-716 8 2.65 ± 0.05 2.59 ± 0.03 
53 LIKRML (387.253) 2 716-721 5 0.42 ± 0.01 0.41 ± 0.04 
54 WAARISE (416.715) 2 740-746 6 0.35 ± 0.00 0.55 ± 0.02 
55 WAARISEE (481.236) 2 740-747 7 0.49 ± 0.03 0.74 ± 0.03 
56 YFSQTDE (889.357) 1 748-754 6 1.50 ± 0.01 1.09 ± 0.01 
57 YFSQTDEEKQQGLPVVM (999.974) 2 748-764 15 5.79 ± 0.04 4.48 ± 0.03 
58 FSQTDEEKQQGLPVVM (918.44) 2 749-764 14 6.19 ± 0.03 4.70 ± 0.02 
59 DEEKQQGLPVVM (686.839) 2 753-764 10 5.09 ± 0.01 4.21 ± 0.12 
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60 EKQQGLPVVM (564.804) 2 755-764 8 4.17 ± 0.03 3.34 ± 0.04 
61 FITDM (626.285) 1 785-789 4 1.55 ± 0.02 1.38 ± 0.01 
62 FITDMF (773.353) 1 785-790 5 1.47 ± 0.04 1.12 ± 0.04 
63 FITDMFDAWDAFV (789.349) 2 785-797 12 2.56 ± 0.03 2.13 ± 0.02 
64 FDAWDA (724.293) 1 790-795 5 0.25 ± 0.02 0.12 ± 0.04 
65 FVDLPDL (818.429) 1 796-802 5 0.78 ± 0.03 0.76 ± 0.00 
66 VDLPDL (671.361) 1 797-802 4 0.68 ± 0.02 0.61 ± 0.02 
67 MQHLDNNF (509.7205) 2 803-810 7 0.72 ± 0.03 0.57 ± 0.01 
68 MQHLDNNFKYWKGLDE (679.983) 3 803-818 15 2.15 ± 0.09 1.91 ± 0.01 
69 FKYWKGLDE (593.297) 3 810-818 8 1.79 ± 0.04 1.65 ± 0.01 
Table 3.2: Summary of H/D exchange data for free RIαAB and RIαAB bound to PDE8AC. Peptides 
showing significant differences (>0.5 Da) are in bold. 
 
No. 
Pepsin Digest  








Maximum deuterons exchanged 






1 EISPPPPNPV (523.775) 2 79-88 4 2.8 ± 0.15 1.9 ± 0.03 
2 AISAE (490.215) 1 97-101 4 1.5 ± 0.02 1.1 ± 0.02 
3 AEVYTEE (840.362) 1 100-106 6 2.5 ± 0.1 2.4 ± 0.04 
4 YVRKVIPKDYKTM (547.64) 3 111-123 11 5.4 ± 0.08 4.8 ± 0.09 
5 YVRKVIPKDYKTMAA (594.996) 3 111-125 13 6.5 ± 0.18 5.8 ± 0.09 
6 VRKVIPKDYKTMAA (540.643) 3 112-125 12 6.1 ± 0.1 5.6 ± 0.09 
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7 LAKAIEKNV (493.604) 2 126-134 8 3.7 ± 0.08 2.7 ± 0.04 
8 LAKAIEKNVL (549.845) 2 126-135 9 4.3 ± 0.07 3.3 ± 0 
9 FSHLDDNE (488.700) 2 136-143 7 1.4 ± 0.01 1.1 ± 0.02 
10 RSDIF (637.33) 1 144-148 4 0.6 ± 0.04 0.2 ± 0.01 
11 DAMFPVSF (913.412) 1 149-156 6 1.3 ± 0 1.1 ± 0.04 
12 FPVSF (596.308) 1 153-156 3 1.1 ± 0 0.7 ± 0 
13 IAGET (490.251) 1 157-161 4 1 ± 0.02 0.8 ± 0.01 
14 FYVIDQGEM (1101.49) 1 172-180 8 2.2 ± 0.05 1.1 ± 0.01 
15 FYVIDQGEMDV (1315.59) 1 172-182 10 2.8 ± 0.13 1.4 ± 0.1 
16 YVIDQGEMDV (1168.519) 1 173-182 9 2.4 ± 0.06  1.5 ± 0.04 
17 DVYVNNE (852.3734) 1 181-187 6 2.2 ± 0.04  1.5 ± 0.02 
18 YVNNE (638.278) 1 183-187 4 1.5 ± 0.02  1.4 ± 0.04 
19 WATSVGEGGSFGEL (698.818) 2 188-201 13 5.3 ± 0.10  3.0 ± 0.02 
20 ALIYGTPRAAT (567.315) 2 202-212 9 4.9 ± 0.05  3.4 ± 0.04 
21 ALIYGTPRAATVKAKTNVKL (705.753) 3 202-221 18 8.0 ± 0.16  4.9 ± 0.01 
22 LIYGTPRAATVKAKTNVK (644.38)  3 203-220 16 7.4 ± 0.17  4.2 ± 0.08 
23 YGTPRAATVKAKTNVKL (606.686) 3 205-221 15 6.7 ± 0.20  4.4 ± 0.03 
24 VKAKTNVKL (500.825) 2 213-221 8 2.6 ± 0.04  1.8 ± 0.02 
25 WGIDRDSY (506.225) 2 221-229 7 1.6 ±0.03  0.8 ± 0.00 
26 RRILMGST (467.265) 2 230-237 7 2.6 ± 0.02  2.0 ± 0.10 
27 RRILMGSTL (523.805) 2 230-238 8 3.1 ± 0.04  1.9 ± 0.01 
28 FLSKVSIL (453.793) 2 247-254 7 3.0 ± 0.14  2.4 ± 0.01 
29 LSKVSIL (759.497) 1 248-254 6 2.6 ± 0.06  2.1 ± 0 
30 SKVSIL (646.413) 1 249-254 5 2.4 ± 0.02  1.9 ± 0.00 
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31 TVADALE (718.361) 1 264-270 6 3.0 ± 0.09  2.2 ± 0.04 
32 ADALEPVQFEDGQ (709.82) 2 266-278 11 5.3 ± 0.15  1.8 ± 0.00 
33 DALEPVQF (918.456) 1 267-274 6 2.8 ± 0.06  1.5 ± 0.00 
34 PVQFEDGQKIVVQGEPGDEF (1109.535) 2 271-290 18 5.5 ± 0.09  2.6 ± 0.04 
35 EDGQKIVVQGEPGDEF (873.91) 2 275-290 14 4.4 ± 0.07  2.1 ± 0.01 
36 IVVQGEPGDEFF (668.82) 2 280-291 10 4.1 ± 0.08  2.7 ± 0.05 
37 IILEGSA (702.403) 1 292-298 6 1.1 ± 0.02  0.9 ± 0.00 
38 QRRSENEE (524.24) 2 302-309 7 2.4 ± 0.06  1.9 ± 0.05 
39 QRRSENEEF (597.775) 2 302-310 8 2.5 ± 0.05  2.2 ± 0.01 
40 FVEVGRLGPSDY (669.835) 2 310-321 10 3.0 ± 0.06  1.6 ± 0.01 
41 VEVGRLGPSDY (596.3) 2 311-321 9 2.4 ± 0.04  1.5 ± 0.07 
42 LGPSDYFGEI (549.26) 1 316-325 8 4.6 ± 0.05  3.2 ± 0.00 
43 FGEIAL (649.355) 1 322-327 5 2.3 ± 0.04  0.8 ± 0.01 
44 LMNRPRAAT (1029.562) 2 328-336 7 3.3 ± 0.02  1.6 ± 0.01 
45 MNRPRAAT (458.739) 2 329-336 6 3.1 ± 0.04  1.4 ± 0.04 
46 ARGPLKCV (422.243) 2 339-346 6 1.2 ± 0.07  0.8 ± 0.07 
47 VKLDRPRF (515.805) 2 346-353 6 2.2 ± 0.05  1.2 ± 0.02 
48 LDRPR (328.692) 2 348-352 3 1.6 ± 0.01  0.9 ± 0.01 
49 ERVLGPCSDIL (601.31) 2 354-364 9 3.8 ± 0.01  1.6 ± 0.01 
3.3.6 Real time monitoring of PDE8-mediated dissociation of cAMP bound to 
the PKA R-subunit  
We then set out to explore if HDXMS was able to monitor in real time, dissociation of bound cAMP 
upon complexation with PDE8AC as has previously been shown with RegA and RIαA 
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(Krishnamurthy, Moorthy et al. 2013). This would result in progression of PDE-PKAR interactions 
from an ‘Encounter’ complex (RIαAB: cAMP: PDE8AC) to an ‘End state’ complex (RIαAB: PDE8AC). 
The PDE-PKAR interactions described in the earlier section represent the ‘End state’ complex in the 
reaction. We monitored the effects of cAMP on Apo RIαAB dynamics by HDXMS by focusing on a 
peptide spanning the cAMP binding site (residues 202-221).  The peptide in apo RIαAB shows the 
most deuterium exchange (Figure 3.16A), compared to the cAMP-bound state (Figure 2.16B), 
consistent with cAMP binding the pocket with high affinity (Badireddy, Yunfeng et al. 2011). Even in 
the absence of excess cAMP, this region shows low levels of deuteration even after 1 h of deuterium 
exchange. This is interesting as it indicates a stable interaction and reflects the high affinity of cAMP 
for the R-subunit. Interestingly the ‘End state’ complex (Figure 3.16C, centroid indicated in blue) 
exchanges deuterium at a level intermediate to the apo (centroid indicated in red) and cAMP-bound 
states (centroid indicated in green). This further indicates that PDE association and cAMP binding to 
the apo protein alter dynamics in distinct ways. 
According to the previously described model (Moorthy, Gao et al. 2011), PDEs would ‘encounter’ 
cAMP bound RIα and begin the dissociation-hydrolysis cycle. To probe this dissociation- hydrolysis 
cycle in real time, we carried out HDXMS of cAMP bound RIαAB in the presence of 
substoichiometric amounts of PDE8AC. The reaction was initiated by adding PDE8AC to cAMP 
bound RIα at a lower 1:3 molar ratio simultaneously with D2O buffer and the reaction was monitored 
in a time dependent manner, as described in materials and methods. Peptides from both PKA RIαAB 
and PDE8AC were analyzed in parallel to monitor dynamics of the proteins in the ‘Encounter’ 
complex. 
The global deuterium exchange profile of cAMP bound RIα in the ‘Encounter’ complex for early time 
points show a close correlation to cAMP bound RIα (Figure 3.17) top panel). A comparison of RIαAB 






Figure 3.16: PDE8AC mediates dissociation of cAMP bound to both CNB-A and CNB-B of RIαAB: 
Mass spectra of peptide spanning cAMP binding pocket of A) apo RIαAB in CNB-A domain at 
different deuterium labeling times. Red triangle indicates centroid. B) cAMP-bound RIαAB in the 
presence of excess cAMP. Green triangle indicates centroid. C) PDE8AC-bound apo RIαAB (‘End 
state’ complex). Blue triangle indicates centroid, red and blue indicate centroid values for apo and 
cAMP-bound states respectively and are shown for comparison. Mass spectra of peptide spanning 
cAMP binding pockets in CNB-A (D) and CNB-B (E) for cAMP-bound RIα  in the presence of 
substoichiometric amounts of PDE8AC (‘Encounter’ complex). 
Closer inspection of the peptides spanning the cAMP binding regions, residues 202-212 in CNB-A 
and residues 328-336 in CNB-B, reveals these regions to exhibit a bimodal distribution in deuterium 
exchange kinetics (Figure 3.16 D and E). Bimodal distributions generally indicate the prevalence of 
EXI mode of exchange kinetics (Weis, Wales et al. 2006), caused by local unfolding and refolding 
events at specific loci of the protein. However, in this particular example, cAMP dissociation from the 
cAMP binding pocket of RIαAB, occurs in a time dependent manner, resulting in the presence of three 
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distinct forms of RIαAB, namely an apo form, cAMP bound form and a PDE bound form (as seen in 
Figure 3.16 A, B and C). These three forms exist in a constantly changing dynamic equilibrium which 
is dependent on the rate of PDE binding, cAMP dissociation and hydrolysis.  At earlier time points the 
cAMP bound form is most prevalent, but as the reaction proceeds with increasing labeling times, 
RIαAB tends towards the apo form because of increasing dissociation of cAMP. Almost all present 
RIαAB is in the apo form by 30 min. All three forms exist in varying ratios at any given point in time, 
which results in a time dependent bimodal distribution due to ensemble averaging in HDXMS. 
Peptides from PDE8AC in the ‘Encounter’ complex were also analyzed to probe the dynamics of 
PDE8AC in a catalytically active state. Comparison of PDE8AC in the ‘encounter’ state with the apo 
state reveals that regions responsible for cAMP binding show decreased deuterium exchange, while 
certain regions also show increased deuterium exchange (Figure 3.18, top panel). The presence of 
both decreased dynamics and increased dynamics within the same protein is indicative of a 
catalytically active protein. This is in contrast to the consistently decreased dynamics exhibited by 
PDE8AC in the ‘End state’ complex (Figure 3.11). Comparison of the ‘Encounter’ and ‘End state’ 
complexes reveals that the two conformations are distinct from one another, with significant 
differences in various regions of the protein (Figure 3.18, bottom panel).
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Figure 3.17: Comparison of 
RIαAB in the ‘Encounter’ 
complex with the ‘End state’ 
complex: Top panel; Absolute 
difference in number of 
deuterons (inferred from 
difference in mass in Da, y-axis) 
between RIαAB in the ‘Encounter’ 
complex and the apo state are 
depicted in a difference plot, 
with pepsin digest peptides 
labeled along the x-axis. Peptides 
(points on the graph) in the 
positive range (red line) undergo 
increased deuterium exchange in 
the ‘Encounter’ complex when 
compared to the apo state, while 
peptides in the negative range 
(blue line) undergo decreased 
exchange in the ‘Encounter’ 
complex. Bottom panel; 
Difference plot comparing RIαAB 
in the ‘Encounter’ complex and 
‘End state’ complex. Peptides in 
the positive range (red line) 
undergo decreased deuterium 
exchange in the ‘End state’ 
complex in comparison to the 
‘Encounter’ complex, while 
peptides in the negative range 
(blue line) undergo decreased 
exchange in the ‘Encounter’ 




Figure 3.18: PDE8AC exhibits mutually 
distinct dynamic profiles in the 
‘Encounter’ complex and ‘End state’ 
complex: Top panel; Difference plot 
comparing PDE8AC in the ‘Encounter’ 
complex to the apo state. Peptides in the 
positive range (red line) undergo 
increased deuterium exchange in the 
‘Encounter’ complex, while peptides in 
the negative range (blue line) undergo 
decreased deuterium exchange in the 
‘Encounter complex’. Peptide residue 
numbers are marked along the x-axis 
while absolute difference in deuterons 
(measure in Daltons (Da)) is marked 
along the y-axis. Bottom panel; 
Difference plot comparing PDE8AC in the 
‘Encounter’ complex to PDE8AC in the 
‘End state’ complex. Peptides in the 
positive range (red line) undergo 
decreased deuterium exchange in the 
‘End state’ complex in comparison to the 
‘Encounter’ complex, while peptides in 
the negative range (blue line) undergo 
decreased deuterium exchange in the 
‘Encounter’ complex in comparison to the 
‘End state’ complex. Time points are 
depicted in different colors as explained 




3.3.7 Model of PDE8A-RIa interface by computational docking suggests 
substrate channeling in cAMP hydrolysis* 
Molecular docking was carried out to model the PDE8-PKA RIα interface based on the HDXMS 
results. Since size exclusion chromatography of PDE8AC indicated a majority of PDE8AC existed as a 
dimer in solution, and the PDE8 structure (PDB ID: 3ECN) crystallized as a dimer, the dimeric 
structure of the catalytic domain of PDE8, was used for docking with monomeric RIα(113-379) 
((PDB ID:1RGS)). Such a complex would show a stoichiometry of one PDE dimer interacting with 
one monomer of RIα(113-379).  
RIα exists in two distinct conformations, bound to PKA catalytic subunit (H-form) and bound to 
cAMP (B-form). We hypothesize that the B-form of RIα must interact with PDEs (Encounter 
complex) for hydrolysis of the tightly bound cAMP, leading to cAMP signal termination (Figure 3.1). 
These can occur through a simultaneous interaction of the two cAMP-bound CNB-domains or via 
tandem binding of each cAMP-bound CNB domain to individual PDE units in the dimer. Since it is 
known that the two cAMP binding domains in RIα are connected by a dynamic C-helix (Kornev, 
Taylor et al. 2008, Moorthy, Badireddy et al. 2011), we reasoned that the central helix undergoes 
dynamic rearrangements, making equally plausible, accommodation of both CNB domains binding 
simultaneously or in tandem. Furthermore, mapping of PDE8-RIα interactions by HDXMS suggests 
that the PDE8 binding interface is symmetric, while differential exchange across the two CNB 
domains of RIα is nonuniform. These are suggestive of an asymmetric interaction surface across the 
individual CNB domains of RIα. To factor in dynamics of the interdomain linker, HADDOCK runs 
were set up in two different ways: The cAMP-bound conformation of RIα (PDB ID: 1RGS chain B) 
was modeled i) as one whole unit with a rigid helix linker, and ii) as two separate cAMP binding 
domains sans the linker. In the latter runs, to circumvent the limitation of docking programs in 
modeling large conformational changes, each CNB domain was independently docked to mimic the 





HADDOCK, are closer to native complexes if the docking is driven by restraints based on 
experimental data. In our case, these constraints were provided by results from HDXMS. The changes 
in deuterium exchange upon complexation in PDE8AC and RIαAB are rendered in surface 
representation in Figure 3.19 A and B respectively. 
In our computational experiment, we first docked RIα as a rigid unit. Upon inspection of the 
solutions, it was clear that the two cAMP binding domains cannot be made simultaneously accessible 
to the catalytic sites of PDEs. It is conceivable that one of the RIα cAMP binding domains acts first; 
after it extracts the cAMP, it is released, which enables the other cAMP binding domain to bind to 
PDE. However, since the cAMP binding domains in RIα are highly homologous, and the linker C-
helix is highly dynamic (Kornev, Taylor et al. 2008), we proceeded to investigate whether the 
geometry of the two proteins, aided with some flexibility in the central helix of RIα, could allow 
simultaneous docking of the two domains. Thus in subsequent docking experiments, the two domains 
of RIα were docked onto the PDE8 dimer individually. The high structural similarity of the two 
domains suggests that they could also bind to each of the PDE8 catalytic sites in a quasi-symmetrical 
way. 
It should be kept in mind that the scoring, and even more so the ranking, in the computational 
reconstruction of protein complexes remains problematic (Lensink and Wodak 2010). Thus we use 
docking to generate geometrically feasible models of the interaction proposed in this study, and use 
the HADDOCK’s native score as guidance, but also as only one of the constraints that the model 
should satisfy. The chosen pose for CNB-B domain has the best HADDOCK score of -37.55 while 
CNB-A with a HADDOCK score of 43.29 belongs to the top 8% in its class (Figure 3.19 C). The 
number of intervening atoms, criterion (ii),  for CNB-B was among the top 3%, smallest in the 200 
chosen poses, and for CNB-A among the top 30%, suggesting that the degree of the conformational 




Figure 3.19: Evidence for cAMP channeling between CNB binding site and PDE active site from 
interaction interface: A) HDXMS results of RIαAB interaction mapped onto a surface representation 
of the structure of dimeric PDE8AC and color coded as per Figure 3.12. B) HDXMS results of 
PDE8AC interaction mapped onto a surface representation of the structure of RIαAB and color coded as 
per Figure 3.13. C) Docking model of the PDE8AC:RIαAB complex highlighting proximity of the 
cAMP-binding sites on the R-subunit to the PDE active site. Proposed mechanism for channeling in 
dissociation and hydrolysis of cAMP bound to RIα.  Inset: Close-up of the PDE active site in the 
model of the PDE8-RIα complex with the PDE8 (PDB ID: 3ECN) in blue and RIα (113-379)(PDB 
ID: 1RGS) in grey surface representation. cAMP is shown in yellow stick representation. Catalytic 
metal ions: Zn2+ (yellow sphere) and Mg2+ (magenta sphere) atoms are part of the hydrolytic core. 
Conserved residues important for substrate recognition are yellow, metal ion anchoring and hydrolytic 
center are green. RIα in surface representation (only cAMP:A domain (residues 113-244) shown for 
clarity). A single chain of PDE8A (chain A) alone shown for clarity. Residues 662-679 have been 
hidden to enable clear view of the active site. PDE binding mediates dissociation of the phosphate of 
cAMP from RIα (indicated by arrow). 
3.4 Discussion 
In this study we report the description of a signaling complex of PDEs with PKA RIα through a 
combination of orthogonal experimental and computational approaches. This constitutes a 
fundamental signaling complex in the termination phase of cAMP signaling.  Our results support a 
universal model for how PDEs bind both CNB domains of RIα and catalyze hydrolysis of bound 
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cAMP leading to signal termination. This complex shows broad conservation from dictyostelia to 
mammalian systems.   
HDXMS studies of PDE:PKAR complexes localized the interactions to span the cAMP binding 
pockets of PKA RIα and the regions lining the catalytic site of PDEs. This has been observed in 
evolutionarily distant PDEs tested, namely RegA and the full length and catalytic domain fragment of 
mammalian PDE8. On the PDEs, residues that showed decreased deuterium exchange were mostly 
located proximal to the catalytic pocket or were residues involved in dimerization (Figure 3.6A, 
Figure 3.19A). RIα on the other hand showed protein-wide decreases in deuterium exchange across 
several regions upon complexation with PDE8AC as seen in Figure 3.19B. These include the cAMP 
binding pockets in both CNB-A and CNB-B, the N-terminal helical subdomain and interdomain 
helical connector regions. However in the cAMP bound state, large decreases in exchange are seen 
mainly at the cAMP binding pockets at CNB-A and CNB-B with little effects at other regions. These 
two states would thus represent two distinct end point conformations of RIα consistent with our 
results from docking.   
Computational docking guided by results from HDXMS provides a model for the PKA RIα-PDE8 
interface. This solution was readily generated through docking with minimal rearrangements in the 
interdomain linker of RIα. Given the intrinsic ability of RIα to toggle between multiple 
conformational states (Badireddy, Yunfeng et al. 2011), and the high dynamics of the interdomain C-
helix, such a rearrangement is likely through conformational selection. Together, this work highlights 
how computational docking with HDXMS and fluorescence spectroscopy can enable rapid mapping 
of the dynamics of transient interactions into multi-protein signaling complexes. 
Analysis of HDXMS data and the docking model, reveal that highly conserved residues responsible 
for substrate recognition, are at a close proximal distance to the cAMP that is bound to RIα. This 
provides a model for mechanism of action, whereby active site coupling between the PDE and RIα 
engages residues important for cAMP binding and allostery, thereby weakening key hydrogen bonds 
between RIα and cAMP. The cAMP released from RIα is subsequently captured by substrate 
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recognition residues on PDE and is channeled into the active site to be hydrolyzed into 5’AMP 
(Figure 3.19C inset). The model shown here is that of monomeric RIαAB in complex with PDE8AC 
dimer. We believe this can be extended to model dimeric full-length RIα in complex with 2 dimers of 
full-length PDE. 
Real time monitoring of PDE8AC-mediated cAMP dissociation by HDXMS allowed detailed 
examination of the changes to the cAMP binding pockets in both CNB domains. These provided 
powerful insights that experimentally complemented the docking model. The results of computational 
docking shown in Figure 3.19C shows PDE8A interacting with cAMP-bound RIαAB in the ‘Encounter 
state’ complex. Comparison of HDXMS of ‘Encounter’ state complex with the ‘End state’ complex 
showed important differences highlighting the time-bound dissociation of cAMP. Most importantly 
we were able to directly monitor PDE8AC-dependent cAMP dissociation simultaneously from both 
CNB domains in a time-dependent manner. This additionally highlights an important application of 
HDXMS in monitoring dynamics of transient interactions in real time at peptide resolution and 
complements traditional fluorescence spectroscopy approaches (Figure 3.7). 
 An important question that is relevant to cAMP signaling is in understanding how cAMP bound to 
the PKA R-subunit is hydrolyzed to reset PKA. Our results demonstrate how PDE8 binds RIα and 
facilitates dissociation of cAMP from both CNB domains. This further highlights how RIα might 
serve to buffer intracellular cAMP and ‘channel’ it to the active site of PDE8. Substrate channeling is 
characteristic of metabolic enzymes (Huang, Holden et al. 2001) but is being proposed here for the 
first time in cAMP signaling. Sequestering of cAMP-bound RIα by PDEs has important implications. 
This allows for localized pools of cAMP to activate PKA in microdomains. It also facilitates 
adaptation to steady state levels of cAMP by completing the cAMP cycle through regeneration of the 
inactive holoenzyme. This also ensures that reactivation of PKA would occur preferentially upon 
large fluxes of cAMP levels in the cell (Leiser, Fleischer et al. 1986). PDE-PKA RIα interactions 




In the previous chapter, RegA mediated cAMP dissociation from the PBC of RIα was monitored by 
HDXMS. In this chapter we have mapped the interaction interface between PDEs and RIα, and it was 
seen that the main interaction interface is on the catalytic pocket of RegA and the cAMP binding 
pocket of RIα. It was further seen that the interaction interface is conserved across all PDEs. 
Fluorescence polarization experiments were carried out to rapidly screen for PDEs capable of 
mediating dissociation of cAMP from RIα. PDE8A was found to be a likely candidate, and HDXMS 
was used to map the interaction interface. HDXMS was also used  for Real time monitoring of cAMP 
release from RIα. It was seen that cAMP dissociation and ultimately cAMP pathway signal 
termination is mediated by active site coupling between PDEs and RIα.  
This study has broad implications in the field of cAMP signaling. This study is the first report on 
PDE-PKAR interactions in mammalian systems and provides a model for how cAMP signal 
termination occurs. This study also highlights how HDXMS can be used to monitor reactions in real 
time by monitoring certain ‘marker’ peptides that are directly involved in the reaction mechanism. 
In the previous 3 chapters, Structural mass spectrometry was used as a tool to elucidate 
conformational dynamics in signaling pathways, particularly to map out dynamics of transient states 
in the cAMP pathway. The following two chapters aim to establish a role for structural mass 
spectrometry in drug discovery screening (Chapter 4) and to apply structural mass spectrometry to 
increasingly complex biological systems (Chapter 5). The next chapter derives from previous work on 
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4 Detecting low affinity binders by hydrogen/deuterium 
exchange mass spectrometry: An application for Fragment 
based ligand discovery 
4.1 Introduction 
Over the past decade, our understanding of cellular functions and processes, especially in the field of 
cell signaling has progressed at a great pace. This has been accompanied by the discovery of a large 
number of proteins that are postulated to be high value targets for drug discovery approaches 
(Schreiber 2005). These proteins are of high interest to the field of chemical biology and the 
pharmaceutical industry as targets for drug design. Recent advances in combinatorial chemistry and 
high throughput screening (HTS) have enabled rapid screening of large compound libraries against 
important drug targets. This is often dependent on structural information obtained by virtual ligand 
screening techniques and structure based drug design. These techniques require screening of millions 
of compounds and are dependent on the presence of large compound library and crystal structures of 
the target proteins (Shoichet 2004, Scapin 2006, Hajduk and Greer 2007).  
Fragment based ligand design (FBLD) has in recent years proven to be an attractive alternative 
approach to the traditional HTS techniques to develop inhibitors against therapeutically important 
target proteins. Fragments are small, hydrophilic molecules that are derived from the breakdown of 
large ligand molecules. Fragments constitute the active moieties of these large ligand molecules and 
serve as the building blocks to form larger tighter binding molecules. They typically form very weak 
interactions with target proteins, and only after multiple rounds of combinatorial design does a 
fragment give an inhibitor molecule with improved affinity and specificity. The major advantage in 
FBLD is that the design of the ligand and its active moieties can closely be monitored and controlled 
thereby ensuring success in later stages of the drug discovery pipeline.  
A major challenge in FBLD is detecting very weak affinity interactions, and the screening methods 
available to measure these interactions have been limited (Hajduk and Greer 2007). The most 
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commonly used biophysical methods for screening are: thermal melting, surface plasmon resonance, 
crystallography, nuclear magnetic resonance, and isothermal calorimetry. The limitations include poor 
dynamics range for the low affinity screening, high demand on protein and throughput of analysis. 
Crystallography has been mainly used as a methodology to validate fragment hits found by other 
techniques (Schmidt and Rademann 2009). X-ray crystallography has a clear advantage over other 
techniques as it gives a detailed three-dimensional picture of the binding interaction. However, atomic 
structures do not give a detailed map of the dynamics of protein-ligand interactions. This technique 
also has the inherent limitations in that, crystals with good diffractibility are essential. FBLD by 
crystallography generally involves soaking the crystals in fragment solutions which might further 
damage the crystals. Structure activity relationships by NMR (SAR by NMR) has proven to be the 
gold standard for mapping fragment-protein interactions and gives high resolution data on protein 
structure and dynamics (Shuker, Hajduk et al. 1996). This method has been used to successfully 
develop drug molecules against numerous targets (Meyer and Peters 2003). 
Figure 4.1: Drug discovery strategies: Rational drug discovery is the process by which millions of 
ligands screened by high throughput screening techniques to find a molecule that has a high affinity to 
the drug target. In fragment based drug discovery, small fragments are tested which may bind only a 
portion of the ligand binding pocket. Multiple fragments are screened and linked by combinatorial 
chemistry to arrive at a high affinity ligand molecule. 
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From previous chapters it was seen that Hydrogen/Deuterium Exchange Mass Spectrometry 
(HDXMS) is a powerful tool to monitor a variety of perturbations. It was seen that HDXMS is a 
highly sensitive and rapid approach to characterize the effect of perturbations on the conformational 
dynamics of proteins (Hoofnagle, Resing et al. 2003, Kaveti and Engen 2006). This technique has 
rapidly emerged as an invaluable tool for biophysicists, structural biologists and protein chemists to 
correlate protein structure to its function. The main advantages of HDXMS is that each experiment 
requires small amounts of protein, there is no size limit and high resolution structural information is 
not necessary to decipher ligand binding regions.  Recent advances in instrumentation for HDXMS 
experiments include an automated robotic system coupled to an Electrospray mass spectrometer. This 
enables rapid amide exchange measurements with high reproducibility and low back exchange effects 
(Wales, Fadgen et al. 2008).  
Hsp90 (heat shock protein 90) is an important member of the chaperone class of proteins and is 
involved in protein folding pathways, stabilizing various proteins such as steroid receptors, and is also 
involved in protein degradation pathways (Schneider, Sepp-Lorenzino et al. 1996). It also stabilizes a 
number of proteins involved in tumor growth, and hence is the target of numerous anti-cancer drugs 
(Solit and Rosen 2006). Inhibitors of Hsp90 have been identified and isolated from natural sources, 
namely Geldanamycin and Radicicol. Structural biology of these molecules reveals that they bind to 
the N-terminal ATPase domain and inhibit the entire molecule. It was thus seen that the N-terminal 
domain alone was sufficient to guide the design of inhibitors to inhibit the entire molecule. In this 
study we use two high affinity ligands, Radicicol and a Geldanamycin derivative 17-N-Allylamino-
17-demethoxygeldanamycin (17-AAG). Their binding affinities for Hsp90 are 19 nM and 33 nM 
respectively. Hsp90 has also been the subject of numerous FBLD approaches (Huth, Park et al. 2007, 
Brough, Barril et al. 2009, Murray, Carr et al. 2010) and in this study we test whether HDXMS is 
sensitive to weak affinity fragments by selecting three fragments that were previously found to bind to 
Hsp90 and lead to the development of molecules which are currently in clinical trials against Hsp90. 
Of the three fragments, two fragments are phenolic compounds (Murray, Carr et al. 2010) with 
binding affinities ~500 µM and an aminopyrimidine class molecule (Brough, Barril et al. 2009) with a 
binding affinity of 20 µM. 
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We have for the first time demonstrated that HDXMS is sensitive enough to detect weak affinity 
inhibitors. Our approach provides a method not only for screening low affinity fragments that bind to 
a target protein but also to combine ligand binding information with structural and conformational 
dynamics information as well.   
Our results show that all three fragments showed evidence for binding to Hsp90. We also observed 
the ligand binding and resultant allosteric effects can be differentiated by monitoring time dependence 
of the effects observed. Finally we propose a workflow for how HDXMS can carve a niche for itself 
into the current FBLD pipeline. 
4.2 Materials and Methods 
4.2.1 Materials 
Unless otherwise mentioned all ligands/compounds were purchased from Sigma Aldrich (St. Louis, 
MO).   
4.2.2 Protein Expression and Purification* 
The gene coding for M1-E236, the ATP binding domain of human hsp90 isoform 1, were subcloned 
into the pNIC28-Bsa4 vector (GenBankTM accession number EF198106), yielding an expression 
construct with an N-terminal hexahistidine tag and a TEV protease recognition site. The positive 
recombinant clone was retransformed and expressed in T1 phage-resistant BL21(DE3) E. coli strain 
(Merck). For expression, the cells were grown at 37°C in a LEX system using 0.75 L of Terrific Broth 
medium supplemented with 8 g/L glycerol, 50 μg/mL of kanamycin, and 34 μg/mL of 
chloramphenicol. When OD600 reached ca. 2, the temperature was reduced to 18°C. After 30–60 min, 
the expression of the target protein was induced by addition of 0.5 mm isopropyl β-d-
thiogalactopyranoside (IPTG) and incubated for 17–20 h. The cells were harvested by centrifugation 
and resuspended in lysis buffer (100 mM HEPES, 500 mM NaCl, 10 mM imidazole, 10% (v/v) 
glycerol, 0.5 mM TCEP, pH 8.0) supplemented with Protease Inhibitor Mixture Set III, EDTA free 





sonication on ice using Vibra-Cell processor (Sonics & Materials Inc., Newtown, CT, USA). The 
lysate was clarified by centrifugation at 47,000 × g for 25 min at 4 °C, and the supernatant was 
filtered through a 1.2-μm syringe filter. Filtered lysates were loaded onto 1 mL of nickel-
nitrilotriacetic acid Superflow resin (Qiagen Inc., Valencia, CA, USA) in IMAC wash buffer 1 (20 
mM HEPES, 500 mM NaCl, 10 mM imidazole, 10% (v/v) glycerol, 0.5 mM TCEP, pH 7.5) and 
washed with IMAC wash buffer 2 (20 mM HEPES, 500 mM NaCl, 25 mM imidazole, 10% (v/v) 
glycerol, 0.5 mM TCEP, pH 7.5). Bound proteins were eluted with 500 mM imidazole and loaded 
onto a HiLoad 16/60 Superdex-200 column (GE Healthcare, Waukesha, WI, USA) pre-equilibrated 
with equilibration buffer (20 mM HEPES, 300 mM NaCl, 10% (v/v) glycerol, 0.5 mM TCEP, pH 
7.5). Fractions containing the protein of interest were pooled. TCEP was added to a final 
concentration of 2 mM, and the sample was concentrated using Vivaspin 20 filter concentrators (15-
kDa MW cutoff) (GE Healthcare) at 15 °C. The final protein concentration and yield was 16.5 
mg/mL, 6 mg.  
 
4.2.3 Amide Hydrogen/Deuterium Exchange Mass Spectrometry 
Amide exchange reaction for ligand free protein was initiated by diluting 1 µL of 100 µM stock 
Hsp90 protein in 99.9% D2O buffer (20 mM HEPES, 300 mM NaCl, 10% (v/v) glycerol, 0.5 mM 
TCEP, pH 7.5) to obtain a final D2O concentration of 90%. For experiments monitoring ligand 
binding to Hsp90, concentrated ligands in DMSO were diluted into 99.9% D2O buffer. Hsp90 was 
subsequently added to the D2O buffer to initiate deuterium exchange reaction. This is carried out so 
that Hsp90 is not denatured by the high DMSO concentration in the ligand solution. Radicicol and 17-
AAG were maintained at a final concentration of 20 µM and EA1 and EA4 were maintained at a final 
concentration of 5 mM. A list of all ligands tested along with their molecular weight and KD values 
are given in Table 4.1. It has to be noted that, the amino pyrimidine fragment was only tested for 2 
timepoints (1 min and 10 min) due to non-availability of the compound as it is no longer 
commercially available. 
HDXMS was carried out as described in the materials and methods section of Chapter 3. 
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Table 4.1: Table lists all ligands tested for binding to Hsp90 by HDXMS along with their molecular 





4.3 Results and Discussion 
4.3.1 Dynamic regions of Hsp90 are proximal to the substrate binding pocket 
HDXMS experiments of apo Hsp90 were carried out as described in materials and methods. A total of 
42 peptides were obtained corresponding to a sequence coverage of 95% of the primary of Hsp90. All 
peptides were quantified and each peptide was plotted against the relative deuterium uptake value 
(Figure 4.2 A). Relative deuterium uptake is the ratio of average number of deuterium ions 
incorporated to the maximum exchangeable amides. This is a parameter to define the dynamics of 
regions of the protein. Relative deuterium uptake (RDU) plot of Hsp90 indicates many regions of the 
protein show >0.6 relative deuterium uptake values. It was important to classify regions of the 
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proteins showing increased dynamics as compared to the rest of the protein. Thus the following 
criterion was used to identify highly dynamic regions vs regions which are more ordered.  
ܦݕ݊ܽ݉݅ܿ	ݎ݁݃݅݋݊	݂݅	ܴܦܷ ൐ 0.5 ൈ ݉ܽݔ݅݉ݑ݉	ܴܦܷ	݂݋ݎ	ݐ݄݁	݌ݎ݋ݐ݁݅݊ 
Equation 1 
For Hsp90, the maximum RDU value was seen to be 0.67, thus regions showing RDU values greater 
than 0.335 were considered dynamic regions (highlighted by blue boxes in figure 4.2 A). Regions 
showing high dynamics were mapped onto the surface representation of Hsp90 and interestingly it 
was seen that all these regions were proximal to the ligand binding pocket (figure 4.2 B). This was 
consistent with the notion that ligand binding pockets tend to be dynamic loci and respond to ligands 
via conformational selection (Boehr, Nussinov et al. 2009, Badireddy, Yunfeng et al. 2011). This 
suggests that the dynamic regions proximal to the ligand binding pocket, are sampling multiple 















Figure 4.2: Dynamic regions line the ligand binding pocket: A) Relative deuterium uptake values 
(y-axis) is plotted for each peptide from the N to C terminus (x-axis) of Hsp90. Various time points 
were quantified and colored according to key. Dynamic regions were determined according to Eqn. 1 
and boxed in blue. B) Regions showing high dynamics were plotted onto the surface representation of 
Hsp90 (PDB Id: 4EGK) in blue. Radicicol present in the ligand binding pocket is shows as green 
sticks. 
4.3.2 Mapping high affinity ligand binding sites on Hsp90 by HDXMS 
HDXMS was used to determine the regions of Hsp90 involved in ligand binding. To this end two high 
affinity ligands, namely Radicicol, a natural antibiotic, and 17-AAG, a Geldanamycin derivative were 
tested by HDXMS (Table 4.1). These ligands have very high affinities for Hsp90 with KD in the low 
nanomolar range. 
A difference plot summarizing results from HDXMS is shown in Figure 4.3A, regions which show 
decreased deuterium exchange are depicted by points in the positive scale and regions showing 
increased exchange are depicted in the negative scale. Both high affinity ligands tested showed 
decreased deuterium exchange across the entire protein indicating that the dynamic apo Hsp90 adopts 
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a stable structure upon ligand binding (Figure 4.3). Interestingly, both Radicicol and 17-AAG caused 
decreased deuterium exchange at the same regions of the proteins. These regions were mainly 
centered around a helix-loop-helix region spanning residues 91-119. Other regions showing 
significant decreases in deuterium exchange are at the N-terminal linker region spanning residues 2-
16, the long helix-loop motif spanning residues 45-76 and a β strand-loop motif part of a β sheet 
spanning residues 171-197. All these regions are proximal to the ligand binding site except the N-
terminal linker region. Previous structural characterization of the Hsp90-ATP interaction has shown 
that all these regions form important interactions with the ligand (Prodromou, Roe et al. 1997, Ali, 
Roe et al. 2006). These high affinity ligands are known to bind at the ligand binding pocket, (Schulte, 
Akinaga et al. 1998, Murray, Carr et al. 2010) and thus serve as a good template to define the regions 
of the protein that directly interact with the ligand (Figure 4.4 A). Subtractive analysis of all peptides 
lining the binding pocket reveals a minimal ligand binding region, highlighted in blue in Figure 4.4 A. 
This minimal binding region is the shortest stretch of amino acids (4 residues) that shows a clear 
reduction in deuterium exchange upon ligand binding. It spans residues 104 to 107. Regions that 
showed high dynamics in the apo state along with decreased deuterium exchange in the ligand bound 
state were mapped onto the structure of Hsp90 (Figure 4.4 B). It was observed that these regions 
perfectly line the outer edge of the binding pocket, further establishing the importance of these 
regions for ligand recognition and binding. 
In HDXMS experiments, regions that exchange readily with solvent are highly important especially 
when monitoring exchange in the fast dynamics regime (<10 min of deuterium labeling). These 
regions are the regions that will respond to perturbations for two reasons, firstly they rapidly exchange 
with the label and hence would also be the regions where changes in deuterium exchange are readily 
monitored. Secondly, regions that rapidly exchange with solvent are dynamic in nature, and as seen 
earlier, and are important for ligand sensing and binding. Defining these dynamic regions is 
important, as they are the regions which are most responsive to ligand binding. Once we have a 
detailed knowledge of these dynamic regions, we can easily carry out rapid screening of weakly 
binding ligands by monitoring changes at the dynamic regions. 
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Figure 4.3 : Summary of Hsp90- high affinity ligand interactions by HDXMS: The absolute difference in numbers of deuterons (inferred from difference 
in mass in Daltons (Da) (y-axis) between the free and ligand bound state is plotted for each pepsin digest fragment listed from the N to C terminus (x-axis) of 
Hsp90 for each Deuterium exchange time point (t= 0.5, 2, 5, 10 min) in a ‘difference plot’. Shifts in the positive scale represent decreases in deuterium 
exchange and shifts in the negative scale represent increases in deuterium exchange when compared to the apo Hsp90. The top panel shows regions showing 
differences upon Radicicol binding and the bottom panel shows differences upon 17-AAG binding. Regions showing significant differences (>1 Da) are 







Figure 4.4: High affinity ligands bind at the ATP binding pocket of Hsp90: A) Regions showing 
decreased exchange upon ligand binding (either Radicicol or 17-AAG) are depicted in purple onto the 
structure of Hsp90. The minimal binding region is in blue. B) Regions that showed high dynamics in 
the apo state as well as decreases upon ligand binding are mapped onto the structure of Hsp90 in red. 
For both structures, Radicicol bound at the ligand binding pocket is depicted as cyan sticks. PDB ID: 
4EGK. 
 
4.3.3 Low affinity fragments EA4 and EA1 bind at the same loci as the high 
affinity ligand 
To test whether HDXMS is capable of detecting binding interactions between proteins and low 
affinity fragments, three fragment molecules were used to test for binding with Hsp90 (grey box, 
Table 4.1). Two of the fragments were phenolic compounds while the third fragment was an 
aminopyrimidine class molecule. By definition, fragments are small molecules with very low binding 
affinities and all three fragment compounds tested were >200 Da and had KDs in the micromolar 
range. The phenolic compounds had binding affinities ~0.5mM (Murray, Carr et al. 2010) and the 
aminopyrimidine (2,4,6 AMP) molecule had a KD of ~20 µM (Brough, Barril et al. 2009). HDXMS 






Results show that, though the phenolic compounds are the same class of molecule and similar in 
reactive species, they showed significantly different effects on binding to Hsp90. It was seen that EA4 
seemed to form more stable interactions at the binding pocket (residues 109-119) and showed 
decreased deuterium exchange pattern similar to the high affinity ligands. EA1 on the other hand 
caused increased dynamics at the binding pocket but showed decreased deuterium exchange at the 
other important loci (regions showing significant differences are boxed in blue in Figure 4.5). The 
aminopyrimidine molecule, 2,4,6 AMP, showed similar deuterium exchange effects to EA4 molecule. 
While the regions which showed decreased deuterium exchange for the fragment molecules were the 
same as seen for the high affinity ligands, the magnitude of difference was significantly less than 
those seen for the high affinity molecules. This effect was mainly observed at the ligand binding site, 
centered at residues 109-119. Radicicol and 17-AAG caused decreased deuterium exchange of upto 3 
Da (Figure 4.3), EA4 binding lead to a decrease in deuterium exchange of ~1 Da. EA1binding on the 
other hand leads to an increase in deuterium exchange of upto 0.75 Da. Mass spectral envelopes for a 
peptide spanning the ligand binding pocket upon binding all ligands tested is shown in figure 4.6A. 
Other regions of the ligand binding pocket showed decreased exchange upon fragment binding, 
equivalent to decreased deuterium exchange seen upon high affinity ligand binding. The changes 
upon ligand binding were seen to be time-dependent and the significance of this is discussed in detail 
in the next section. 
At almost all loci, the fragment molecules accessed the same regions that the high affinity ligands 
accessed. This is expected as the high affinity ligands are large molecules that can access the entire 
conformational space of the binding pocket. The fragments being smaller molecules should only be 
able to access a subset of the regions available to the high affinity. While it was remarkable that the 
fragments tested showed effects at all loci that the high affinity ligands bind, what was unexpected 
was the EA4 molecule causing long range conformational stabilization effects at a region unchanged 
by both high affinity ligands. This region is boxed in red in Figure 4.5 (top panel). This peptide is part 
of a helix region that is distal to the binding site and spans residues 201 to 213 (Figure 4.6B).
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Figure 4.5: Summary of Hsp90-low affinity ligand interaction by HDXMS: The absolute difference in numbers of deuterons (inferred from difference in 
mass in Daltons (Da) (y-axis) between the free and ligand bound state is plotted for each pepsin digest fragment listed from the N to C terminus (x-axis) of 
HSp90 for each Deuterium exchange time point (t= 0.5, 2, 5, 10 min) in a ‘difference plot’. Shifts in the positive scale represent decreases in deuterium 
exchange and shifts in the negative scale represent increases in deuterium exchange when compared to apo form of Hsp90. The top panel shows regions 
showing differences upon EA4 binding and the bottom panel shows differences upon EA1 binding. Regions showing significant differences (>1 Da) are 
boxed in red. Time points are colored according to key.
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Figure 4.6: Low affinity ligand EA4 binds at the ATP binding pocket of Hsp90: A) Mass spectral 
isotopic envelopes of a peptic peptide fragment spanning residues 91-119 of Hsp90. Isotopic 
envelopes are shown for the apo protein and compared with ligand bound states. Red triangles 
indicate centroids of the envelope. B) Regions showing decreased deuterium exchange in Hsp90 upon 
EA4 binding are mapped onto the structure of Hsp90 in green. The region showing decreased 
deuterium exchange unique to EA4 binding is labeled in red. The EA4 molecule in the binding pocket 
is in blue sticks. PDB ID: 2YE4. 
4.3.4 Differentiating ligand binding and ligand mediated conformational 
changes 
One of the most important conclusions from this study was the prevalence of a time dependence on 
observed differences in deuterium exchange seen upon ligand binding. Radicicol being the highest 
affinity ligand tested showed decreased deuterium exchange across all time points at all loci (Figure 
4.7 A). 17-AAG, the next highest affinity ligand showed decreased deuterium exchange across all 
time points at almost all loci except the ligand binding pocket spanning residues 91-119 (Figure 4.7 
B). At this loci, it was seen that ligand induced decreases in deuterium exchange were greatest at 
earlier time points. As labeling time increased it was seen that the difference between the apo form 
and ligand bound form diminished. The greatest time-dependent effects were observed upon EA4 
binding to Hsp90. It was seen that at the binding site peptide, earlier time points showed the greatest 
decreases in deuterium exchange and as labeling time increases these differences decreased to be 





significant differences but as labeling time increases the differences increased (Figure 4.7 C). These 
results are summarized in figure 4.7, where regions showing decreased deuterium exchange after 30 s 
of deuterium labeling are in orange and regions showing decreased exchange after 5 min of deuterium 
labeling are in blue. 
Figure 4.7: Time dependent differences in deuterium exchange upon ligand binding: A) 
Difference plot of Radicicol binding to Hsp90 comparing 30 sec and 5 min time points. B) Difference 
plot of 17-AAG binding to Hsp90 comparing 30 s and 5 min time points. C) Difference plot of EA4 
binding to Hsp90 comparing 30 s and 5 min timepoints. 
The dissociation constant KD is the ratio of the dissociation rate (kd) by the association rate (ka), and 
for small molecules, association rates are generally diffusion rate controlled. A high KD value implies 
that the dissociation rate is also a high value. Thus the lower deuterium exchange values observed at 
the binding site are most likely the result of the fragment having a high on/off rate at the binding 
pocket. As mentioned in section 4.3.1, the regions lining the ligand binding pocket are highly dynamic 
regions thus they exchange deuterium ions rapidly. Due to the ligands intrinsic on/off rate, deuterium 
exchange occurs rapidly in the time span the pocket is not occupied by a ligand. In earlier time points, 
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the probability of ligand not occupying the pocket is low, so the pocket is protected from deuterium 
exchange. As labeling time increases, the probability of ligand occupancy in the pocket also decreases 
thereby allowing deuterium exchange at the pocket. This effect leads to diminishing differences 
between apo state and ligand bound as labeling time increases. This is defined by the following 
equation 
݇݋ܾݏ	ൌ ௞ௗൈ௞௘௫௞௔ሾ௟௜௚௔௡ௗሿା௞௘௫ Equation 2 (Mandell, Baerga-Ortiz et al. 2001) 
Where kobs is the observed deuterium exchange rate, ka is the association rate and kd is the dissociation 
rate, kex is the inherent deuterium exchange rate for a given amide and [ligand] is the concentration of 
ligand used. Thus the observed deuterium exchange rate is inversely proportional to the ligand 
concentration and directly proportional to the KD. Thus as the KD (kd/ka)increases the observed 
deuterium exchange rate at a particular amide also increases, this is offset by the addition of excess 
ligand. If ligand is added at a considerable excess then equation 2 condenses to equation 3.  
݇݋ܾݏ ൌ ௞ௗൈ௞௘௫௞௔ሾ௟௜௚௔௡ௗሿ  Equation 3 
 
Figure 4.8: Time dependent differences caused by EA4 binding to Hsp90: Regions showing 
differences at early time points are labeled in orange and regions differences at later time points are 
labeled in blue onto structure of Hsp90. EA4 molecule is in cyan stick representation at the ligand 




In most experiments, the ligand concentration is maintained high enough such that observed 
deuterium exchange rate is governed by equation 3. But in the case of fragments, the KD value is very 
high and ligand added at a very high concentration is still not enough to offset deuterium exchange to 
occur at an amide at the binding site. On the other hand it has to be remembered that, even though the 
ligand has a fast on/off rate inside the binding pocket, the pocket would on average always be 
occupied by a ligand. This is ensured by maintaining a high ligand concentration. Thus regions of the 
protein that indirectly respond to ligand binding (i.e. allosteric regions) are activated by the continued 
presence of ligand in the pocket. As time increases, the differences from conformational stabilization 
would incrementally add up to be reflected in significant differences at later time points. 
It has to be noted that differences between binding effects and conformational stabilization effects 
would only be observed in systems with a fast on/fast off rate. Also the slowest ligand off rate that can 
be probed by this approach is yet to be described and at present would need to be tested empirically. 
This observation is of a qualitative nature and would be useful to possibly  differentiate what is likely 
to be the binding sites from other regions that respond to ligand binding outside of the ligand-binding 
pocket. Allosteric effects and other conformational stabilization effects theoretically occur in the µs to 
ms time regime and hence the observations described at later time points do not directly relate to 
allosteric effects. 
 
4.3.5 Workflow for fragment based ligand discovery by HDXMS 
 
HDXMS is thus proven to be sensitive to weak affinity fragment binding to target proteins. A 
workflow for how HDXMS can aid current efforts in fragment based ligand discovery is proposed 
























Figure 4.9: Workflow for HDXMS in fragment based ligand design: High throughput assays serve 
as a funnel to reduce the number of ligands tested from >2000 to ~200. HDXMS based lead 
compound identification is followed by combinatorial chemistry. The resulting products are 
iteratively screened and validated by HDXMS to obtain a tight binding ligand that is further validated 
by structural biology. 
 
Most fragment libraries contain more than 2000 fragment molecules, and thus it is not feasible to test 
every fragment for binding to target protein by HDXMS. This would be a time consuming process 
and also consume large amounts of target protein. An alternative is to use high throughput binding 
assays to coarsely screen for fragments that potentially bind to the target protein. The top 200 hits are 
taken for further testing by HDXMS.  
HDXMS experiments are first carried out using a high affinity ligand to define the regions that show 
the greatest exchange upon ligand binding as seen in section 4.3.1. Shorter labeling times were more 
sensitive to weak affinity ligand binding at the binding pocket; hence all ligands are subjected to 
HDXMS with the target protein for a short labeling time of < 2 min.  
To increase efficiency of the data analysis process only the peptides showing decreased exchange 
upon high affinity ligand binding are tested for fragment ligand binding. Ligands showing positive 
hits are chosen for lead compound design by fragment based ligand discovery. Combinatorial 
chemistry is used to modify the ligands or link two ligands together. The resulting molecules are 
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iteratively screened by HDXMS and modified by combinatorial chemistry to obtain a tight binding 
ligand. This high affinity ligand is further validated by structural means. Thus HDXMS can be used as 
a highly sensitive screening tool which provides both ligand binding and associated protein dynamics 
information.  
4.4 Conclusions 
In this study it HDXMS was used map out regions that are highly dynamic based on deuterium ions 
incorporation. These highly dynamics regions were the same regions that also showed decreases in 
deuterium exchange upon high affinity ligand binding. Weak affinity fragment molecules were tested 
and showed that HDXMS is sensitive enough to detect very weak binders. A workflow is proposed 
for how HDXMS can be used in the fragment based ligand discovery pipeline. 
In recent years, with advances in mass spectrometry and separation science, HDXMS has proven to be 
a powerful technique to map protein-ligand interactions. In this study, an important application for 
HDXMS in drug discovery is postulated.  
In the first part of the next chapter, HDXMS is used to map interactions between an partially 
disordered protein and a DNA fragment. In the second part, HDXMS is used to monitor interactions 









































5 Role of conformational dynamics in complex biological 
systems 
In this chapter, I highlight the role of HDXMS in elucidating conformation dynamics in complex 
biological systems. I also attempt to relate the existing structural data to the known functional data by 
understanding the dynamics of the system. This chapter is split into two parts, Part I is on the 
conformational dynamics of a partially disordered DNA binding protein. Part II is on the interactions 
between a virus and its maturation protease. 
5.1 Part I- DNA-dependent Conformational Switching and H-
NS-mediated Gene Silencing 
5.1.1 Introduction 
In various pathogenic bacteria, a locus of foreign acquired genes are responsible for expression of 
pathogenicity-specific genes (Hacker and Kaper 2000). In Salmonella, these are referred to as 
Salmonella Pathogenicity Islands (SPI) which play a central role in infection propagation through 
transepithelial migration survival. Salmonella tightly regulate the expression of these acquired gene 
clusters in order to minimize the negative effects of these genes and to express them only during 
infection and under conditions of stress. Genes encoded by the SPI-2 gene locus comprise a 
specialized type three secretory system to resist host immune cells. Specific environmental cues in 
response to infection stimulate SPI-2 expression and tight regulation of this process is critical for the 
survival of Salmonella. In the absence of these environmental signals, SPI-2 is kept silenced by an 
important nucleoid protein called H-NS (Heat-stable nucleoid protein).  H-NS is an important bulwark 
against unregulated SPI-2 gene expression in the absence of specific environmental signals and is 
found in most gram negative bacteria. Silencing prevents foreign genes from being deleterious to the 
host, thus H-NS serves as an “immune sentinel” to repress newly acquired genes. H-NS thus plays a 
critical role in regulating numerous genes in response to the external environmental changes of 
bacteria such as temperature and osmolarity (Atlung and Ingmer 1997).  
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Despite the fundamental nature of H-NS-DNA interactions, the molecular details of how H-NS 
interacts with DNA are lacking, which in turn precludes an understanding of the molecular basis for 
gene silencing and regulation. Recently, two modes of H-NS binding to DNA using magnetic 
tweezers and atomic force microscopy (AFM) was described (Liu, Chen et al. 2010). A bridging 
mode describes H-NS binding to DNA and promoting looping accompanied by putative 
oligomerization of H-NS. The other, polymerization mode leads to stiffening of target DNA with no 
alteration in DNA secondary structure. These two binding modes possibly underlie the two H-NS 
activities in vivo, compaction of the nucleoid and repression of gene expression. This study also 
revealed a magnesium-dependent (Mg) ionic switch between the two modes of H-NS binding and 
highlighted Mg-induced alteration of H-NS binding to DNA from polymerization to bridging mode. 
We hypothesize that the large differences in binding modes must reflect alternate conformations of H-
NS in the two modes (Esposito, Petrovic et al. 2002, Arold, Leonard et al. 2010) (Figure 5.1.1) 
 Figure 5.1.1: Spatial representation of 
full length H-NS using solution 
structures of the N-terminal 
dimerization domain dimer(in 
blue/green) and C terminal DNA 
binding domain (PDB ID: 1HNR) (in 
yellow) connected by a disordered 
linker region (green dashed line). The 
N-terminal domain has been observed to 
dimerize either in an antiparallel 
configuration (A) (PDB ID: 1NI8), B) 
(PDB ID:3NR7)  or (C) parallel 
configuration (PDB ID:1LR1). N1, C1 
and N2, C2 are the N and C termini of 
each H-NS monomer in the dimer. The 
core of the dimerization domain is 
contributed by two amphipathic helices 
generating a hydrophobic core (red). 
 
Two techniques in structural mass 
spectrometry:- i) Ion mobility mass spectrometry (IMS)(Sharon and Robinson 2007) and ii) Amide 
hydrogen/deuterium exchange mass spectrometry (HDXMS)(Hoofnagle, Resing et al. 2003) represent 
powerful approaches to map conformational dynamics of proteins in solution . We have used IMS to 
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interrogate the putative multiple conformations in solution. To map the changes in H-NS between the 
two binding modes, we have used HDXMS of H-NS under polymerization and bridging mode 
conditions. Additionally, a major gap in understanding H-NS-mediated gene silencing is its apparent 
ability to bind nonspecifically to stretches of genomic DNA, even though it has been shown to have a 
preference for A-T rich and curved DNA, preferentially found within gene promoter regions 
(Spassky, Rimsky et al. 1984, Tupper, Owen-Hughes et al. 1994) (Liu, Chen et al. 2010). We 
additionally hypothesize that the basis for the dual nature of H-NS-binding to both A-T rich motifs, 
henceforth referred to as nucleation-motif DNA (N-motif DNA) and nonspecifically to genomic DNA 
(GDF) is through distinct conformations of H-NS stabilized through interactions with both classes of 
target DNA. In this study, we have used HDXMS to interrogate the conformations of H-NS in H-NS-
Genomic DNA and H-NS-Promoter DNA complexes. Our IMS results show that H-NS is a highly 
dynamic protein that is a mixture of monomeric and dimeric states in the gas phase and exists as an 
ensemble of multiple conformations. HDXMS results also reflect the ensemble property of apo H-NS 
in solution and highlight the distinct conformations adopted by H-NS in H-NS-Genomic DNA and H-
NS-Promoter DNA complexes and under Polymerization and Stiffening modes of binding DNA. 
Based on these results, a model for H-NS mediated gene silencing based on Conformational Silencing 
is proposed. 
5.1.2 Materials and methods 
5.1.2.1 DNA fragments 
 
 A 145 bp N-motif DNA Fragment containing part of the gene promoter and some coding regions of 
capsid protein (protein F) with a single AT-rich motif ‘AGGATAAATT’ in front of the start codon, 
was amplified from PhiX174 by PCR using two primers: ‘5-CGTCTTTGGTATGTAGGTGGTCA-
3’and‘5-CAATCTGACCAGCAAGGAAGCCA-3’ (Sigma-Aldrich). The overall A-T content was 
calculated to be ~53%. A second 141 bp Genomic DNA Fragment (GDF) was amplified from the 
coding region for the gene encoding the PhiX174 minor spike protein (protein H) by PCR using 
primers ‘5-CACGCCAGAATACGAAAGAC-3’ and ‘5- GGCGCATAATCTCGGAAACCT-3’ 
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(Sigma-Aldrich Pte Ltd, Singapore). Its overall AT content was calculated to be ~54.6% and this 
fragment lacked any A-T rich motifs.  
5.1.2.2 H-NS over-expression and purification 
An H-NS expression clone pBAD-HNS was transformed into E. coli strain BL21* and protein was 
expressed with a 6X-His tag at the C-terminus. Cells were grown until OD600 to 0.6 and induced 
overnight with arabinose (0.1%) in 18 C. Cells were pelleted and store in -20C until required. For 
protein purification, cell pellets were resuspended in lysis buffer (20 mM Tris-HCl pH 7.4, 20 mM 
NaH2PO4, 500 mM NaCl, 10 mM imidazole) containing protease inhibitor (cOmplete, Roche) and 
sonicated for 3 min (2 sec. on, 4 sec. off, 30% amplitude on a Sonics Vibra-Cell sonicator. To lyse 
cells. The sample was centrifuged at 17000×g for 30 min  at 4 C (Sigma 3-18K). The supernant was 
then incubated with Talon cobalt His-tag resin (Clontech) for 1 h at 4C. The resin was washed with 5 
ml wash buffer A (20 mM Tris-HCl pH 7.4, 20 mM NaH2PO4, 500 mM NaCl, 10 mM imidazole, 3 
mM BME), followed by wash buffer B (20 mM Tris-HCl pH 7.4, 20 mM NaH2PO4, 500 mM NaCl, 
10 mM imidazole, 500 mM KCl and 20 mM Tris-HCl pH 7.4, 20 mM NaH2PO4, 500 mM NaCl, 10 
mM imidazole and 3 mM BME), wash buffer C (20 mM Tris-HCl pH 7.4, 20 mM NaH2PO4, 1 M 
KCl, 10 mM imidazole and 3 mM BME), and wash buffer D (20 mM Tris-HCl pH 7.4, 20 mM 
NaH2PO4, 500 mM NaCl, 20 mM imidazole, 3 mM BME). H-NS protein was then eluted in 300 l of 
elution buffer (20 mM Tris-HCl, 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole and 20 mM 
Tris-HCl pH 7.4, 20 mM NaH2PO4, 500 mM NaCl, 10 mM imidazole, 3 mM BME). The purity of 
protein was evaluated by SDS PAGE and the protein concentration was measured using Coomassie 
(Bradford) Protein Assay Kit (Thermo Fisher Scientific) according to manufacturer protocol.  
5.1.2.3 Amide Hydrogen/Deuterium Exchange Mass Spectrometry  
HDXMS experiments on H-NS were carried out together with Dr. Gao Yunfeng, a then research 
fellow at Department of Biological Sciences, National University of Singapore. H-NS protein was 
changed into binding buffer A using Bio-Gel P6 micro bio-spin column (Bio-Rad) according to 
manufacturer’s recommendations. The protein concentration was determined by Bradford assay 
(Thermo Fisher Scientific). The H-NS was incubated with DNA fragment in 100:1 molar ration in 
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binding buffer A at room temperature for 1 hour. Deuterium exchange was carried out by mixing 2 μl 
of 100-150μl of H-NS  with 28 μl of D2O (99.90%) buffer resulting in a final concentration of 93.3% 
deuterated buffer A (20 mM TrisCl, pH 8.0, 50 mM NaCl, 5 mM BME). Exchange was carried out at 
20ºC for various times (0.5, 1, 2, 5 and 10min). The exchange reaction was quenched by adding 30 μL 
of pre-chilled 0.1% TFA to adjust pH to 2.5. 50 μl of the quenched sample was then injected on to a 
nano-UPLC sample manager at 4 C (beta test version, Waters, Milford, MA). HPLC based 
separation and mass spectrometry along with peptide identification and data analysis were carried out 
as mentioned in chapter 3 
5.1.3 Results 
5.1.3.1 Ion mobility mass spectrometry of apo H-NS  
We set out to determine the preferred oligomeric state of H-NS using Ion mobility mass spectrometry 
(IMS), a powerful technique (Sharon and Robinson 2007)that is well suited to report on the shape 
morphology of proteins in the gas solution phase. Results showed that H-NS existed in a mixture of 
monomers and dimeric states with the monomeric state being the preferred state (Figure 5.1.2).  
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Figure 5.1.2: A. Mass spectrum of native H-NS in 200 mM Ammonium Acetate pH 8.0 data. The 
broad range of charge states reflects conformational heterogeneity at the low m/z values, while the 
higher m/z species (m/z~1400 and above) represent the H-NS dimer. At every charge state, the peak 
doublets are reflective of the intact protein with and without the N-terminal Methionine processed. B. 
Driftscope 2.1 plot of IMS-ToF analysis of HNS in 200mM Ammonium acetate pH 8.0 data, showing 
unstructured monomers (white arrows), multiply structured monomers (blue arrows) and multiply 
structured dimers (yellow arrows). C. 3D Driftscope 2.1 plot of IMS-ToF analysis of HNS in 200 mM 
Ammonium acetate pH 8.0, shows multiple conformations for the monomer and dimer, each with the 
same mass/charge but distinct drift times, reflective of heterogeneous shape morphologies in solution. 
Interestingly, both the monomeric and dimeric species showed two distinct drift time profiles for the 
same mass-to-charge ratio of the ions examined. This provided clear evidence for conformational 
heterogeneity with at least two shape morphologies and suggested that H-NS existed as an ensemble 
of two or more distinct conformations in solution.  
The mass spectra for the pH 7.0 and pH 8.0 buffered experiments show a wide range of charge states 
(11+ to 25+) and tending towards a relatively low m/z range, usually indicative of a denatured protein, 
however as HNS is believed to be have a high degree of disorder this observation is expected.  Dimer 




Collisional Cross Sections for each of the monomers were compared to establish the number of 
potential structures in the ensemble.  It is postulated that 4 distinct monomer structures exist.   
5.1.3.2 Effects of DNA binding on H/D exchange in H-NS	
To probe the conformational changes occurring in H-NS upon DNA binding, HDXMS experiments 
were carried out on apo H-NS and H-NS bound to DNA using both 140 bp DNA fragments, N-motif 
and GDF, as described earlier. Thirty peptides were obtained which corresponded to ~90% of the 
primary sequence of H-NS full length protein (Listed in Table 5.1.1). Analysis of deuteration 
exchange of apo H-NS protein revealed that many peptides show complete exchange in all the 
available backbone amide positions in 2 min, indicating that H-NS is a highly dynamic protein.  The 
results are shown in table 5.1.1. Three peptides which spanned the residues 29-39 were of specific 
interest as they exhibited bimodal profiles for deuterium exchange as shown in Figure 5.1.3 A. These 
peptides span the N-Terminal dimerization domain of H-NS. The corresponding regions in the 3D 
structure of H-NS dimer are depicted in Figure 5.1.3 B.  
Bimodal distributions indicate either that the protein exists in quasi-equivalent states or exhibits EX1 
deuteration kinetics (Weis, Wales et al. 2006, Gertsman, Fu et al. 2010). Analysis of the isotopic 
profiles of the three peptides revealed that the peak width increased sharply after 2 min deuterium 
exchange and decreased after 30 min indicating EX1 kinetics (Weis, Wales et al. 2006).Also it was 
seen that while the intensities of the higher exchanging peak increased with deuteration times, the 
overall number of deuterons incorporated did not change. This is again consistent with EX1 hydrogen 






Figure 5.1.3: A)Electrospray ionization quadrupole time-of-flight (ESI-Q-TOF) mass spectra (A) for 
a peptide (m/z =730.4, z = 1), spanning residues 30-35, upon deuterium exchange (Dex).  Two 
distinct exchange envelopes representative of a low exchanging conformation and a higher 
exchanging conformation were observed after 2 min Dex with a bimodal distribution characteristic of 
EX1 deuterium exchange kinetics and reflecting conformational heterogeneity within the region. B) 
Peptides exhibiting EX1 kinetics of deuterium exchange are highlighted in red in solution structures 
of the N terminal dimerization domain of H-NS in both (B) parallel (PDB:1NI8 ) and (C) antiparallel 
(PDB:1LR1) configurations. All peptides showing this pattern span the dimerization interface. 
 
HDXMS analyses of both H-NS: DNA complexes were carried out using concentrations of protein 
and DNA optimized to ensure all the target DNA was fully saturated with H-NS. Amide H/D 
exchange analysis of the H-NS-N-motif complex revealed two regions of reduced deuterium 
exchange (Figure 5.1.4). A region spanning residues 80-99 is part of the linker region and N-terminal 
region of the C-terminal DNA binding region of the protein. The region exhibited reduced deuterium 
exchange only upon binding to N-motif but not GDF.  
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The region spanning residues 30-35 of apo H-NS which showed a bimodal distribution showed an 
altered profile when the N-motif DNA was complexed to H-NS with a shift favoring the low 
exchanging population. Interestingly, only very slight differences were observed in the GDF-H-NS 
complex (Figure 5.1.4 B). Furthermore, the bimodal distribution showed an even distribution of the 
higher and lower exchanging conformation. This suggested that H-NS conformational equilibria were 
sensitive to DNA binding. 
Figure 5.1.4: (A) Electrospray ionization quadrupole time-of-flight (ESI-Q-TOF) mass spectra of a 
peptide (m/z = 546.1, z =4) spanning H-NS residues 80-99  The isotopic envelope for (i) 
Undeuterated sample, (ii) apo H-NS (10 min Dex) , (iii) H-NS:N-motif DNA complex (10 min Dex) 
and (iv) H-NS: Genomic DNA complex (10 min Dex). Dashed line highlights the approximate 
centroid of apo H-NS and is provided as a reference point for comparison with the other two samples 
(B) Mass spectrum of H-NS N –Terminal peptide spanning residues 30-35, after 10 min of deuterium 
exchange, exhibiting bimodal distribution with the higher exchanging population being more 
predominant in the apo condition. On addition of N-motif DNA , the bimodal distribution shifts with 
majority of the population tending towards the lower exchanging population. On addition of Genomic 
DNA, the bimodal distribution shows a greater separation of higher and lower exchanging envelopes. 
(C). Kinetics of deuterium exchange in residues (80-99) of H-NS binding to DNA with and without 
N-Motif DBA. ( ) apo H-NS  () H-NS:N-motif DNA  complex and ()H-NS: Genomic DNA 
complex. D). In the unbound state, H-NS exists as an ensemble. Mg2+ or Nucleation-motif DNA 
alone selectively stabilize the dimer. This ability forms the basis for selectivity of H-NS function. 
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5.1.3.3 Effects of Mg2+ binding on H-NS conformational equilibria	
Previous studies revealed that in the presence of Mg2+ ions, H-NS, which normally carries out gene 
silencing in the ‘Stiffening mode’, shifts to the ‘Bridging mode’ of Gene silencing (Liu, Chen et al. 
2010). Analysis of deuterium exchange revealed that the most significant effect of Mg2+ was seen in 
the region spanning residues 30-35. The bimodal distribution that was observed in apo H-NS protein 
(Figure 5.1.3) was shifted in the presence of Mg2+, to the same extent as seen in the H-NS-N-motif 
complex (Figure 5.14). This indicated that Mg2+ locked the H-NS protein into one conformation or 
preferentially ‘selected’ a particular conformation. H-NS-N-motif complex in the presence of Mg2+ 
had similar deuterium exchange profile compared to apo H-NS with Mg2+. H-NS-GDF complex in the 
presence of Mg2+ had two important effects observed in the deuterium exchange profile. Firstly, in the 
C-terminal DNA binding domain, it was seen that the region exhibited increased dynamics (Fig. 5.1.5 
A). In the N terminal dimerization domain, the region spanning residues 30-35 there is evidence for a 
bimodal distribution (Figure 5.1.5 B). These results show that in the presence of Mg2+, N-motif with 
'AT rich' motif has no effects on the conformational dynamics of H-NS. GDF DNA containing the 
‘random’ DNA sequence, on the other hand, increases the dynamics of both the N terminal 





Figure 5.1.5: (A) Electrospray ionization quadrupole time-of-flight (ESI-Q-TOF) mass spectra of a 
peptide (m/z = 546.1, z =4) spanning H-NS residues 80-99  The isotopic envelope for (i) 
Undeuterated sample, (ii) apo H-NS (10 min Dex) , (iii) H-NS:N-motif DNA complex (10 min Dex) 
and (iv) H-NS: Genomic DNA complex (10 min Dex). Dashed line highlights the approximate 
centroid of apo H-NS and is provided as a reference point for comparison with the other two samples 
(B) Mass spectrum of H-NS N –Terminal peptide spanning residues 30-35, after 10 min of deuterium 
exchange, exhibiting bimodal distribution with the higher exchanging population being more 
predominant in the apo condition. On addition of N-motif DNA , the bimodal distribution shifts to a 
unimodal form. On addition of Genomic DNA, the bimodal distribution is more pronounced. C). In 
the unbound state, H-NS exists as an ensemble. Mg2+ or N-motif DNA alone selectively stabilize the 
dimer. While GDF drives H-NS conformation to a dynamic form.  
 
5.1.3.4 Deuterium exchange tables 







m/z Ｚ H-NS apo H-NS:PDF H-NS:GDF
SEALKILNNIRTLRAQARE (2-20) 18 549.8 4 17.2 ± 0.0 17.3 ± 0.0 17.2 ± 0.1 
ALKILNN (4-10) 6 785.5 1 4.7 ± 0.1 4.7±0.0 4.7 ± 0.0 
KILNNIRT (6-13) 7 486.3 2 5.5 ± 0.1 5.6 ± 0.1 5.6 ± 0.0 
IRTLRA (11-16) 5 365.238 2 3.4 ± 0.0 3.5 ± 0.0 3.4 ± 0.0 
IRTLRAQARE (11-20) 9 405.241 3 7.7 ± 0.0 7.6 ± 0.0 7.7 ± 0.1 
MLEKLEV (29-35) 6 431.2 2 ND ND ND 
LEKLEV (30-35) 5 730.44 1 ND ND ND 
EVVVNE (34-39) 5 688.3 1 ND ND ND 
EVVVNERREEESAA (34-47) * 13 808.9 2 9.2 ± 0.2 7.9 ± 0.0 8.6 ± 0.1 
VVNERREEESAA (36-47) * 11 694.8 2 7.5 6.8 ± 0.0 7.1 ± 0.0 
VEERTRKLQQ (51-60) 9 643.8 2 6.2 ±0.2 6.5 ± 0.0 6.6 ± 0.1 
YREML (61-65) 4 711.35 1 2.3 ± 0.0 2.5 2.5 ± 0.0 
MLIADGID (58-71) 7 847.422 1 5.0 ± 0.1 5.0 ± 0.0 5.1 ± 0.05 
IADGID ( 66-71) 5 603.3 1 3.2 ± 0.05 3.2 ± 0.1 3.2 ± 0.0 
IADGIDPNE ( 66- 74) 7 943.431 1 4.4 ± 0.7 4.5 ± 0.0 4.5 ± 0.0 
IADGIDPNEL (66- 75) 8 1056.51 1 5.1 ± 0.1 5.3 ± 0.0 5.2 ± 0.0 
IADGIDPNELL (66-76) 9 1169.6 1 6.0 ± 0.3 6.4 ± 0.0 6.2 ± 0.0 
LNSLAAVKSGTKAKRAQR (76-93) 17 475.536 4 8.7 ± 0.2 8.7 ± 0.1 8.8 ± 0.1 
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AAVKSGTKAKRAQRPAKYSY (80-99) * 18 546.1 4 11.4 ± 0.1 10.8 ± 0.1 11.8 ± 0.2 
KSGTKAKRAQRPAKYSYV (83-100)* 16 510.545 4 11.2 ± 0.1 11.0 ± 0.1 11.4 ± 0.1 
VDENGETKTWTGQGRTPAV (100-118) 17 682.669 3 12.1 ± 0.3 12.5 ± 0.0 12.1 ± 0.1 
VDENGETKTWTGQGRTPAVI ( 100-119) 18 720.367 3 12.7 ± 0.3 13.2 ± 0.0 12.9 ± 0.1 
VDENGETKTWTGQGRTPAVIKKAMDEQGKS 
(100-129) 
28 653.135 5 20.1± 0.3 20.2 ± 0.1 20.5 ± 0.1 
ETKTWTGQGRTPAVI (105-119) 13 822.9 2 9.4 ± 0.3 9.7 ± 0.05 9.5 ± 0.1 
WTGQGRTPAVIKKAMDEQGKSLDDF (109-133) 23 695.357 4 17.5 ± 0.3 16.7 ± 0.0 17.2 ± 0.0 
IKKAMDEQGKSLDD (119-132) 13 526.6 3 8.1 ± 0.10 8.0 ± 0.0 8.2 ± 0.0 
IKKAMDEQGKSLDDF (119-133) 14 575.6 3 8.5 ± 0.1 8.3 ± 0.0 8.5 ± 0.0 
KKAMDEQGKSLDD (120-132) 13 488.906 3 7.8 ± 0.15 7.9 ± 0.0 8.0 ± 0.0 
ND: Centroids could not be determined due to EX1 kinetics governing deuterium exchange. *Highlighted 
peptides showing reduce deuterium exchange upon binding to N-motif DNA. aAverage number of deuterons 
exchanged determined from the mean and standard values after  10 min Dex.  All deuterium exchange values 
reported were corrected for a 17% back exchange by multiplying the centroid values by a multiplication factor 
of 1.3.  
 
Table 5.1.2: Summary of Deuterium exchange (10 min Deuterium exchange) for  H-NS, Nmotif-H-
NS and GDF-H-NS complexes in the presence of 10 mM Mg2+ (Bridging mode conditions). 
Peptide No. of exchangeable 
amides 
m/z Ｚ H-NS:Mg2+ H-
NS:PDF:Mg2+ 
H-NS:GDF:Mg2+
SEALKILNNIRTLRAQARE (2-20) 18 549.8 4 17.3 ± 0.1 17.2 ± 0.1 17.5 ± 0.1 
ALKILNN (4-10) 6 785.5 1 4.7 ± 0.0 4.7 ± 0.0 4.7 ± 0.01 
KILNNIRT (6-13) 7 486.3 2 5.6 ± 0.1 5.5 ± 0.0 5.8 ± 0.0 
IRTLRA (11-16) 5 365.2 2 3.5 ± 0.0 3.5 ± 0.0 3.6 ± 0.0 
IRTLRAQARE (11-20) 9 405.2 3 7.7 ± 0.0 7.5 ± 0.13 7.9 ± 0.0 
MLEKLEV (29-35) 6 431.2 2 ND ND ND 
LEKLEV (30-35) 5 730.4 1 ND ND ND 
EVVVNE (34-39) 5 688.3 1 ND ND ND 
EVVVNERREEESAA (34-47) * 13 808.9 2 7.4 ± 0.0 7.2 ± 0.1 8.1 ± 0.1 
VVNERREEESAA (36-47) * 11 694.8 2 6.8 ± 0.0 6.5 ± 0.1 7.2 ± 0.0 
VEERTRKLQQ (51-60) 9 643.9 2 6.5 ± 0.0 6.5 ± 0.1 6.8 ± 0.0 
YREML (61-65) 4 711.3 1 2.0 ± 0.0 2.1 ± 0.01 2.1 ± 0.0 
MLIADGID (58-71) 7 847.4 1 4.8 ± 0.1 5.0 ± 0.1 5.0 ± 0.1 
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IADGID ( 66-71) 5 603.3 1 3.2 ± 0.0 3.2 ± 0.0 3.2 ± 0.0 
IADGIDPNE ( 66- 74) 7 943.4 1 4.7 ± 0.0 4.6 ± 0.0 4.7 ± 0.0 
IADGIDPNEL (66- 75) 8 1056.5 1 5.5 ± 0.2 5.3 ± 0.0 5.4 ± 0.0 
IADGIDPNELL (66-76) 9 1169.6 1 6.4 ± 0.1 6.4 ± 0.0 6.4 ± 0.0 
LNSLAAVKSGTKAKRAQR (76-93) 17 475.5 4 8.9 ± 0.2 8.9 ± 0.1 9.4 ± 0.1 
AAVKSGTKAKRAQRPAKYSY (80-99) * 18 546.1 4 11.3 ± 0.0 10.9 ± 0.1 12.4 ± 0.1 
KSGTKAKRAQRPAKYSYV (83-100) 16 510.5 4 11.0 ± 0.0 10.1 ± 0.1 12.3 ± 0.1 
VDENGETKTWTGQGRTPAV (100-118) 17 682.7 3 12.5 ± 0.1 12.5 ± 0.0 12.7 ± 0.0 
VDENGETKTWTGQGRTPAVI ( 100-119) 18 720.4 3 13.3 ± 0.1 13.3 ± 0.0 13.5 ± 0.1 
VDENGETKTWTGQGRTPAVIKKAMDEQGKS 
(100-129) 
28 653.1 5 20.1 ± 0.5 20.2 ± 0.2 21.7 ± 0.1 
ETKTWTGQGRTPAVI (105-119) 13 822.9 2 9.6 ± 0.2 9.7 ± 0.0 10.1 ± 0.1 
WTGQGRTPAVIKKAMDEQGKSLDDF (109-133) 23 695.4 4 17.0 ± 0.2 16.8 ± 0.2 18.4 ± 0.0 
IKKAMDEQGKSLDD (119-132) 13 526.6 3 8.0 ± 0.1 7.8 ± 0.1 8.7 ± 0.0 
IKKAMDEQGKSLDDF (119-133) 14 575.6 3 8.4 ± 0.1 8.3 ± 0.1 9.0 ± 0.0 
KKAMDEQGKSLDD (120-132) 13 488.9 3 7.5 ± 0.0 7.5 ± 0.1 8.0 ± 0.0 
ND: Centroids could not be determined due to EX1 kinetics governing deuterium exchange. *Peptides showed 
increased deuterium exchanges upon binding to GDF in the presence of 10 mM Mg 2+. aAverage number of 
deuterons exchanged determined from the mean and standard values for a 2-min.   
Table 5.1.3: Summary of Deuterium exchange (10 min Deuterium exchange) for Apo H-NS and H-
NS (+Mg2+) 
Peptide No. of exchangeable 
amides 
m/z Ｚ H-NS apo H-NS:Mg2+ 
SEALKILNNIRTLRAQARE (2-20) 18 549.8 4 17.2±0.05 17.31±0.09 
ALKILNN (4-10) 6 785.5 1 4.66±0.07 4.69±0.04 
KILNNIRT (6-13) 7 486.3 2 5.5±0.13 5.62±0.12 
IRTLRA (11-16) 5 365.238 2 3.41±0.04 3.47±0.03 
IRTLRAQARE (11-20) 9 405.241 3 7.66±0.02 7.69±0.0 
MLEKLEV (29-35) 6 431.2 2 ND ND 
LEKLEV (30-35) 5 730.44 1 ND ND 
EVVVNE (34-39) 5 688.3 1 ND ND 
EVVVNERREEESAA (34-47)  13 808.9 2 9.20±0.22 7.39±0.03 
VVNERREEESAA (36-47)  11 694.8 2 7.46 6.83±0.01 
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VEERTRKLQQ (51-60) 9 643.867 2 6.25±0.2 6.53±0.0 
YREML (61-65) 4 711.35 1 2.34±0.01 1.96±0.0 
MLIADGID (58-71) 7 847.422 1 4.99±0.13 4.80±0.15 
IADGID ( 66-71) 5 603.3 1 3.17±0.05 3.22±0.02 
IADGIDPNE ( 66- 74) 7 943.431 1 4.42±0.7 4.70±0.02 
IADGIDPNEL (66- 75) 8 
1056.51
1 
1 5.14±0.14 5.50±0.16 
IADGIDPNELL (66-76) 9 1169.6 1 5.97±0.26 6.45±0.07 
LNSLAAVKSGTKAKRAQR (76-93) 17 475.536 4 8.71±0.25 8.95±0.18 
AAVKSGTKAKRAQRPAKYSY (80-99)  18 546.1 4 11.42±0.14 11.26±0.0 
KSGTKAKRAQRPAKYSYV (83-100) 16 510.545 4 11.22±0.14 11.04±0.0 
VDENGETKTWTGQGRTPAV (100-118) 17 682.669 3 12.07±0=.35 12.51±0.15 
VDENGETKTWTGQGRTPAVI ( 100-119) 18 720.367 3 12.75±0.34 13.27±0.1 
VDENGETKTWTGQGRTPAVIKKAMDEQGKS (100-
129) 
28 653.135 5 20.11±0.299 20.14±0.5 
ETKTWTGQGRTPAVI (105-119) 13 822.9 2 9.44±0.27 9.62±0.19 
WTGQGRTPAVIKKAMDEQGKSLDDF (109-133) 23 695.357 4 17.51±0.26 17.05±0.16 
IKKAMDEQGKSLDD (119-132) 13 526.6 3 8.14±0.13 7.99±0.1 
IKKAMDEQGKSLDDF (119-133) 14 575.6 3 8.49±0.09 8.42±0.11 
KKAMDEQGKSLDD (120-132) 13 488.906 3 7.82±0.15 7.52±0.05 
ND: Centroids could not be determined due to EX1 kinetics governing deuterium exchange. *Peptides showed 
reduce deuterium exchanges with 10 mM Mg 2+ (Bridging mode conditions).aAverage number of deuterons 
exchanged (2 min deuterium exchange).  All deuterium exchange values reported were corrected for a 17% 
back exchange by multiplying the centroid values by a multiplication factor of 1.3.  
 
5.1.4 Discussion 
Ion mobility experiments provided compelling evidence that H-NS exists in an ensemble of 
conformations. It is known that H-NS is a partially disordered protein, but interestingly, IMS revealed 
that H-NS preferentially populates a subset of 4 populations as opposed to a continuum of 
conformations. This suggests that the anti-parallel and parallel forms of H-NS would be quasi-stable 
forms of H-NS. HDXMS studies of H-NS with N-motif DNA and GDF revealed that N-motif DNA 
drives H-NS to a stable conformation while GDF does not alter the stability of H-NS. Mg2+ was 
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previously shown to influence H-NS to switch from the ‘sitffening’ form to the ‘bridging’ form (Liu, 
Chen et al. 2010). Experiments with H-NS in the presence of Mg2+ provided interesting results when 
DNA fragments were introduced. In the presence of Mg2+, N-motif DNA had no further stabilization 
effect on H-NS but GDF was seen to cause local unfolding of existing Mg2+ mediated stable 
conformation. These results provide an explanation for how DNA and Mg2+ influence conformational 
switching in H-NS. These results are summarized in Figure 5.1.6 
This study highlights the role of H-NS in understanding the interplay between dynamics and function 
in disordered proteins. While the availability of a three-dimensional structure would greatly aid data 
analysis, it is not essential to tease out a correlation between dynamics and function of proteins with a 














Figure 5.1.6: Figure 5. Model for H-NS Dynamics and function: H-NS exists as an ensemble of 
interconverting parallel and antiparallel conformations with a hydrophobic core at the dimer interface 
formed by two amphipathic helices maintaining the dimer.  Mg2+ or N-motif DNA alone stabilize 





5.2 Part II- Monitoring transient virus capsid-maturation 
protease interactions by HDXMS in the maturation pathway of 
HK97 bacteriophage 
5.2.1 Introduction 
Virus maturation is an integral part of the lifecycle of the virus and it corresponds to a transition from 
an initial non-infectious to an infectious and robust virion. Viruses are maturation begins with the 
production of large amounts of the individual subunit proteins. The virus maturation pathway begins 
by the spontaneous association of these subunit proteins driven by an association energy that favors 
assembly over disassembly. But there are provisions for self-correction to correct mismatched 
interactions.(Caspar 1980, Katen and Zlotnick 2009). In this study, a lambdoid dsDNA phage HK97 
is studied as a model system to understand virus maturation dynamics. It constitutes an accessible 
model system for studying maturation of such viruses due to its well characterized genetics and ease 
of handling (Veesler and Johnson 2012). Its capsid maturation pathway is mediated by intermediate 
particle forms (Figure 5.2.1) which constitute discrete steps in the maturation pathway and each step 
can be isolated using a combination of molecular biology and biochemical techniques. The HK97 
capsid precursor protein is composed of two main regions, the scaffolding protein (δ-domain, residues 
2-103) and the coat subunit (residues 104-385) which spontaneously forms a mixture of hexamers and 
pentamers upon association. In vivo, 415 coat subunits (60 hexamers and 11 pentamers) assemble 
with a dodecameric portal along with an unknown number of protease molecules in an icosahedral 
configuration called Prohead-1 (Figure 5.2.1). This is a reversible state and it is possible to revert back 
to the individual subunit molecules by maintaining the right conditions. Activation of the viral 
protease, which occurs after particle assembly, is initiated by the protease mediated digestion of the 
scaffolding domains and autodigestion of the aforementioned protease to produce small peptide 
fragments that diffuse out of the particle to yield Prohead-2. This step is in an irreversible step and 
constitutes a key step in the activation of the virus maturation pathway (Gertsman, Gan et al. 2009, 
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Huang, Khayat et al. 2011). The Prohead-2 state is a meta-stable local free-energy minimum state and 
is primed to fold to a lower energy conformation constituting the expansion and cross linking segment 
of the virus maturation pathway. Native mass spectrometry based quantification of the number of 
protease molecules in each Prohead 1 capsid particle revealed, ~120 copies of protease molecules 
exist in each viral capsid (Veesler, Khayat et al. 2013). 
In this study HDXMS is used to map the interactions that the protease makes with viral capsid 
protein. A catalytically dead protease is used, so the virus is trapped in a transient state. The 
scaffolding domain is present in the first 100 amino acids of the viral capsid protein, thus the protease 
interactions were expected to occur at N-terminal region of the protein. Interestingly conformational 
stabilization effects distal to the interaction site were also observed. A distinction between binding 
and conformational stabilization could be made based on the time dependent changes observed. 
Adapted from (Gertsman, Gan et al. 2009) 
Figure 5.2.1: HK97 maturation pathway involves three main steps, the reversible association of 
hexons and pentons of the coat protein to form Prohead-1 state, the irreversible protease mediated 
cleavage of the scaffolding domain and the spontaneous expansion and cross-linking steps. 
5.2.2 Experimental procedures 
5.2.2.1 Viral capsid expression and purification 
Intact HK97 bacteriophage Prohead 1 particle with inactive protease was expressed and purified by 
previously described methods in (Gertsman, Gan et al. 2009) . Intact Prohead 1 particle  was obtained 
from our collaborator, Prof. John E. Johnson’s lab at Scripps Research Institute at La Jolla, California. 
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5.2.2.2 Amide hydrogen/deuterium exchange mass spectrometry 
Prohead 1 with and without maturation protease was maintained at 5 mg/ml concentration to get 
adequate signal in the mass spectrometric analysis. All deuterium exchange experiments were carried 
out in a 99.9% D2O buffer containing 20mM Tris-HCl, 50mM NaCl, maintained at pH 7.5. HDXMS 
experiments were carried out as described in materials and methods of chapter 3. 
5.2.3 Results and Discussions 
5.2.3.1 The maturation protease binds at the N terminal scaffolding domain 
HDXMS experiments were carried out comparing Prohead 1 state in presence and absence of the 
maturation protease. A total of 81 peptides were obtained which corresponded to 93% coverage of the 
primary sequence. It was seen that the protease molecules interact mainly at the N terminal 
scaffolding domain. Protease binding at the N terminal caused stabilization of the entire scaffolding 
domain. These effects were observed almost exactly until the end of the 100 amino acid scaffolding 
domain (Figure 5.2.2).  
These stabilization effects were observed as a decrease in deuterium exchange across almost all 
peptides across the first 100 residues. The main decreases in deuterium exchange were seen at 
residues 5-21 and 22-44 with deuterium exchange protection of almost 2 Da observed.  As mentioned 
earlier, only 120 protease molecules exist in each viral capsid protein while each capsid has more than 
400 capsid protein molecules. There is a vast excess of capsid protein to protease molecules. These 
results are remarkable as 1:4 molar ratio of protease of capsid protein gives almost 2 Da of protection 
at the binding site. It can be postulated that if equimolar ratios of protease to capsid protein exist, the 
deuterium exchange decrease would only be greater. 
5.2.3.2 Conformational stabilization effects caused by protease binding affect distal regions of 
the capsid protein 
While protease binding showed significant decreases at the scaffolding domain, all other regions of 
the protein showed decreased deuterium exchange indicating, protease binding stabilizes the capsid.  
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Certain regions of the protein showed significant (>0.5 Da) decreases in deuteration greater and these 
regions represent the conformational stabilization effects seen upon protease binding.  
Figure 5.2.2: Summary of HDXMS results from HK97 interactions with processing 
protease:Top panel: Mirror plot of the relative deuterium exchange across pepsin digest fragments 
from N to C-terminus. Each plot represents a time point of deuterium labeling (t=30s, 1min, 2min, 
5min, 10min), color coded as indicated. Bottom panel: Difference plot showing the average mass 
difference resulting from deuterium exchange between the two Prohead-1 forms, i.e. protease-free 
minus protease-containing procapsids. Positive differences represent regions that are protected from 
deuterium exchange in presence of the protease.  Regions showing direct binding effects at the 
scaffolding domain are boxed in blue. Regions showing conformational stabilization effects are boxed 
in red.  





Stabilization effects were mainly observed in regions distal to the protease binding site. These regions 
were mostly seen at residues spanning residues 127-149, 215-247, 264-270 and 288-306 (Figure 
5.2.2). These regions are plotted onto, the structure of the hexameric capsid protein in Figure 5.2.3. 
These regions may be distal to each other on the monomeric form of the capsid protein but in the 
hexamer, structure these regions form a contiguous surface. There is the existence of two rings of 
stabilization effects, one ring follows the outer edge of the hexamer and the other effect is 
concentrated at the center of the hexamer. 
 
 
Figure 5.2.3: HDXMS results mapped onto HK97 structures: Structure of the hexameric HK97 
subunit molecule (PDB ID: 3QPR), looking at the hexamer side on (left) and front on (right). This 
structure does not contain the N terminal scaffolding domain. Regions showing significant 
stabilization effects are mapped in red.  
An important observation was of time dependence in deuterium exchange differences. As seen in the 
previous chapter, the binding site shows large differences in deuterium exchange at early time points 
while the allosteric effects show greater changes at later time points. This is an indication that the 
protease molecule follows an fast association/dissociation pattern. The protease molecule is an 
enzymatic molecule which cleaves the scaffolding domain before binding and cleaving its next target. 
In our experiment, the protease molecule is inactive, but it is still capable of binding target domains. 
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The molecule shuttles between the scaffolding domains of the capsid protein, without cleaving the 
scaffolding domains, thus it leads to increased exchange over time at the binding interface, but 
conformational stabilization effects take place at a slower timescale and hence are observed upon 
protease binding.  
5.3 Conclusions  
This chapter focused on deciphering protein dynamics of an partially disordered protein and a viral 
maturation pathway. In both examples, it was seen that a thorough understand of the dynamics of the 
system provided deep insights into the function of the protein. The complexity of the systems studied 
made analysis of the results that much more challenging. But it was seen that parallels could be drawn 
from studies carried out on soluble proteins (explained in earlier chapters) and applied to understand 












6 Concluding Remarks and Future directions 
The aim of my research has been to use protein dynamics information obtained from structural mass 
spectrometry and correlate it with its function. I describe how dynamics plays a key role in the 
activation phase of the cAMP signaling pathway. The dissociation of the PKA holoenzyme is brought 
about by cAMP binding and induces increased dynamics in the regulatory subunit of PKA, this causes 
allosteric effects across the interaction interface to cause increased dynamics at the catalytic subunit. 
In the termination phase of the cAMP signaling pathway, the formation of a transient ternary complex 
was monitored along with ligand release, providing insights into how PDEs mediate release and 
hydrolysis of cAMP from PKA. PDE8A was found to be a mammalian homolog of RegA and found 
to cause the dissociation of cAMP bound to PKA. The interaction interface between PDE8 and PKA 
regulatory domain was also described for the first time and a model for how cAMP termination 
progresses, was provided. HDXMS was subsequently applied to fragment screening and deciphering 
dynamics and function of complex biological systems. 
These results pave the way for future directions to further understand how transient states play a role 
in biological regulation. 
1. Monitoring cAMP mediated dissociation of PKA holoenzyme 
In this study we had used Rp-cAMPS, a cAMP analog which captures the ternary complex in a 
metastable state. HDXMS of the PKA holoenzyme interaction with cAMP can be monitored by 
starting the deuterium exchange reaction along with the addition of cAMP. Real time monitoring of 
cAMP binding and PKA holoenzyme dissociation can provide interesting insights into the processes 
involved in the dissociation of the complex. 
 
2. Interactions between RegA and the PKA regulatory subunit from Dictyostelium 
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Previously described RegA-PKA, were between a Dictyostelium RegA and a mammalian PKA. In this 
study, a model was described for PDE-PKA interactions in a mammalian system. Similar experiments 
can be carried out in proteins from Dictyostelium to confirm whether the proposed model is 
evolutionarily conserved. 
3. Deciphering stoichiometry of the PDE-PKA complex 
In this study we propose a model where the PDE8 dimer binds to the tandem CNB domains of PKAR. 
To experimentally prove the actual stoichiometry of the complex, native mass spectrometry 
techniques can be employed to calculate the overall mass of the complex and its constituent 
components. This will provide detailed insight into the intact complex and confirm our model on 
PDE-PKA interactions. 
4. PDE-PKA interactions occur only in the presence of cAMP 
The sequence of events in the cAMP signaling pathway dictates that PDE-PKA interactions can only 
occur when PKA R is bound to cAMP. As it is the termination phase of the cAMP pathway, PDE 
would only recognize the cAMP bound form of PKA R. While this seems logical, to prove this 
concept, ion mobility mass spectrometry of the complex can be carried out. Ion mobility mass 
spectrometry describes the cross section of a molecule in the microsecond regime, thus complex 
formation and dissociation can be monitored in the presence and absence of cAMP. 
5. HDXMS in fragment screening of membrane proteins 
The sensitivity and robustness of HDXMS, makes this technique ideally suited to be included in the 
fragment screening pipeline. This screening technique can be applied to challenging drug targets 
which are currently inaccessible to traditional structure based fragment screening techniques. While 
membrane proteins are high value drug targets that influence entire signaling pathway, they are 
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